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In glia inward rectifying potassium channels (Kir) are predominantly 
responsible for the high selective membrane permeability to K+, for the 
maintenance of the RMP close to the EK and for the clearance of excess 
K+ released during action potentials by the process of K+ buffering
. 
In this 
study I have investigated the expression, subcellular localisation and 
heteromer forming ability of Kir4.1, Kir5.1 and Kir2.1 subunits in optic 
nerve glia. Immunocytochemistry results demonstrated the expression of 
Kir4.1, Kir5.1 and Kir2.1 subunits in the optic nerve astrocytes and 
oligodendrocytes. I used immunocytochemical approach and Western blot 
analysis of the optic nerve plasma membrane fraction to prove the in vitro 
and in vivo functional expression of Kir4.1, Kir5.1 and Kir2.1 subunits in 
optic nerve glia. As Kir4.1 is known to form heteromeric channels with the 
Kir5.1 and Kir2.1 subunit I investigated the in vivo and in vitro heteromer 
forming ability of these Kir subunits using co-immunoprecipitation and 
immunocytochemistry techniques and found evidence for heteromeric 
Kir4.1/Kir5.1, Kir4.1/Kir2.1 and Kir5.1/Kir2.1 and homomeric Kir4.1 
channels in optic nerve astrocytes and oligodendrocyte. By using shRNA 
and genetic ablation of the Kir4.1 subunit I found that Kir4.1 regulates the 
expression and subcellular localisation of the Kir5.1 and Kir2.1 subunits. 
With Western blot analysis I demonstrated that in the absence of the 
Kir4.1 subunit Kir2.1, Kir6.1 and Na/K ATPase α1, the subunits involved in 
the K+ buffering, compensate for the lack of functional Kir4.1. However, as 
a result of the metabolic stress due to the increased ATP consumption by 
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the Na/K ATPase the mitochondrial fraction and the activity of KATP 
channels were found to be increased in the brain of the Kir4.1 knock out 
mice. The increased expression of Na/K ATPase α1 subunit, known to be 
involved in K+ buffering, in the the absence of the Kir4.1 subunit affirms 
the role of Kir4.1 in K+ buffering. In astrocytes homomeric Kir4.1, Kir2.1 
and heteromeric Kir4.1/Kir2.1, Kir4.1/Kir5.1 channels are believed to be 
involved in K+ buffering and their disfunction has been associated with 
epilepsy.  Heteromeric Kir4.1/Kir5.1 channels are suggested to be involved 
in CO2/H+ chemosensation in the optic nerve. Due to the unique pH 
sensitivity of the Kir4.1/Kir5.1 channel, it has been identified as an 
astrocytic CO2/H+ chemoreceptor in the retrotrapezoid nucleus, associated 
with the control of respiration.  Silent Kir5.1/Kir2.1 channels may regulate 
these processes. As optic nerve oligodendrocytes also express Kir4.1, 
Kir5.1 and Kir2.1 subunits, they may also be involved in K+ buffering 
and/or CO2/H+ chemosensation via these Kir channels, and therefore 
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1.1 Neural Cells in the Central Nervous System 
There are two major classes of neural cells within the central nervous 
system (CNS) - neurons and glia. Both neurons and glia are derived from 
the neuroectoderm and have a common neural stem cell (NSC) lineage – 
hence, they are both neural cells. The defining difference between the two 
cell types is that neurons are able to generate action potentials, whereas 
glia can not. However, not all neurons fire action potentials and even the 
fundamental dogma that glia are electrically inexcitable has recently been 
challenged (Káradóttir et al., 2008). It has been estimated that 90 percent 
of the cells in the human cortex are glial cells, although in most areas of 
the CNS and in lower mammals, there is more likely to be equal number of 
neurons and glia (Verkhratsky and Butt, 2007). In this thesis, I will focus on 
glial cells, which consist of macroglia (ectodermal origin) and microglia 
(mesodermal origin), as described in Figure 1.1. 
The three types of macroglia are the astrocytes, oligodendrocytes and the 
ependymal cells; astrocytes and oligodendrocytes, will be discussed in 
further detail below. The walls of the ventricles in the brain and the central 
canal in the spinal cord are formed by the ependymal cells, hence creating 
a separating layer between the cerebrospinal fluid (CSF) and CNS cellular 
compartments. Ependymal cells are involved in the movement and 
secretion of CSF and in the exchange of substances between the two 
compartments. In contrast to the neural origin macroglia, microglia 
originate from macrophages that invade the brain during early 
development and settle throughout the CNS, hence acting as the first and 
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main form of active immune defense in the CNS. Quiescent microglia are 
capable of activation in response to various kinds of brain injuries and 
infections, and become phagocytic and/or neurotoxic releasing microglia. 
Finally, Schwann cells myelinate peripheral axons and are the principal 
glia of the peripheral nervous system (PNS), corresponding to 
oligodendrocytes in the CNS.  
 
Figure1.1 Types of glia in central and peripheral nervous system 
 
1.1.1  Astrocytes 
Star-like astrocytes, also known as astroglia, are the most abundant and 
diverse glial cells in the CNS. Astrocytes are identified by their expression 
of glial fibrillary acidic protein (GFAP) intermediate filament, which is 
involved in the formation of the cytoskeleton, although not all astrocytes 
express GFAP to the same extent. Several subtypes of astrocytes are 
present in the CNS, including the fibrous and protoplasmic astrocytes, 
respectively located in the white and grey matter. In addition, there are 










adult as specialised Bergmann glia in the cerebellum, and Muller glia in 
the retina. Fibrous and protoplasmic astrocytes are true astrocytes, with 
the classical stellate morphology. Protoplasmic astrocytes have more 
numerous and finer processes than fibrous astrocytes, but both types 
contact the blood vessels with their specialised foot process termed 
perivascular endfeet.  Other small, specialised populations of astrocytes 
are velate and interlaminar astrocytes, tanycytes, pituicytes, perivascular 
and marginal astrocytes (Verkhratskiǐ and Butt, 2007). 
 
Astrocytes play a number of active roles in the brain that are summerised 
in Figure 1.2. During development, radial glia form a scaffold that is vital 
for neuronal migration and brain development (Rakic, 1978); astrocytes 
also regulate neuro-, glio- and synapto-genesis (Doetsch, 2003, Tsai et al., 
2012). Astrocytic endfeet are involved in the establishment of the blood 
brain barrier, and astrocytes are thought to serve as mediators in the 
neuronal regulation of blood flow (Parri and Crunelli, 2003). In addition, 
astroglia are responsible for the metabolic support of the neurons, and for 
the uptake and removal of neuronal transmitters (Simard and Nedergaard, 
2004, Wolburg et al., 2009). One of most important role of the astrocytes is 
the regulation of ion concentrations in the extracellular space, in particular 
H+ ions (pH) and K+ ions (Horio, 2001). Astrocytes also modulate synaptic 
transmission by releasing astroglial neurotransmitters, thus directly 
modulating neuronal activity (Allen and Barres, 2005, Fields and Stevens-
Graham, 2002, Haydon, 2001). 
 Figure 1.2  Number
 
1.1.2  Oligodendrocytes
Oligodendrocytes or oligodendroglia are specialised to insulate axons of 
the CNS by the production of a fatty multilamellar layer termed myelin 
sheath. The main difference between Sc
of the PNS) and oligodendrocytes, is that a single oligodendrocyte can 
myelinate multiple (as many as 50) axons, whereas Schwann cells 
myelinate only one axon. Myelinated axons appear white to the naked 
eye, hence the part
"white matter". Myelination increases the speed of the electrical impulse by 
the saltatory conduction of action potentials at the unmyelinated regions 
called nodes of Ranvier 
correctly (hypomyelination), or failure to maintain the myelin sheath 
 of different functions of astroglia in the CNS. 
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(demyelination), impairs the conduction of signals in the affected nerves 
and often leads to neurological diseases, e.g. the demyelinating CNS 
condition multiple sclerosis. Oligodendrocytes originate from 
oligodendrocyte precursor cells (OPC’s), which can be identified by their 
expression of cell specific surface markers including the platelet derived 
growth factor alpha (PDGFαR) and the NG2 chondroitin sulfate 
proteoglycan (CSPG) (Nishiyama et al., 1996). OPC migrate from the 
subventricular zone (SVZ) to the developing white and gray matter, where 
they differentiate into mature myelinating oligodendrocytes (Boiko and 
Winckler, 2006, Kiernan and Ffrench-Constant, 1993). Hence, proper 
myelination of the CNS requires the proliferation and migration of OPCs, 
and their differentiation into myelinating oligodendrocytes, in response to a 
wide range of signalling pathways. 
 
Figure 1.3 Oligodendrocytes myelinate multiple axons in the CNS, allowing rapid 
saltatory conduction of action potentials at the unmyelinated regions called nodes of 





Figure 1.4 Four step-maturation of neural stem cells towards the oligodendroglial 
lineage. Oligodendrocyte progenitor cells (OPCs), pre-oligodendrocytes, immature 
oligodendrocytes and mature (myelinating) oligodendrocytes can be distinguished by their 
increasingly complex morphology, by their proliferating, migrating and myelinating 
potentials, as well as by their expression of a wide range of well defined markers.Adapted 
from (Buchet and Baron-Van Evercooren, 2009) 
The exact mechanisms underlying these events are not completely 
unravelled, but a number of growth factors, morphological events, 
signalling molecules and transcription factors have been identified (Figure 
1.4) (Boiko and Winckler, 2006, Miron et al., 2011).  
 
1.1.3  NG2 glia 
In 1981 William Stallcup and colleagues identified a new population of 
NG2 expressing cells that did not co-express mature cell specific markers 
for either oligodendrocytes or astrocytes in the adult brain as a possible 
common source of neuron and glia (Stallcup, 1981). During development, 
these cells termed ‘NG2 glia’ give rise to myelinating oligodendrocytes, 
although in the adult CNS 90 % of the NG2 cells are not mitotically active. 
Following an injury or demyelination, however, NG2 glia can become 
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mitotically active and are capable of generating oligodendrocytes, 
astrocytes and possibly neurons (Chekenya and Pilkington, 2002, 
Komitova et al., 2011, Leoni et al., 2009, Stallcup and Huang, 2008 Zhao 
et al., 2009). NG2 cells express receptors specific for the synapses and 
they even form functional synapses with neurons (Bergles et al., 2010, Ge 
et al., 2006, Kukley et al., 2008, Paukert and Bergles, 2006, Sakry et al., 
2011).  
 
1.1.4 Studies on optic nerve glia 
The optic nerve is a typical white matter tract (Bolton and Butt, 2005) that 
is frequently used as a model tissue for studying axon-glial interactions, 
since it is easy to isolate and, does not contain neural cell bodies making it 
anatomically simple. The mammalian optic nerve contains 100 000-1.7 
million axons of retinal ganglion cells, together with the oligodendrocytes, 
astrocytes, NG2-glia and microglia (Butt et al., 2004). Studies on the 
amphibian optic nerve revealed that the depolarisation of the glial 
membrane potential upon neuronal activity is caused by the accumulation 
of K+ in the intercellular clefts (Orkand et al., 1966). Moreover, it was 
established that optic nerve glia cells are characterised with strongly 
negative resting membrane potential (RMP), which demonstrated 
Nernstian sensitivity to extracellular potassium ion concentration ([K+]o). To 
study glial cell physiology within the optic nerve, a popular method is the 
use of immunostaining and confocal microscopy, as this technique is 
suitable for the determination of the subcellular localisation and possibly 
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even the role of ion channels and other proteins identified to expressed by 
glia. Another approach to study physiological events is to measure the 
axonal activity, extracellular ion concentrations, glia cell membrane 
potentials, and electrically evoked compound action potentials (CAP’s) 
within the optic nerve. With these techniques, it was revealed that 
oligodendrocytes in the optic nerve are organised in interfascicular rows of 
five or more cells, while the perinodal processes of astrocytes and NG2 
cells contact the axons at nodes of Ranvier, the only sites of exposed 
axolemma in myelinated axons (Black and Waxman, 1988, Butt et al., 
1999). The extended end foot processes of astrocytes form the glia 
limitans or enseath the blood vessels of the optic nerve vasculature, while 
their primary processes may extend orthogonally and radially, and they 
divide the nerve bundles into smaller compartments called fascicles 
(Figure 1.5). 
 Figure 1.5 Confocal images of rat optic nerve glia, intracellular
rhodamine dextra (a, b), or immunofluorescence labelled with the NG2 anibody (c, d). (a) 
Oligodendrocytes have 5
tongues of the internodal myelin sheath. (b) Astrocyte
perpendicular and parallel to the axonal axis, which terminate in bulbous swellings or end 
feet at the pia and on blood vessels. Primary processes bear fine collaterals and spines 
that contact nodes of Ranvier (see Figure 4). (c, d
cells, with the morphological phenotype of astrocytes, but the antigenic phenotype of 
OPCs. Processes terminate on and extend fine spines to contact nodes of Ranvier (see 
Figure 7). Scale bar, 50
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1.2 Inward Rectifier Potassium channels 
1.2.1 Kir channel subtypes, structure and physiology 
Inward rectifier potassium (Kir) channels pass K+ more easily in the inward 
direction than out of the cell, they are strictly dependant on extracellular 
potassium concentration [K+]o and steeply dependant on the voltage and 
are modulated by intracellular factors and second messengers (Doupnik et 
al., 1995, Hille B, 1992, Isomoto et al., 1997, Nichols and Lopatin, 
1997,Ruppersberg, 2000). The inward rectification results from the voltage 
dependant block of the outward currents by intracellular polyamines and 
ions (predominantly spermine and Mg2+) at potentials positive to the 
equilibrium potential for K+ (EK) (Oliver et al., 2000, Ruppersberg, 2000). 
Hence, Kir channels generate a large inward K+ conductance when the 
RMP is negative to the EK, maintaining the RMP close to the EK.  
 
Figure 1.6 Basic structure of the Kir- and voltage-gated K+ channel subunits: The 
primary structure of the Kir channel subunit (left) in comparison to the primary structure of 
voltage gated K+ channels. Kir subunits possess two transmembrane (TM1 and TM2) 
regions and one pore-forming (H5) loop, voltage-gated K+ (Kv) channel subunits however 
contain six transmembrane (TM1-TM6) regions and one pore forming loop. Adapted from 
(Hiroshi Hibino et al., 2010) 
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Kir channels form tetramers. The basic structure of Kir channel α subunit is 
conserved and comprises of a common motif of two trans-membrane 
domains (TM1 and TM2) connected by an extracellular pore-forming 
region (H5) and cytoplasmic amino (NH2)- and carboxy (COOH)-terminal 
domains (Fig. 1.6). All potassium channels share a common pore structure 
that serves as the K+ ion-selectivity filter. 
 
The most commonly used inhibitors for Kir channels are Ba2+ and Cs+, as 
they effectively block most of the Kir channels in a voltage dependant 
manner (French and Shoukimas, 1985, Hagiwara et al., 1976, Hagiwara et 
al., 1978, Oliver et al., 1998). At low micromolar concentrations, Ba2+ 
specifically blocks Kir channels, but at high concentrations Ba2+ can also 
block voltage gated K+ (Kv) channels (Franchini et al., 2004, Quayle et al., 
1993). The widely used voltage-gated K+ channel blockers 4-
aminopyridine (4-AP) and tetraethylammonium (TEA), however, have little 
effects on Kir channels (Hagiwara et al., 1978, Oonuma et al., 2002).  
 
The 19 Kir subunit genes identified to date are classified on the basis of 
their molecular and electrophysiological properties into seven subfamilies 
(Kir1.0-Kir7.0; Figure 1.7) (Hassinen et al., 2008, Hibino et al., 2010, 
Ruppersberg, 2000, Ryan et al., 2010, Stanfield et al., 2002) . These 
seven Kir channel subfamilies can be further classified into four functional 
groups, namely classical Kir channels, G protein-gated Kir channels, ATP-
sensitive K+ channels and K+-transport channels. 
  
1.2.2 Classical Kir channels
Classical Kir channels,
show strong inward rectification. To date, 6 members of the family have 
been identified, Kir2.1
Kir2.5 and Kir2.6 
very little outward current 
intracellular Mg2+ and polyamine 
primary structure composed of transmembrane and cytoplasmic regions 
and ion selectivity filter are conserved among all Kir2.x subunits. Members 
of the Kir2.x subfamily assemble in tetramers to form functional
Figure 1.7 Evolutionary tree of the inwardly rectifying potassium channel subunits
Amino acid aligment and phyl
Due to their biophysical properties Kir channel are divided into 4 groups.
(Hibino et al., 2010)  
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ric or heteromeric channels in vivo and in vitro, with different biophysical 
properties (Preisig-Müller et al., 2002). The functional expression of Kir2.x 
family members is detected in various different cell types, including 
astrocytes (Li et al., 2001), cardiomyocytes (Melnyk et al., 2002), 
endothelial cells (Yang et al., 2003), neurons (Prüss et al., 2005) and 
skeletal muscle (Ryan et al., 2010). Mutations in the gene (KCNJ2) 
encoding Kir2.1 channel are associated with many channelopathies 
resulting in various cardiac disorders, such as Andersen-Tawil syndrome 
or Long QT 7, which involves more than 30 mutations that suppress Kir2.1 
currents by disrupting the formation of heteromeric assemblies (Donaldson 
et al., 2004, Tristani-Firouzi and Etheridge, 2010) (Figure 1.8). 
 
Figure 1.8 Mutations in the KCNJ2 gene that encodes Kir2.1 subunit are associated with various 
cardiac disorders. Mutations in Kir2.1 subunit represented with black color are associated with 
Anderson-Tawil or long QT7 syndrome (LQT7; black), with red color are associated with 
catecholaminergic polymorphic ventricular tachycardia (CPVT; red), with green color are 
associated with familial atrial fibrillation (FAF; green), and with blue are associated with short 
QT3 syndrome (SQT3; blue). Adapted from http://what-when-how.com website. 
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Kir2.x channels are activated by PIP2 (Xie et al., 2007, Xie et al., 2008), 
and their activity can be modified by kinases. K+ currents associated with 
Kir2.1, Kir2.2, Kir2.3 channels are inhibited upon their phosphorylation by 
PKC, although the suppression of Kir2.1 currents by PKC is controversial, 
whereas Kir2.2 currents are activated by PKA (Henry et al., 1996, Karle et 
al., 2002, Scherer et al., 2007, Zitron et al., 2004, Zhu et al., 1999). 
Members of the Kir2.x family are regulated by several other factors 
including pH; e.g. Kir2.3 is activated by intracellular and extracellular 
alkalisation, whereas Kir2.4 is only activated by extracellular alkalisation. 
The pH sensitivity of Kir2.3 and Kir2.4 is due to a single histidine residue in 
the TM1 to H5 linker region (H117 in Kir2.3, H130 in Kir2.4)(Coulter et al., 
1995, Hughes et al., 2000). A characteristic of the Kir2.2 channel is that 
hypopolarisation decreases the steady-state open probability 
(Po)(Takahashi et al., 1994). 
 
All Kir2.x subunits possess endoplasmic reticulum (ER) export (F-C-Y-E-
N-E C-terminus) (Stockklausner et al., 2001)(D Ma et al., 2001) and Golgi 
export signals (Y-X-X-Ф and [DE]XXXL[LI]) (Hofherr et al., 2005, Ma et al., 
2011). Hence, subsequent to their synthesis, Kir2.x subunits that leave the 
ER are transported to the Golgi apparatus for post-translational 
modification, and due to the Golgi export signal they are sorted to the cell 
surface. Several loss-of-function mutations in Kir2.1 impair trafficking to 
the plasma membrane, including ∆95–98, V302M and ∆314–315 
mutations that are linked to the Long QT 7 syndrome. The surface 
expression of cardiac Kir2.1 subunits is negatively regulated by their Rac1 
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(Rho family GTPase) dependent internalisation (Boyer et al., 2009). The 
internalisation of Kir2.1 and Kir2.3 is mediated by dynamin and clathrin-
dependent endocytosis (Mason et al., 2008).  
 
Members of Kir2.x family are widely expressed by neurons and glia cells in 
the central and peripheral nervous system (Howe et al., 2008, Prüss et al., 
2005). Neural expression of Kir2.1 is detected throughout the brain, but is 
particularly high in the olfactory bulb and superior colliculus (Correia et al., 
2004, Prüss et al., 2005). Kir2.2 is present in several forebrain nuclei, 
hypothalamus, cerebellum, and spinal cord. Kir2.3 is also widely 
expressed by neurons in olfactory bulb, retina, basal ganglia and cortex, 
with particularly intensive expression detected in cerebellar Purkinje 
neurons (L. Chen et al., 2004). Kir2.4 shows widespread distribution 
throughout the brain and most neurons display weak immunopositivity for 
Kir2.4, with highest expression identified in brainstem motoneurons 
(Töpert et al., 1998). The multiple types of Kir2.x subunits expressed by 
neurons assemble as heterotetramers to form functional Kir channels, 
which are believed to be involved in the maintenance of the RMP, 
regulation of neuronal excitability and dendritic morphology (Cazorla et al., 
2012, Falk et al., 2008, Okada and Matsuda, 2008) . Kir2.x currents are 
modulated by various neurotransmitters, most notably via M1 muscarinic 
acetyl choline (Ach) receptors and D2 dopamine receptors (Carr and 
Surmeier, 2007, Cazorla et al., 2012, Shen et al., 2007), which are 
implicated in Parkinson’s disease (Weixing Shen et al., 2007). 
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The expression of the classical Kir channels in neurons is found to be 
limited to perikaryon and dendrites (Inanobe et al., 2002, Prüss et al., 
2005). Kir2.x subunits are localised to specialised membrane 
microdomains in cells, such as the postsynaptic membrane of neurons and 
the basolateral membrane of the renal epithelia (Inanobe et al., 2002, Le 
Maout et al., 2001). The function and direct targeting of the Kir2.x subunits 
is believed to be regulated by the formation of protein-protein interactions 
with the PDZ-domain containing proteins (Leyland and Dart, 2004, Olsen 
et al., 2002); PDZ proteins are known to anchor proteins such as 
glutamate receptors and Kv channels and specifically direct them to the 
postsynaptic sites (Cohen et al., 1996, Craven and Bredt, 1998, Höltje et 
al., 2007, Kim and Sheng, 2004, Wong and Schlichter, 2004). PDZ 
proteins interact with class I PDZ binding motif (X-S/T-X-V/I) containing 
Kir2.x subunits, and so PDZ-proteins are strong candidates for the 
directed targeting of Kir2.x subunits to neuronal postsynaptic membranes 
(Songyang et al., 1997).  
 
Glia cells of the central and peripheral nervous system also express 
various members of the Kir2.x family. The primary role of the classical Kir 
channels in glia is believed to be the clearance of excess potassium from 
the extracellular space released upon neuronal activity, termed K+ 
buffering. Classical Kir channels are strong candidates for K+ buffering, 
due to their biophysical properties (strong inward rectification) and their 
highly regulated subcellular localisation. For instance, Kir2.1 is specifically 
localised to the membrane domains of Müller cells that contact retinal 
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neurons, and the expression of Kir2.1 and Kir2.3 in Schwann cells is 
restricted to the microvilli, which are the specialised membrane domains 
that contact the axonal membrane at nodes of Ranvier (Kofuji et al., 2002, 
Mi et al., 1996). Similarly to neurons, the direct targeting of Kir2.x to the 
specific membrane domains of glia cells is believed to be ascribed to their 
interaction with the PDZ proteins, as Kir2.2 was found to be directly 
associated with PDZ domain containing SAP-97 protein in Bergmann glia 
and other cerebellar astroglia (Leonoudakis et al., 2001). Astrocytes from 
the olfactory bulb and olfactory cortex are also known to express Kir2.1 
under physiological conditions, whereas hippocampal astrocytes only 
express Kir2.1 under pathophysiological conditions, such as epilepsy, 
when the astrocytic expression of Kir2.1 subunit is induced by the 
accumulation of extracellular K+ as a result of neuronal hyperexcitability 
(Howe et al., 2008, Kang et al., 2008). 
 
1.2.3 G protein- regulated Kir channels 
G protein- regulated Kir channels (KG channels) are composed of the 
members of Kir3.x family, including Kir3.1 (GIRK1) (Y. Kubo et al., 1993), 
Kir3.2 (GIRK2) (C T Bond et al., 1995), Kir3.3 (GIRK3) (Dissmann et al., 
1996), Kir3.4 (GIRK4/CIR) (Spauschus et al., 1996) and Kir3.5 (XIR) 
subunits (Hedin et al., 1996). G protein-gated Kir channels can be 
activated by wide range of G protein coupled receptors (GPCR), including 
the M1-4-muscarinic, A1-adenosine, α2-adrenergic, D2-dopamine, µ- δ-, and 
κ-opioid, 5-HT1A serotonin, somatostatin, galanin, m-Glu, GABAB, GABAB2, 
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Ox1R, Ox2R and sphingosine-1-phosphate receptors (Hoang et al., 2003, 
Leaney et al., 2001, Uezono et al., 2006, Yamada et al., 1998). Upon the 
binding of their ligand, GPCRs activate a G protein, that is comprised of 
three subunits (α, β, γ), but only the Gβγ subunit can activate the GIRK 
channels, by binding to their cytoplasmic region (Figure 1.9) (Clapham and 
Neer, 1993, Kofuji et al., 1995, Raveh et al., 2009, Sadja and Reuveny, 
2009). Gβγ further controls the activity of the KG channels by regulating 
their affinity for PIP2 binding, as KG channels, like other Kir channels, 
require PIP2 to maintain their activity (Huang et al., 1998). 
 
Figure 1.9 The GIRK channel signaling complex with its modulatory pathways: 
GIRK channels are gated upon the activation of GPCRs that are linked to (Gi/o) type G 
proteins which release Gβγ dimers to directly stimulate the channel activity by stabilizing 
interactions between PIP2 and the GIRK channel. In contrast, GIRK channels are inhibited 
by the activation of GPCRs that are coupled with Gq-type G proteins as they stimulate the 
phospholipase C (PLC) activity, which breaks down PIP2.The activity of the GIRK channel 
is also increased upon the activation of GPCRs that are coupled to Gαs-type G proteins 




KG channels are strong inward rectifying channels inhibited by intracellular 
acidosis, membrane stretching and activated by small redox agent 
dithiothreitol (DTT) (Ji et al., 1998, Mao et al., 2003, Zeidner et al., 2001,). 
Physiologically, cardiac KG channels may play an important role in atrial 
volume-sensing, as their activity is inhibited by the mechanical stretch of 
the atrial myocyte membrane, hence they were identified as the first 
stretch inactivated mechanosensitive potassium channel (Ji et al., 1998). 
The mechanosensitivity of the KG  channels is mediated by the interaction 
of the channel with the PIP2, which is modulated by the activity of PKC 
(Zhang et al., 2004).  
 
Functional G protein-gated Kir channels are formed by the homomeric or 
heteromeric assembly of four Kir3.x subunits (Krapivinsky et al., 1995). 
Due to the tissue and cell specific expression of the different Kir3.x 
subunits and their ability to form diverse native heteromeric KG channels, 
G protein-gated Kir channels play important role in diverse physiological 
events, such as the regulation of heart rate and neuronal excitability 
(Krapivinsky et al., 1995, Signorini et al., 1997). Although Kir3.1 do not 
form native functional homomeric channels (Corey et al., 1998), their 
assembly with Kir3.2, Kir3.3, Kir3.4 or Kir3.5 subunits results in functional 
heteromeric KG channels with different channel properties (Hedin et al., 
1996, Hou et al., 1999). When Kir3.1 or Kir3.3 subunits are expressed 
alone in heterologous systems, they remain in the ER compartment, 
whereas homomeric channels composed of Kir3.2 or Kir3.4 subunits are 
efficiently transported to the cell surface (Kennedy et al., 1999, Ma et al., 
43 
 
2002). There is also evidence for functional Kir3.2/Kir3.3 and Kir3.2/Kir3.4 
heteromeric channels in the brain (Aguado et al., 2008, Duprat et al., 
1995, Jelacic et al., 2000). In the brain, GIRK channels are involved in 
setting the RMP and in the regulation of neuronal excitability (Ehrengruber 
et al., 1997, Torrecilla et al., 2002). Abnormal function of Kir3.2 have been 
implicated in numerous pathophysiological conditions, such as epilepsy, 
Down's syndrome, Parkinson's disease, drug and alcohol addiction 
(Lüscher and Paul A Slesinger, 2010).  
1.2.4 ATP-sensitive K+ channels 
ATP-sensitive K+ channels (KATP) are functional octamers, composed of 
four Kir6.x subunits and four sulfonylurea receptors, SURx (Inagaki et al., 
1995). So far, three different Kir6.x channel subunits have been identified, 
Kir6.1/uKATP-1 (Inagaki et al., 1995), Kir6.2/ BIR (Inagaki et al., 1995), 
and Kir6.3 (C. Zhang et al., 2006), known to form the ion channel pore, 
and three different sulfonylurea receptors, SUR1, SUR2A and SUR2B, 
forming the auxiliary subunit of the KATP channels. KATP channels directly 
couple the metabolic state of a cell to its excitability, as they are inhibited 
by ATPi, except in smooth muscle, and activated by nucleoside 
diphosphates, such as ADP (Ashcroft, 1988, Terzic et al., 1995). The 
activity of KATP channels is stimulated by PKA or PKC mediated 
phosphorylation (Béguin et al., 1999, Light et al., 2000). Although 
functional ATP-sensitive potassium channels were identified on various 
subcellular membranes, including the sarcolemma ("sarcKATP"), inner 
mitochondrial (mitoKATP"), and nuclear membranes ("nucKATP") (Hu et al., 
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1999, Inoue et al., 1991, Quesada et al., 2002), the phosphorylation of 
KATP channels via GPCR mediated PKA signaling pathways increases only 
the surface expression and activity of sarcolemmal KATP channels, while 
the PKC mediated phosphorylation of KATP channels enhances the 
mitochondrial import and activity of mito KATP channels (Béguin et al., 
1999, Garg and Hu, 2007). Electrophysiological studies demonstrated the 
presence of mitochondrial KATP channels in the liver, heart and brain 
(Lacza et al., 2003, Szewczyk, 1996). Native KATP channels were also 
identified in a wide range of cells including cardiac myocytes (Noma, 
1983), pancreatic-cells (Ashcroft et al., 1984, Cook and Hales, 1984), 
skeletal muscle (Spruce et al., 1985), vascular smooth muscle (Standen et 
al., 1989), neuronal cells (Ashford et al., 1988), kidney cells (Russ et al., 
1999), and hepatocytes (Nakagawa et al., 2012).Under physiological and 
pathological conditions, an important feature of the KATP channels is the 
mechanosensitive modulation of their gating (Van Wagoner, 1993). In 
general, the actin filament network plays an important role in the 
transmission of the mechanical stress to cellular responses, and the 
disruption of the actin cytoskeleton enchances the opening of the KATP 
channels (Terzic and Kurachi, 1996, Yokoshiki et al., 1997). Moreover, the 
mechanosensitive modulation of the atrial KATP channels is attenuated by 
ischemia (Van Wagoner and Lamorgese, 1994). KATP channels are 
markedly activated by hypoxia and proved to have a protective role during 
stroke and ischemic attacks (Ballanyi, 2004, Melamed-Frank et al., 2001). 
The activation of KATP currents by hypoxia, induces the hyperpolarisation 
of cardiomyocyte and neuronal membranes, which reduces Ca2+ influx via 
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the voltage gated Ca2+ channels (Ballanyi, 2004, Quayle et al., 2006, 
Yamada and Inagaki, 2005). Furthermore, it was demonstrated in 
hippocampal CA1 neurons that the activation of KATP channels protects 
them from hypoxic-ischemic insults by suppressing the expression of p53 
(L. Huang et al., 2006). The activation of KATP channels in other organs, 
such as kidney and liver, also has protective effects against ischemia 
(Tawfik et al., 2009, Tkachenko et al., 2004). However, only the activation 
of the mitochondrial mitoKATP channels proved to be able to provide 
protection against ischemia induced injuries (McCully and Levitsky, 2003, 
Mironova et al., 2011, Wang et al., 2011). Inhibitors of KATP channels were 
found to strengthen the neuroprotective activity of microglia, therefore they 
may also be used to reduce stroke induced CNS injuries (Ortega et al., 
2012).  
 
1.2.5 K+-transport channels 
K+-transport channels include inwardly rectifying K+ channel Kir1.1 
(ROMK1/KAB-1), Kir4.1 (KAB-2/BIR10); Kir4.2 (IRKK/KIR1.3), Kir5.1 




The first member of this family, Kir1.1, also known as renal outer 
medullary K+ channel (ROMK), was identified as an ATP-dependent 
potassium channel subunit cloned from the rat kidney (Ho et al., 1993). 
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Since then, 6 different alternative splice variants of Kir1.1/ROMK have 
been identified, designated as ROMK1-6 (Kondo et al., 1996, Shuck et al., 
1994). These Kir1.1 subunits  known to form the functional homotetrameric 
Kir1.1 channels are responsible for the small conductance K+ currents 
(SK) in the thick ascending limb (TAL) and cortical collecting duct (CCD) 
segments of the kidney nephrons (Palmer et al., 1997, Lu et al., 2002), 
however recently it was proposed that Kir1.1 subunits also form 
heteromeric channels that contribute to the 70 ps K+ currents of the apical 
membrane of the TAL (Lu et al., 2004). Under basal conditions, Kir1.1 
channels have an important physiological role in K+ secretion and 
regulation of the membrane potential of the connecting tubule (CT) and 
CCD cells, in addition to K+ recycling in the TAL (Palmer et al., 1997, 
Wang, 2005). The role of Kir1.1 in the K+ recycling is to supply enough 
extracellular K+ to permit the continuous operation of the Na+-K+-2Cl- 
cotransporter (NKCC2), and therefore sufficient reabsorbtion of Na+ 
(Figure 1.10) (Hebert et al., 2005). The reabsorption of Na+ at the apical 
membrane by NKCC provides sufficient intracellular Na+ to sustain the 
activity of Na+/K+-ATPase at the basolateral membrane, and thereforethe 
transepithelial transport of Na+. Kir1.1 channels by hyperpolarising the 
membrane potential of TAL cells also accelerate the diffusion of Cl− across 
the basolateral membrane. The combined activities of apical Kir1.1 and 
basolateral CLC-K2 channels generate the lumen- positive transepithelial 
potential that is the main driving force for paracellular Na+, Ca2+, and Mg2+ 




Figure 1.10 Location and function of Kir1.1/ROMK channels in the TAL and CCD 
nephron segments. Kir1.1 channel were localised to the apical membrane of the CCD 
and TAL nephron segment and proved to have critical role in the K+ secretion and 
regulation of the membrane potential of the CCD cells furthermore in the K+ recycling of 
the TAL. Adapted from (Wen-Hui Wang et al., 2002) 
The importance of Kir1.1 in K+ recycling and renal physiology was 
unambiguously demonstrated in Kir1.1 deficient mice and Bartter`s 
syndrome. Kir1.1 deficient mice were characterised with hydronephrosis, 
dehydration, premature death and salt wasting phenotype that resembled 
Bartter`s syndrome (Lorenz et al., 2002, Lu et al., 2002). Notably, weak 
inward rectifying Kir1.1 channels exhibit sensitivity to intracellular but not 
extracellular pH (Tsai et al., 1995). Hence, Kir1.1 channels represent a link 
between K+ homeostasis and pH control (Doi et al., 1996), confirmed by 
loss of function mutations of the Kir1.1 gene in type II Bartter`s syndrome, 
which results in hypokalemic alkalosis (Amirlak and Dawson, 2000, Simon 
et al., 1996).  
 
In the brain, Kir1.1 has been localised with Kir2.3 and Kir4.1/Kir5.1 to cell 
bodies of neurons and glial cells in the chemosensory areas of the 




The subcellular localisation of Kir1.1 channels is regulated by 
phosphorylation via PKA or SGK (serum- and glucocorticoid-inducible 
kinase), which overrides a C- terminal ER retention signal (O’Connell et 
al., 2005, Yoo et al., 2003). PKA mediated phosphorylation augments the 
surface expression, hence activity, of Kir1.1 channels by enhancing the 
PIP2-channel interaction (Liou et al., 1999). This PKA-mediated activation 
of Kir1.1 currents is regulated by a Cl- channel entitled as cystic fibrosis 
transmembrane regulator, CFTR (Lu et al., 2006). Aldosterone induced 
SGK-1 kinase stimulates the surface expression of the Kir1.1 channel by 
the direct phosphorylation of the Kir1.1 channel (D. Yoo et al., 2003) and 
by preventing the clatherin dependant endocytosis of the Kir1.1 together 
with the Na+/H+ exchange regulatory factor (NHERF2) and CFTR (Ring et 
al., 2007, Yoo et al., 2004, Yun et al., 2002). 
 
For many years the composition of mitoKATP channels was controversial, 
but very recently the Kir1.1b subunit was identified as the pore forming 
component of the mitoKATP channels that have a crucial role in the 
protection of cells from the ischemia induced hypoxic injuries (Foster et al., 
2012, Rines et al., 2012). Interestingly, the same alternative splice variant, 
Kir1.1b, that constitutes the mitoKATPs was found to interact with the KATP 
channel subunit SUR2B, as it lacks the N terminal extension (Tanemoto et 
al., 2000). However, the other alternative splice forms of Kir1.1, Kir1.1a 
and Kir1.1c, possessing the N-terminal extension, were found to be unable 
to interact with SUR2B (Dong et al., 2001).  
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Kir4.1 and Kir5.1 
The ATP dependent inward rectifying channel Kir4.1 (also known as 
Kir1.2, BIR10, BIRK-1, KAB-2), was first identified in the brain as it is 
predominantly expressed in glial cells of the CNS (Takumi et al., 1995). 
Kir4.1 is believed to have a critical role in setting the glial membrane 
potential and in the clearance of excess potassium via the process of K+ 
spatial buffering (Chever et al., 2010, Djukic et al., 2007, Neusch et al., 
2006). Kir4.1 subunits form homo- or heteromeric tetramers (Pessia et al., 
1996, Shuck et al., 1997, Yang et al., 1995). There is evidence for the 
existence of native homomeric Kir4.1 channels, but in the kidney and 
brain, Kir4.1 co-assemble with Kir5.1 to form functional pH sensitive K+ 
channels (Hibino et al., 2004, Tanemoto et al., 2000). The co-assembly of 
Kir4.1 with Kir5.1 alters the biophysical properties and the pH sensitivity of 
the channel (Tanemoto et al., 2004a), as the single conductance of 
homomeric Kir4.1 channel ranges between 12-27.2 pS with a pKa value of 
~6, while the single conductance of the Kir4.1/Kir5.1 heteromeric channel 
ranges between 43-59.2 pS with a pKa value of 7.45 (Pessia et al., 
1996,Tanemoto et al., 2000, Yang et al., 2000). Moreover, the co-
assembly with Kir4.1 alters the subcellular localisation of Kir5.1, with 
homomeric Kir5.1 channels displaying intracellular localisation, whilst 
Kir4.1/Kir5.1 heteromeric (and Kir4.1 homomeric) channels are targeted to 
the membrane, due to the phosphorylation dependent interaction between 
the C-terminal PDZ binding motif of the Kir4.1 subunit and the PDZ protein 
membrane-associated guanylate kinase (MAGI-1a long isoform) 
(Tanemoto et al., 2004, Tanemoto et al., 2008). Kir4.1/Kir5.1 heteromeric 
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channels are the major component of the basolateral K+ conductance in 
the TAL, distal convoluted tubule (DCT) and CCD segments of the kidney 
(Lachheb et al., 2008). However, due to their unique sensitivity to 
intracellular pH alterations Kir4.1/Kir5.1 channels can also detect CO2 
changes at physiological pH levels and are implicated in neuronal and 
astroglial central CO2 chemoreception (Cui et al., 2001, D’Adamo et al., 
2011, Mulkey and Wenker, 2011, Wu et al., 2004).  
 
Homomeric Kir4.1 channels are known to be essential for the regulation of 
acid secretion in gastric parietal cells (Song et al., 2011). In parietal cells 
and intermediate cells of the cochlear stria vascularis, homomeric Kir4.1 
channels are sorted to the apical membrane (Ando and Takeuchi, 1999, 
Fujita et al., 2002). The subcellular localisation and the close association 
of the Kir4.1 channels with the H+/K+-ATPase in parietal cells suggests 
that they help providing the extracellular K+ to maintain the activity of the 
H+/K+-pump (Fujita et al., 2002, Kaufhold et al., 2008). In astrocytes, Kir4.1 
channels are associated with Na+/K+-ATPase, as the part of the 
dystrophin-associated protein complex (DAPC) that includes Na+/K+ 
ATPase, Kir4.1, syntrophin, aquaporin-4 and other proteins involved in the 
control of intracellular osmotic conditions and volume regulation in 
astrocytes (Boor et al., 2007, Brignone et al., 2011, Lanciotti et al., 2012), 
indicating K+ and the water homeostasis in the brain is functionally 
coupled by the astrocytes (Guadagno and Moukhles, 2004, Hibino and 
Kurachi, 2007). It was demonstrated that in the specialised astrocytes of 
the retina, called Müller glia, the homomeric Kir4.1 channels are 
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expressed at their perivascular end feet and are clustered by the 
dystrophin-associated protein complex, while the heteromeric Kir4.1/Kir5.1 
channel are localised to the perisynaptic processes and are not clustered 
by the DAPC (Connors and Kofuji, 2002, Fort et al., 2008, Ishii et al., 
2003). Heteromeric Kir4.1/Kir5.1 channels might be clustered by PDZ 
proteins, since PSD-95 and CIPP PDZ domain containing proteins were 
both shown to cluster Kir4.1 channels, furthermore PSD-95 protein is 
expressed in PNS glia and is known to cluster and mediate the functional 
expression of the Kir5.1 channels (Horio et al., 1997, Kurschner et al., 
1998,  Shen et al., 2008, Tanemoto et al., 2002). Kir2.1, which also form 
heteromeric channels with Kir4.1 subunit, was also found to be localised to 
the perisynaptic processes of Müller cells, similarly to Kir4.1/Kir5.1 
channels, and it is believed that homomeric Kir2.1 and Kir4.1/Kir2.1 
heteromeric channels contribute to the K+ clearance (Fakler et al., 1996, 
Kofuji et al., 2002). In contrast to Müller cells, in cortical astrocytes 
homomeric Kir4.1 channels are localised to perisynaptic sites, whereas 
Kir4.1/Kir5.1 heteromeric channels were identified at both perisynaptic and 
perivascular sites (Hibino et al., 2004). However, the assembly of the 
Kir4.1 with other Kir subunits does not always leads to the formation of 
viable channels, as the Kir3.0 subunits are known to inhibit Kir4.1 currents 
by mediating the degradation of the channels (Tucker et al., 1996).  
 
Homo- and heteromeric Kir4.1 channels are differently regulated therefore 
they may have different roles. The channel regulators serotonin (5-HT), 
substance-P (SP), and thyrotropin releasing hormone (TRH), were found 
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to suppress the activity of Kir4.1/Kir5.1, but not the activity of homomeric 
Kir4.1 channels, in the respiratory centre, via PKC and G-protein coupled 
receptors (Rojas et al., 2007, Rojas et al., 2008). Furthermore, glutathione 
disulfide (GSSG) was also found to suppress the function of the 
Kir4.1/Kir5.1 channels during oxidative stress (Jin et al., 2012), whereas 
Na+, by increasing the sensitivity of the channels to PIP2, enhances the 
activity of Kir4.1/Kir5.1, but not Kir4.1 homomeric channels (Rosenhouse-
Dantsker et al., 2008). Homomeric Kir4.1 currents, on the other hand, 
were found to be inhibited by tricyclic antidepressants, such as fluoxetine, 
sertraline, fluvoxamine, amitriptyline, desipramine, nortriptyline and 
imipramine, suggesting they could be used as a therapeutic treatment for 
conditions associated with the gain of function mutations in the Kir4.1 
gene, such as autism accompanied with epilepsy and intellectual disability 
(Ohno et al., 2007, Sicca et al., 2011, Su et al., 2007). In contrast to Kir4.1, 
Kir5.1 homomeric channels were thought to be nonfunctional, however 
their co-expression with PSD-95 leads to the successful surface and 
functional expression of Kir5.1 homomeric channels that were found to be 
inhibited upon PKA mediated phosphorylation (Masayuki Tanemoto et al., 
2002).  
 
Like Kir4.1, Kir4.2 subunits also form functional homo- or heterotetrameric 
channels, but Kir4.2 does not include the ATP binding motif that is present 
in the Kir4.1 and Kir1.1 subunits (Pearson et al., 1999, Shuck et al., 1997). 
Homomeric Kir4.2 channels and the heteromeric channel formed by 
assembly of the Kir5.1 and Kir4.2 subunits, exhibit extreme pH sensitivity 
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and are believed to be involved in the pH-dependent regulation of K+ 
fluxes (M Pessia et al., 2001) in the kidney, liver, skeletal muscle and 
microvascular endothelial cells, where Kir4.2 expression has been 
reported (deHart et al., 2008, Gosset et al., 1997, Pearson et al., 1999, 
Shuck et al., 1997). Kir4.2 also have been shown to increase the migration 
of glioblastoma cells as α9β1 integrin by binding to the 
spermidine/spermine acetyltransferase (SSAT), that augments the 
catabolism of spermine and/or spermidine, inhibitors of Kir4.2 channel, 
enhances the migration of the glioblastoma cells specifically via the Kir4.2 
channel (deHart et al., 2008, Veeravalli et al., 2012). Moreover, Kir4.2, 
similarly to the Kir3.2 gene, is localised to the Down-syndrome 
Chromosome region 1, a 2.5 Mb region at the chromosome 21 thought to 
be essential for the main phenotypic characteristics of Down syndrome, 
suggesting that Kir4.2 may contribute to a range of mental and functional 
disabilities associated with this disease (Gosset et al., 1997, Ohira et al., 
1997). 
 
The loss of function mutations in the Kir4.1 gene, on the other hand, are 
associated with human EAST/SeSAME syndrome, characterised by 
seizures, sensorineural deafness, ataxia, mental retardation, and 
electrolyte imbalance, including salt wasting and hypokalemic alkalosis 
(Reichold et al., 2010, Scholl et al., 2009). Some mutations in KCNJ10, the 
gene encoding the Kir4.1 subunit, such as R65P, T164I, R175Q, R297C, 
cause an alkaline shift in the pH sensitivity, whereas others like G77R, 
C170R, A167V and A167V/R297C, affect the surface expression of the 
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channel, or as the R199Stop, lead to the premature termination of the 
Kir4.1 protein (Reichold et al., 2010, Sala-Rabanal et al., 2010, Williams et 
al., 2010). However, all the mutant channels are rescued upon the co-
expression with intact Kir4.1 subunits. It was also demonstrated that the 
different mutations in the KCNJ10 gene associated with SeSAME 
syndrome cause a variable loss in Kir4.1 function (Tang et al., 2010). 
Moreover, homozygous T57I, R65P, G77R, C140R, T164I and compound 
heterozygous A167V/R297C, R65P/R199Stop mutations were also 
identified in patients with SeSAME syndrome (Sala-Rabanal et al., 2010, 
Scholl et al., 2012). Mice lacking functional Kir4.1 channels exhibited a 
very similar phenotype to human SeSAME syndrome, with seizures, 
sensorineural deafness, Na+ wasting, premature death, vision 
abnormalities, ataxia initiated by axonal swelling and hypomyelination 
(Marcus et al., 2002, Neusch et al., 2001). Oligodendrocytes in the Kir4.1 
knock out mice displayed immature morphology and depolarised 
membrane potential (Neusch et al., 2001) whereas the targeted glial 
ablation of the Kir4.1 resulted in inhibition of K+ and glutamate uptake of 
the astrocytes, depolarisation of the glial membrane potential and 
enhanced short-term synaptic potentiation (Chever et al., 2010, Djukic et 
al., 2007). In contrast, genetic deletion of the Kir5.1 subunit resulted in an 
impaired response of locus coeruleus neurons to hypercapnic acidosis and 
in a renal phenotype characterised by hypokalemia, hypercalciuria and 
hyperchloremia adjacent to metabolic acidosis, different to what was 
identified in the patients with SeSAME syndrome (D’Adamo et al., 2011, 





Kir7.1 channels display very unique pore properties, as unlike other Kir 
channels, they exhibit very low single channel conductance (50 fS), no 
dependence on external K+ and low sensitivity to external Ba 2+ and Cs+ 
(Döring et al., 1998, Krapivinsky et al., 1998). These unique properties of 
the Kir7.1 channel are ascribed to a single amino acid, methionine at 
position 125, localised in the pore region, whereas in the other Kir subunits 
arginine is highly conserved in this position. The replacement of the 
methionine at the position 125 to arginine, dramatically increased the 
single conductance and restored the sensitivity of the channel to Ba2+ and 
external K+ (Döring et al., 1998, Krapivinsky et al., 1998). Similar to the 
other Kir subunits, Kir7.1 currents are also sensitive to the PIP2 content of 
the membrane, and therefore neomycin, a PIP2 scavanger, 
phosphatidylinositol (PI) kinase (quercetin, phenylarsine oxide and 
wortmannin), PI3 kinase (LY-294002, LY-3035110), and PI4 kinase 
inhibitors, were found to suppress Kir7.1 currents (Pattnaik and Bret A 
Hughes, 2009). The activity of Kir7.1 channels is also regulated by 
phosphorylation, as it was found that Kir7.1 currents are increased by PKA 
mediated phosphorylation and decreased by PKC mediated 
phosphorylation (Zhang et al., 2008). Moreover, Kir7.1 currents exhibit 
sensitivity to extracellular and intracellular pH, as they are suppressed by 
the acidification of the extracellular pH, whereas intracellular pH modulates 
channel activity in a biphasic manner, as the maximum activity of the 
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channel is observed at pHi 7.0, and the currents are attenuated by either 
acidification or alkalinisation of the intracellular pH (Hughes and 
Swaminathan, 2008). 
 
The expression of Kir7.1 has been detected in the epithelial cells of the 
kidney, retina, gastric mucosa, small intestine and choroid plexus, as well 
as in the follicular cells of the thyroid (Fujita et al., 2002, Kusaka et al., 
2001, Nakamura et al., 1999). In the epithelial cells of the choroid plexus 
and retina, Kir7.1 protein was found to be expressed at the apical 
membrane, whereas in the follicular cells of the thyroid and epithelial cells 
of small intestine, DCT, proximal tubule, and collecting duct, Kir7.1 is 
sorted to the basolateral membrane. Moreover, Kir7.1 was found to co-
localize with the Na+/K+ ATPase in the thyroid follicular cells and small 
intestine, DCT and collecting duct epithelium at the basolateral membrane, 
and it was proposed that Kir7.1 is functionally coupled with the Na+/K+ 
ATPase and is involved in K+ recycling (Derst et al., 2001, Kusaka et al., 
2001, Ookata et al., 2000). Furthermore, it was demonstrated that the C-
terminal length of the Kir7.1 is an important determinant in the plasma-
membrane localisation of the Kir7.1 channel (Tateno et al., 2006). 
 
Electrophysiological experiments also identified Kir7.1 channel as the 
major component of the K+ conductance in the apical membrane of the 
retinal pigment epithelium (RPE) (Shimura et al., 2001). Moreover, Kir7.1 
is believed to be involved in the development of the retina, as mutations in 
KCNJ13, the gene encoding the Kir7.1 subunit, are associated with the 
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hereditary eye disorders Leber congenital amaurosis and snowflake 
vitreoretinal degeneration. Leber congenital amaurosis (LCA) is a 
condition characterised by early onset of visual loss, impaired retinal 
development and progressive retinal degeneration, caused by 
homozygous mutations of the Kir7.1 gene at positions R166X or L241P 
(Sergouniotis et al., 2011), whereas heterozygous mutation in the Kir7.1 
gene at position R162W is associated with snowflake vitreoretinal 
degeneration, characterised by fibrillar degeneration of the vitreous humor, 
early-onset cataract, minute crystalline deposits in the neurosensory retina 
and detachment of retina (Hejtmancik et al., 2008). Kir7.1 is also involved 
in the regulation of melanosome movement, as mutation in the Kir7.1 gene 
alters the distribution of pigment cells in the zebrafish (Iwashita et al., 
2006). Finally, Kir7.1 protein was also identified as a novel specific 
diagnostic marker for choroid plexus tumors (Hasselblatt et al., 2006, 
Schittenhelm et al., 2012).  
 
1.2.6 Glial Kir channels and [K+]o regulation 
Glial cells express a range of K+ channels including inwardly rectifying K 
channels (Kir), Ca2+ -activated K channels (KCa) and voltage-gated K 
channels represented by voltage activated delayed rectifier channels K 
(Kdr) and voltage inactivated K channels (KA). These have been reviewed 
in depth (Verkhratsky and C Steinhäuser, 2000), and here I will focus on 
glial Kir, which are the subject of this thesis. 
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The presence of Kir channels on the glial cells was first indicated by 
Orkand and colleagues, as they suggested that the accumulated K+ in the 
intercellular cleft upon the stimulation of the amphibian optic nerve is being 
taken up by glia at the sites of high [K+]o and is released at sites of low 
[K+]o by electrically coupled glia, via the process of K+ buffering (R K 
Orkand et al., 1966). Since then, studies determined the involvement of 
Kir4.1 and other Kir channels in K+ buffering by astrocytes (Fig. 1.11) 
(Chever et al., 2010, Neusch et al., 2006). In Müller glia, the Kir subunits 
implicated in the regulation of extracellular K+ exhibit highly localised 
expression as Kir4.1, Kir5.1 and Kir2.1 channel subunits were found to be 
expressed at the perisynaptic processes, whereas at the perivascular 
endfeet only the expression of the Kir4.1 subunit was detected (Kofuji et 
al., 2002, Ishii et al., 2003). Due to this highly localised expression and the 
distinct rectifying properties of the different Kir channels, it is believed that 
the K+ released during neuronal activity is taken up via strongly rectifying 
Kir4.1/Kir5.1 heteromeric and Kir2.1 homomeric channels at the 
perisynaptic sites and released via weakly rectifying Kir4.1 homomeric 




Figure 1.11 A model of K+ spatial buffering. Potassium released during action 
potential propagation is taken up by astrocytes processes at nodes of Ranvier and 
synapses via strongly rectifying Kir channels, both homomeric Kir2.1 channels and 
heteromeric Kir4.1/2.1 and Kir4.1/Kir5.1 channels (1). Potassium is extruded from glia at 
sites of low K+activity via weakly rectifying Kir4.1 homomeric channels (2). The astroglial 
syncytium contains a mixture of astrocytes with strongly negative and weakly negative 
RMPs. The strict dependence of Kir on both voltage and [K+]o facilitates K+ uptake into 
astrocytes with a strongly negative RMP at sites of high [K+]o (1) and, following 
redistribution via gap junctions to astrocytes with weakly negative RMPs (3), facilitates 
the release of K+ at sites of low [K+]o (4). Adapted from (Butt and Kalsi, 2006). 
 
In addition to the Kir channels, Na+/K+ ATPase also has an important role 
in the regulation of the extracellular K+, as it is involved in setting the 
baseline [K+]o levels, determining the rate of the rapid post-stimulus 
recovery and the subsequent undershoot, while Kir channels are involved 
in the regulation of the baseline levels of [K+]o, in decreasing the amplitude 
of the post-activity undershoot and the subsequent slow recovery of [K+]o 
(D’Ambrosio et al., 2002, Bay and Butt, 2012). In retinal Müller cells Kir4.1 
and Na+/K+ ATPase, responsible for K+ homeostasis, and AQP4, involved 
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in water homeostasis, were all found to be clustered by the same 
dystrophin-associated protein complex (DAPC), suggesting that the 
regulation of the K+ and water homeostasis is coupled in astrocytes 
(Brignone et al., 2011, Connors and Kofuji, 2002, Fort et al., 2008). 
Interestingly, studies in the kidney identify that K+ transport requires both 
strongly rectifying and weakly rectifying Kir channels. In the cortical 
collecting duct (CCD) of the nephron, K+ enters from the blood via Na+/K+-
ATPase and strong inward rectifying Kir2.3 at the basolateral membrane, 
and is secreted into the lumen through weak inward rectifying Kir1.1 and 
large conductance Ca2+-activated big-conductance K (BK) channels at the 
apical membrane (Frindt and Palmer, 1989, Le Maout et al., 1997, Li et al., 
2006). Physiologically, astrocytes take up the excess potassium during 
neuronal activity and release it close to blood vessels, resulting in a mild 
increase in the [K+]o surrounding the smooth muscle cells (Hammond, 
2008). Notably, vascular endothelial and smooth muscle cells express 
classical Kir channels (Adams and Hill, 2004, Fang et al., 2005, Nilius and 
Droogmans, 2001), which are activated by raised perivascular K+ released 
from astrocytes (Filosa et al., 2006). Kir2.1 and Kir2.4 in the vascular 
smooth muscle cells, are recognised to be involved in the vasodilatation in 
response to an increase in [K+]o (Bradley et al., 1999, Tennant et al., 
2006). Increased Kir conductance upon a mild elevation in the [K+]o (from 
6 to 15 mM) results in the hyperpolarisation of the arterial smooth muscle 
membranes (from -45mV to -60mV) and dilation of cerebral and coronary 
arteries (Knot et al., 1996, McCarron and Halpern, 1990, Nelson et al., 
1995). This vasodilation is mediated by hyperpolarisation induced closing 
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of voltage-gated Ca2+ channels, hence reducing [Ca2+]I (Knot and M T 
Nelson, 1998). 
 
As they are clustered by the same complex, it was demonstrated that loss 
of Kir4.1 or AQP4 members of the DAPC, results in the partial disruption of 
the whole dystrophin-associated protein complex (Heuser et al., 2012). 
Therefore, mutations in the genes encoding Kir4.1 subunit and AQP4 are 
both associated with mesial temporal lobe epilepsy with hippocampal 
sclerosis, due to the accumulation of the extracellular K+ that alters 
neuronal excitability in the absence of functional Kir4.1 (Heuser et al., 
2010). Moreover, the loss of functional Kir4.1 subunits was also found to 
enhance the sensitivity, while the gain of function of Kir4.1 decreased the 
sensitivity of astrocytes to hypoosmotic stress, confirming the functional 
coupling of the K+ and water homeostasis by astrocytes (Dibaj et al., 2007, 
Obara-Michlewska et al., 2010). However, during spinal cord injury, or 
conditions such as amyotrophic lateral sclerosis (ALS), the expression 
levels of Kir4.1 and AQP4 channels were also found to be altered, hence it 
will cause disturbances in the regulation of the K+ and water homeostasis 
of astrocytes that will lead to the dysfunction and death of the 
motoneurons (Olsen et al., 2010, Bataveljić et al., 2012). 
 
 In addition to impaired water and K+ transport, the loss of Kir4.1, Na+/K+ 
ATPase or AQP4, members of DAP complex, also affects the glutamate 
transport of the astrocytes, as GLutamate ASpartate Transporter (GLAST) 
and glutamate transporter-1 (GLT-1) were both shown to be novel 
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members of the DAP complex (Djukic et al., 2007, Rose et al., 2009, Zeng 
et al., 2007). Chronic guanosine exposure or application of beta-oestradiol 
were found to augment the de novo synthesis of the Kir4.1 subunit and are 
possible treatments after spinal cord injury or ALS to restore impaired 
Kir4.1 channel activity in astrocytes, and therefore K+ and water 
homeostasis and glutamate uptake (Benfenati et al., 2006, Olsen et al., 
2010). 
 
The most complete studies about glial expression of Kir channels have 
been carried out in retinal Müller cells, although expression of the Kir4.1, 
Kir5.1 and Kir2.1 subunits, involved in the regulation of extracellular K+, 
has also been detected in several other brain regions. Kir2.1 subunit was 
found to be expressed in fore-brain, olfactory bulb and cortical astrocytes 
under normal conditions and in the hippocampal astrocytes under 
pathophysiological conditions (Kang et al., 2008, Howe et al., 2008, 
Stonehouse et al., 1999). However, Kir4.1 is expressed in optic nerve, 
hippocampal, thalamic, cortical, olfactory bulb, spinal cord, cerebellar 
(Bergman glia), retrotrapezoid nucleus (RTN) and ependymal astrocytes 
(Hibino et al., 2004, Higashi et al., 2001, Kalsi et al., 2004, Li et al., 2001,   
Wenker et al., 2010), whereas the expression Kir5.1 subunit was detected 
in cortical, olfactory bulb and retrotrapezoid nucleus astrocytes (Benfenati 
et al., 2006, Hibino et al., 2004, Mulkey and Wenker, 2011). In the 
retrotrapezoid nucleus, astrocytes sense hypercapnia induced pH 
acidification by the inhibition of the Kir4.1/Kir5.1 currents and stimulate the 
activity of the RTN pH sensitive neurons that control the breathing by the 
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release of ATP via Ca2+-dependent exocytosis (Gourine et al., 2010, 
Wenker et al., 2010). In contrast, the exact role of Kir2.3 subunit is not 
determined, despite the expression of the Kir2.3 subunit being widely 
detected in astrocytes, suggesting an important but unknown functional 
role for this channel subunit in the astrocytes (Perillán et al., 2000). In 
astrocytes, activity of the Kir2.3 channel is regulated by transforming 
growth factor-β1 via PLC and PKC-δ mediated signaling pathways 
(Perillan et al., 2002). 
 
Although oligodendrocytes are also known to express Kir2.1, Kir2.2, Kir2.3 
and Kir4.1 subunits, the functional role of these subunits in 
oligodendrocyte physiology is less known than in astrocytes. However, it 
was demonstrated that Kir4.1 forms the major K+ conductance of 
oligodendroglia and that it is essential for the development of myelinating 
oligodendrocytes, as oligodendrocytes from mice lacking functional Kir4.1 
display immature morphology and have depolarised membrane potentials 
(Neusch et al., 2001). The importance of the Kir4.1 subunit in 
oligodendrocyte physiology is also highlighted in the demyelinating 
disease multiple sclerosis (MS), as the loss of Kir4.1 is believed to be a 
primary cause of demyelination, since in almost 50% of MS patients an 
autoantibody was detected against the Kir4.1 subunit (Srivastava et al., 
2012). Moreover, mice lacking functional Kir4.1 subunit also exhibit motor 
impairment similarly to MS patients due to hypomyelination of the spinal 




It is also believed that oligodendrocytes contribute to K+ buffering, as 
oligodendrocyte connexins (Cx32 and Cx47) and Kir4.1 were found to 
function in a common pathway to buffer the K+ released during neuronal 
activity (Menichella et al., 2006, Robert and Jirounek, 1994). Moreover, the 
expression of astrocyte-oligodendrocyte gap junctions composed of Cx32 
and Cx47 connexins resembled the expression pattern of the Kir4.1 
subunit that is primarily expressed at the oligodendroglial somata and 
primary processes of the optic nerve, corpus callosum and spinal cord 
oligodendroglia (Kalsi et al., 2004, Kamasawa et al., 2005, Neusch et al., 
2001, Takumi et al., 1995). Furthermore, the subcellular localisation of the 
classical Kir channel subunits in Schwann cell suggested they are also 
involved in K+ buffering, as the expression of Kir2.1 and Kir2.3 subunit was 
localised to the nodal processes of Schwann cells that contact the axons 
at the nodes of Ranvier, the sites of K+ release during action potentials (Mi 
et al., 1996). Oligodendrocytes in the hind-brain were found to express 
Kir2.2 and those in the forebrain express Kir2.1, Kir2.2 and Kir2.3, 
suggesting these strong rectifying Kir channels could also be involved in 
K+ clearance (Stonehouse et al., 1999). 
 
In contrast, the hypoxia activated KATP channels, due to their ATP 
sensitivity, are directly coupled to cellular metabolism and are thought to 
provide protection against hypoxia induced metabolic stress. Indeed, KATP 
channel openers were found to stimulate proliferation of OPC and promote 
myelination under normoxic and hypoxic conditions, by hyperpolarising the 
plasma membrane and consequently inhibiting the influx of the Ca2+ 
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(Fogal et al., 2010). Hence, KATP channel openers could be used for the 
treatment of periventricular white matter injury, a condition usually 
occurring in premature infants due to hypoxia, ischemia or infections, that 
cause necrosis of the white matter near the lateral ventricules. OPCs 
affected in this condition were found to express Kir6.1, Kir6.2 and SUR2 
KATP channel subunits, whereas oligodendrocytes in the corpus callosum 
expressed only the Kir6.2 subunit, possible due to the developmental 
downregulation of the KATP channel subunit expression, similar to what 
was identified in astrocytes (Brockhaus and Deitmer, 2000, Fogal et al., 
2010, Zhou et al., 2002). In astrocytes, the principal pore forming subunit 
of the KATP channels is the Kir6.1 subunit, as hippocampal, cortical, and 
cerebellar astrocytes as well as other specialised astrocytes, such as 
tanycytes, Bergmann and Müller glia, were all found to express Kir6.1, 
whereas the expression of Kir6.2 was only detected in corpus callosum 
and brainstem astrocytes and Bergmann glia, (Karschin et al., 1998, 
Thomzig et al., 2001, Zhou et al., 2002). 
 
In astrocytes, the Kir6.1 subunit is targeted to the plasma membrane of the 
perisynaptic and peridendritic processes, whereas electron microscopy 
(EM) studies detected the expression Kir6.2 subunit in the Golgi, ER and 
plasma membrane of corpus callosum astrocytes (Thomzig et al., 2001, 
Zhou et al., 2002). In retinal Müller cells, the subcellular localisation of 
KATP channels composed of Kir6.1 and SURI subunits overlapped with the 
expression of Kir4.1 subunit, therefore it was proposed that at high ATP 
levels, Kir4.1 is responsible for maintaining the high K+ conductance and 
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hyperpolarised membrane potential of the Müller cells, whereas under 
ATP depletion during ischemia, KATP channels take over these roles 
(Skatchkov et al., 2001, Skatchkov et al., 2002). Iptakalim, a KATP channel 
opener, also protected astrocytes against ischemia induced cytotoxicity, by 
decreasing extracellular glutamate level through the activation of mitoKATP 
channels (Hu et al., 2005). Finally, in microglia the inhibition of KATP 
channels increased the neuroprotective capacity of the microglia upon 










































Endothelium corneal, renal, aortic and 
cerebral endothelial cells 
Fang et al., 2005, Millar et 
al., 2008, Yang et al., 2003  
Cardiac I(K1) current  Cardiac muscle ventricular > atrial 
cardiomyocytes 
Miake et al., 2003, 
Zaritsky et al., 2001  
Hyperpolarisation 
→myoblast fusion 
Skeletal muscle myoblast Fischer-Lougheed et al., 
2001, Konig et al., 2006 
Setting the Em 
vasodilatation 
Smooth muscle vascular smooth muscle cells Karkanis et al., 2003, Wu 
et al., 2007  
 
Neuronal excitability, 




widespeard expression in the 
brain 
Cazorla et al., 2012, Chen 





Epithelium vestibular type I and II hair 
cells  
Correia et al., 2004, Levin 




Heamatocyte endothelial progenitor cells, 
macrophages  
Jang et al., 2011, Vicente 
et al., 2003 
 
K+ spatial buffering 
 
Glia 
Astrocytes: Müller cells, 
piriform complex glia 
Howe et al., 2008, Iandiev 
et al., 2006 
Oligodendrocyte Stonehouse et al., 1999 
Schwann cells: Mi et al., 1996 
Vasodilatation Pericyte vasa recta pericytes Cao et al., 2007 





Osteoclast Komarova et al., 2001, Wang 





Setting the Em 
vasodilatation 
 
Endothelium aortic, cerebral endothelial 
cells 
Fang et al., 2005, Millar et 
al., 2008 
 




cardiomyocytes Zaritsky et al., 2001, Zobel 






















Cell excitability Skeletal muscle  sternomastoid muscle Leonoudakis et al., 2004 
Setting the Em 
Myogenic tone 
 
Smooth muscle cerebral and coronary vascular 
smooth muscle  
Smith et al., 2008, Wu et 
al., 2007 
Neuronal and dendritic 
excitability 
 
Neurons widespread expression in the brain 
Prüss et al., 2005, 
Stonehouse et al., 2003  
 
Setting the Em 
 
Epithelium Retinal and renal epithelial 
cells 
Leonoudakis et al., 2004, 
Yang et al., 2008 
 
K+ spatial buffering 
 
Glia 
Astrocyte and Bergmann glia in 
the cerebellum 
 
Leonoudakis et al., 2001 
Oligodendrocyte: fore and 
hindbrain 
 






  Kir2.3 







Wildhirt et al., 2008 
 
Cardiac I(K1) current 
 
Cardiac muscle atrial > ventricular 
cardiomyocytes  
He et al., 2008, Melnyk et 
al., 2002,  
Setting the Em of the 
dendritic spines 
 
Neurons postsynaptic membrane of 
excitatory neurons 
Inanobe et al., 2002, 




Epithelium basolateral membrane of renal 
epithelia -CCD 
Millar et al., 2006, Olsen 
et al., 2002  
 
K+ spatial buffering 
 
Glia 
Astrocytes: nucleus tractus 
solitartius 
Perillán et al., 2000, 
Yamamoto et al., 2008 
Oligodendrocyte Stonehouse et al., 1999 





Setting the Em 
 
Smooth muscle pulmonary vascular smooth 
muscle 






Motoneurons, retinal bipolar 
cells 
Prüss et al., 2003, Prüss et 




Kir2.5 Cardiac I(K1) current Cardiac muscle cardiomyocytes Hassinen et al., 2008 



















Myogenic tone  
GI tract I(KACh) 
 
Smooth muscle Gastrointestinal (GI) smooth 
muscle cells 




Cardiac Muscle Atrial and ventricular 
cardiomyocytes 
Krapivinsky et al., 1995, 






symphatetic, substantia nigra, 
Purkinje neurons and granuale 
cells 
Aguado et al., 2008, Guo 
and Ikeda, 2004, Leaney, 








Thyrotroph cells Kurachi and Ishii, 2004, Morishige et al., 1999 





GI tract I(KACh) 
 
Smooth muscle Esophageal and gastro-intestinal smooth muscle cells 








ventral tegmental area, 
substantia nigra, spinal cord, 
retrorubral nucleus, cerebellar 
nuclei 
Blednov et al., 2003, 
Marker et al., 2004, Reyes 







GI tract I(KACh) 
 











cerebellar Purkinje, unipolar 
brush, stellate and basket cells, 
axons of hippocampal, LC and 
supraependymal neurons  
Aguado et al., 2008, Cruz 
et al., 2008, Fernández-
Alacid et al., 2009, Grosse 
et al., 2003, Kozell et al., 
2009, Prüss et al., 2008 
Kir3.4 
 
Myogenic tone  
GI tract I(KACh) 
 










Cardiac Muscle Atrial and ventricular 
cardiomyocytes 
Krapivinsky et al., 1995, 
Wickman et al., 1998  
Membrane excitability 






nuclei, Golgi cells 
Aguado et al., 2008, 
Kloukina et al., 2012, 
Perry et al., 2008  
Em hyperpolarisation  




















































Arterial endothelial cells Katnik and Adams, 1995, Yoshida et al., 2004 
Protection against 








Mitochondria > and 
sarcolemma of cardiomyocytes
 
Morrissey et al., 2005, Nie 
et al., 2012, Y. Liu et al., 
2001, Zhou et al., 2005, 
 





Mito> sarcKATP channel of 
skeletal muscle cells 
Ng et al., 2010, Spruce et 
al., 1985, Suzuki et al., 
1997  










Vascular smooth muscle 
 
Bai et al., 2012, Blanco-
Rivero et al., 2008, Fan et 
al., 2009, Liang et al., 
2011  
 




Mito > sarcKATP channel of 
uterus, bladder, renal, colon, 
penis, gallbladder, airway 
smooth muscle 
Ekman et al., 2012, Han et 
al., 2008, Park et al., 2008, 
Sutovska et al., 2009, 
Vadziuk et al., 2010, Zhou 




Liver Mito and sarcKATP channel 
of hepatocytes 
Nakagawa et al., 2012, 








































Epithelium  Retinal pigment epithelial 
cells, alveolar 
Leroy et al., 2004, Yang et 
al., 2008, Zhou et al., 2007 
 
K + buffering 
 
Glia 
Astrocyte: Müller glia, 
hippocampal, cortical, and 
cerebellar astrocytes, 
tanycytes, and Bergmann glia 
 
Eaton et al., 2002, 






Brain pericyte, renal 
descending vasa recta,  
Bondjers et al., 2006, Cao 
et al., 2007, Paul et al., 
2012  
Salivary secretion Exocrine gland Submandibular gland Zhou et al., 2010 
 
K+ transport Reproductive 
system 
 
Oocytes Lybaert et al., 2008, Du et 
al., 2010 





















Arterial and pulmonary 
endothelial cells 
Milovanova et al., 2006, 
Yoshida et al., 2004, 











Sarcolemmal KATP channel 
(Kir6.2/SUR2A) 
cardiomyocytes 
Crawford, 2002, Gumina 
et al., 2003, Kane et al., 
2006, Liu et al., 2004, 
Saegusa et al., 2005, Yang 
et al., 2013, Zingman et 
al., 2002  
 




Skeletal muscle cells 
Banas et al., 2011, 
Jovanović et al., 2008, 




Smooth muscle  
 
Myometrial myocytes 
Park et al., 2008, Xu et al., 
















































cerebral ischemia by 








Widely distributed in the brain 
mainly in glucose-sensing, 
hypothalamic, hippocampal, 
cortical neurons, dorsal root 
ganglia 
Bahi-Buisson et al., 2007, 
Grabauskas et al., 2013, 
Lacza et al., 2003, Parton 
et al., 2007, Thomzig et 
al., 2005, Sun et al., 2006, 






epithelium, dermal epithelial 
matrix 
Lybaert et al., 2008, 
Pouokam et al., 2013, 
Shorter et al., 2008  
 
 







Astrocyte: Bergmann glia, 
Satellite glia, corpus callosum 
astrocyte 
Ming Zhou et al., 2002 




Fogal et al., 2010, Zhou et 
al., 2002 
Schwann cells Zoga et al., 2010 
Microglia Ortega et al., 2012 
K+ transport Pericyte Vasa recta pericyte  Cao et al., 2007 
 




Zhou et al., 2010 
 






Butler et al., 2010, Kawase 
et al., 1996, Kim and 














Ileal L- and K-cells 
Pancreatic α, β, δ cells 
 
 
Flanagan et al., 2009,  
Miki et al., 1998, 









Suzuki et al., 1997, 










































Ventricular cardio myocytes 
 
Dong et al., 2001, Foster et 
al., 2012,  
Setting the Em 
Cellular excitabilty 
 
Smooth muscle Bladder, myometrium smooth 
muscle 
 








Axons of retinal ganglion 
cells, petrosal ganglion, cell 
bodies of carotinoid body 
glomus cells, and 
chemosensory areas in the 
brain 
 
Chen et al., 2004, 
Yamamoto et al., 2008, 
Yamamoto et al., 2008 
K+ recycling- 30 pS 
small conductance 
and 70 pS K+ channel 




Renal, urinary tract epithelium 
 
Boim et al., 1995, Lu et 
al., 2002, Lu et al., 2004, 
Spector et al., 2008  
 










Yamamoto et al., 2008 
Type 1 taste cells/glia like 
cells  











Petrosal ganglion cells, 
vestibular ganglion, axons of 
glomus cells of carotid body  
 
Udagawa et al., 2012, 







































Acid secretion, renal 
K+ recycling and 
excretion, 




Gastric parietal cells, 
vestibular sensory, renal 
epithelium 
Lachheb et al., 2008,  
Marcus et al., 2002, Song 
et al., 2011, Udagawa et 
al., 2012,  
 
 
K+ buffering, Setting 
the Em 








Astrocytes: Müller cells, 
satellita cells in trigeminal 
ganglion, vestibular ganglion, 
astrocytes in amygdaloid 
nuclei, optic nerve, 
retrotrapezoid nucleus, 
cerebral cortex, 
hippocampus, spinal cord 
Fort et al., 2008, Harada et 
al., 2013 Obara-
Michlewska et al., 2011 
Olsen et al., 2006, Kalsi et 
al., 2004, Tang et al., 
2009, Udagawa et al., 
2012, Vit et al., 2008 





nerve, spinal cord, gray 
matter OPC 
Kalsi et al., 2004, 
Maldonado et al., 2013, 






Type III taste buds 
 















Liver Basolateral membrane of hepatocyte apical luman 
Hill et al., 2002, Pearson et 
al., 1999 
 




Temporal lobe , putamen, 
neural retina 
Gosset et al., 1997, 
Kurschner et al., 1998, , 







Gastric parietal cells, retinal 
pigment and kidney 
epithelium 
He et al., 2011, Lourdel et 
al., 2002, Sindic et al., 
2009, Thiery et al., 2000, 
Yang et al., 2008  






































Submucosal gland cells 
 
Wu et al., 2004 




































Retinal, locus coeruleus 
neurons, cell bodies of nucleus 
raphe obscurus, pre-Bötzinger 
complex neurons, axons and 
cell bodies of nucleus tractus 
solitaries neurons and glomus 
cells of carotid body, axons of 
petrosal ganglion  
 
 
D’Adamo et al., 2011, 
Ishii et al., 2003, Rojas et 
al., 2008, Yamamoto et al., 




K+ channel in the 
basolateral membrane 






Renal tubular epithelium 
 
Lachheb et al., 2008, 
Paulais et al., 2011, 
Tanemoto et al., 2000 







Astrocytes: Müller glia, 
retrotrapezoid nucleus, 
olfactory bulb, cortical 
astrocytes 
Benfenati et al., 2006, 
Hibino et al., 2004, Ishii et 
al., 2003, Wenker et al., 
2010 
pH-dependent 




Acinar cell of pancreas Liu et al., 2000, Pessia et 
al., 2001 
Regulation of insulin 
secretion ? 
 
Endocrine gland Pancreatic islets of Langerhans 
 























type II, IV and V fibrocytes of 
the spiral ligament and limbus 
of the cochlear later wall 
 












Iris, intestine epithelium, 
apical membrane of retinal 
pigment and choroid plexus 
epithelium, basolateral 
membrane of renal, 
epithelium  
 
Nakamura et al., 1999, 
Ookata et al., 2000, 
Sergouniotis et al., 2011, 
Yang et al., 2003, Yasuda  




Follicular cells Basolateral membrane of thyroid follicular cells  
 
Nakamura et al., 1999 






The aims of this study is to determine the expression, subcellular 
localisation and heteromer forming ability of Kir4.1, Kir5.1 and Kir2.1 
channels in optic nerve glia. To establish the effect of the Kir4.1 on the 
expression and subcellular localisation of the Kir5.1 and Kir2.1 subunits 
moreover on expression of other subunits (Kir6.1 and Na/K ATPase α1) 







Materials and methods 
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2.1  Animals  
2.1.1  Animal strains and procedures 
All animals were killed humanely by lethal cervical dislocation, in 
accordance with regulations issued by the Home Office of the United 
Kingdom under the Animals (Scientific Procedures) Act, 1986. In this 
project a number of wild type and transgenic mouse strains were utilised 
including C57BL/6, C57BL/10 or CFLP wild type strains and GFAP-EGFP, 
PLP-DsRed and Kir4.1 knock out transgenic mouse strains. In 
TgN(GFAPEGFP)GFEC-Fki mice the enhanced green fluorescent protein 
(EGFP) is driven by the astrocytic GFAP promoter enabling the 
identification of the individual astrocytes due to the confinement of the 
fluorescent indicator EGFP to the astrocytes (Nolte et al., 2001). In 
TgN(PLP-DsRed1) transgenic the DsRed is driven by the mature 
oligodendrocyte cell specific marker PLP providing fluorescent red 
oligodendrocytes (P. G. Hirrlinger et al., 2005). Both of these strains were 
kindly donated by Dr. Frank Kirchhoff (Max Planck Institute for 
Experimental Medicine, Gottingen, Germany). The Kir4.1 channel knock 
out mice used in this project, originally generated by Kofuji and colleges, 
were kindly donated by Prof. Christian Steinhäuser (Institute of Cellular 
Neurosciences, University of Bonn, Germany)(Kofuji et al., 2000). In 
homozygous state the genetic deletion of Kir4.1 subunit leads to the 
premature death of the mice within the first three weeks of their life 
therefore Kir4.1 KO mice were bred in a heterozygous background. To 
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distinguish the homozygous from the heterozygous littermates genotyping 
was used.  
2.2  Chemicals and solutions 
2.2.1  Solutions and bacterial culture media 
All chemicals are Sigma (Sigma-Aldrich Company Ltd., Gillingham) or 
Fisher (Fisher Scientific UK Ltd, Loughborough) products, unless 
otherwise stated. Lyophilised oligonucleotides were reconstituted in TE 
buffer at pH 8.0 containing: 10 mM Tris·HCl (pH 8.0) and 1 mM EDTA. 
Lysogeny broth (LB) medium used for the growth of bacteria during 
plasmid cloning, was supplied in tablet form and it was supplemented with 
15g/L of agar for preparation of LB bacterial culture plates. Bacterial media 
was stored in darkness at 4oC until use. 
 
Optic nerve and whole brains obtained for Western blot, plasma 
membrane purification and immunoprecipitation experiments were briefly 
stored in ice cold artificial cerebrospinal fluid (aCSF) comprising of: 
133 mM NaCl; 3 mM KCl; 1.5 mM CaCl2; 1.2 mM NaH2PO4; 1 mM MgCl2; 
10 mM D-glucose; 8.55 mM HEPES, at pH 7.4 (by dropwise addition of 
NaOH) supplemented with 1x complete mini protease inhibitor cocktail 
Roche (Roche Diagnostics Limited, Burgess Hill) 
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2.3 Cell culture  
2.3.1 Optic nerve explants  
Mice aged P7-11 were humanely killed by cervical dislocation and optic 
nerve explant cultures were prepared as described previously by 
(Greenwood and Arthur M Butt, 2003). In brief, optic nerves were carefully 
dissected and maintained in pre-warmed (37°C) and p regassed (5% CO2) 
dissecting media, constituted of Dulbecco’s Modified Eagle Medium 
(DMEM) (Sigma) medium, supplemented with 4 mM L-glutamine, 10% 
foetal bovine serum (FBS; Invitrogen) and 0.1% gentamicin (Invitrogen, 
Life Technologies Ltd., Paisley). From this point on optic nerve were kept 
under sterile conditions therefore optic nerves were cut to 1-2 mm 
fragments by hand under a laminar flow cabinet immediately in a 200 µl of 
filter sterilized pre-warmed dissecting media, using a scalpel blade. Then, 
for the further the dissociation, optic nerves fragments were triturated with 
a 1 ml Gilson pipette tip, and then a 200 µl Gilson tip. Optic nerves 
fragments along with the media were then transferred onto laminin 
(Invitrogen) and poly-l-ysine (Sigma) coated 13 mm diameter coverslips in 
24 well plate and incubated at 37°C in 5% CO 2 overnight to allow the 
adhesion of the explants. After 24 hours the dissecting media was 
substituted with a low serum (0.5 %) modified Bottenstein and Sato (B&S) 
culture medium (Bottenstein and G. H. Sato, 1979), supplemented with 
10ng/ml recombinant human PDGF-AA (R&D Systems) and 0.1 % 
gentamicin but minus the thyroid hormones. After 3-4 days in vitro (DIV) 
the medium was replaced to B&S media supplemented with 0.5mM 
dibutyryl cAMP for up to 10 DIV. Explanted cells were then cultured in B&S 
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media with 0.1 % gentamicin for up to 15 DIV, changing media every 3-5 
days. 
2.3.2 Transfection  
Transfection reagents affect viability of cells, in particular in antibiotic 
containing media.  Therefore, 24 hours (h) prior to transfection, media was 
changed for antibiotic free medium. Optic nerve explant cultures were 
transfected at 10 DIV with psiSTRIKE vectors containing scrambled 
control or Kir4.1 siRNA, kindly provided by Dr. Virginia Hawkins (University 
of Portsmouth), using LipofectamineTM 2000 reagent (Invitrogen) 
according to the manufacturers instructions. Briefly, plasmid DNA and 
LipofectamineTM 20000 reagent were used at concentration ratios of 1:1.5 
DNA (µg): Lipofectamine™ 2000 (µl) for all plasmids, using 0.8 µg or 2 µg 
of DNA per coverslip. Plasmid DNA and transfection reagents were each 
diluted in 50 µl Opti-MEM® (Invotrogen) and incubated at room 
temperature (RT) for 5 min. After, combining DNA and transfection reagent 
solutions and 20 min incubation at room temperature, 100 µl per coverslip 
transfection mixture was added to the cells, then plates were gently mixed 
by swirling and incubated at 37ºC in 5% CO2. Transfected cells could be 
visualised by fluorescent microscope due to the GFP expression within 




2.4  Molecular techniques  
2.4.1 Genotyping  
As the homozygous ablation of Kir4.1 subunit leads to the premature 
death of Kir4.1 KO animals in their 2-3 postnatal week, Kir4.1 KO mice 
were kept in a heterozygous background. Genotyping was used determine 
the genetic background of all mice used for experimental or breeding 
purposes. For the genotyping of the homozygous, heterozygous and wild 
type mice the methods previously described by Kofuji and colleges were 
followed (Kofuji et al., 2000). Briefly, genomic DNA was isolated from 
mouse tails or ears using the Mouse Tail Quick Extraction Solutions 
(Biopioneer Inc) and PCR amplification with Kir4.1 forward, Kir4.1 reverse 
and neomycin forward primers (Table 2.1) was carried out. Each of the 35 
cycles of PCR consisted of denaturation (30 sec at 94oC), annealing (45 
sec at 57oC) and elongation steps (60 sec at 72oC) and the reaction 
amplified a 634 bp product for a wild type allele, and a 383 bp product for 
the allele containing the knockout construct. PCR products were run at 




Table 2.1 Oligonucleotides used for genotyping and gene silencing (shRNA) 
Target gene for Accession # Primer pairs bp 
Genotyping 
Kir4.1 NT_039185.8 forward 5’-TGGACGACCTTCATTGACATGCAGTGG-3’                                        166-192 bp- 
reverse 5’-CTTTCAAGGGGCTGGTCTCATCTACCACAT-3’                                 770-799 bp 
634 
Neomycin Resistance NA forward 5’-GATTCGCAGCGCATCGCCTTCTATC-3’ 383 
shRNA 












2.4.2 Western Blotting  
The whole brains or optic nerves dissected from the P8-P60 mice were 
snap-frozen in liquid nitrogen and stored -80oC or homogenised 
immediately upon dissection using a glass homogeniser then syringes in a 
homogenization buffer containing: 12.5 mM NaCl; pH~8 2mM Tris/HCl; 0.2 
mM phenyl-methyl sulphonyl fluoride (PMSF), distilled water and 1x 
complete mini protease inhibitor cocktail (Roche) all kept on ice. Samples 
were centrifuged with 12000 rpm for 5 min 4oC the aspirated supernatant 
was placed in a fresh tube that was kept on ice; the pellet discarded. 
Quantification of protein concentration was carried out with bicinchoninic 
acid assay (Sigma) using a standard curve bovine serum albumin (BSA) 
concentration curve constructed by the spectrophotometer absorbance 
readings at 550 nm. Samples were mixed with Laemmli sample buffer and 
heated at 95°C (except samples for the identificati on of Na+/K+ ATPase α1 
subunit that were heated to 65°C according to the m anufacturers 
recommendation as when the samples are heated to 95°C Na +/K+ ATPase 
α1 form aggregates that run ~150 kDa) for 5 min with β-mercaptoethanol 
then kept on ice until loading. Samples were mixed and loaded on 10 % 
acrylamide SDS- polyacrylamic gel submerged in electrophoresis buffer 
pH~8 containing of 25 mM Tris base 190 mM glycine 0.1% SDS and run at 
80 mV until the samples had reached the running gel then run at 150 mV. 
Proteins were immediately transferred to a polyvinyllidene difluoride 
membrane (Amersham) by electrophoresis at 4oC with 100 V for an hour 
which was afterwards, incubated for 1 hour in blocking solution containing 
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of 5 % dried milk in Tris buffered saline (TBS; 150 mM NaCl 10 mM Tris 
pH 7.4) with 0.05 % Tween 20. Primary antibody incubation was carried 
out overnight at 4°C and secondary antibody horsera dish peroxidase-
conjugates added at 1:2000 to 1:15000 for one hour at 20 °C. Extensive 
washing of the membranes in TBS with ice cold 0.05% Tween 20 was 
performed after each incubation and immunocomplexes were revealed 
using an enhanced chemiluminescence method (Amersham).  
2.5  Isolation of plasma membrane fraction 
The whole brains (n=3) and optic nerves (n=20) of wild type Kir4.1 KO 
animals were homogenised using a glass homogeniser then syringes in 
subcellular fractionation buffer containing 250 mM sucrose, 20 mM 
HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 DTT 
and 1x protease inhibitor cocktail. Samples were centrifuged at 4°C with 
750 G for 10 min to remove the nuclear fraction. Supernatant was placed 
in a new Eppendorf tube and centrifuged with 10 000 G at 4°C two times 
to remove the mitochondrial fraction. Supernatant was placed in an 
ultracentrifuge tube and centrifuged with 40 000 G at 4°C for 1 hour. The 
supernatant was removed while the pellet containing the crude plasma 
membrane fraction was resuspended in 400 µl fractionation buffer using a 
25 G needle. 40 000 G at 4°C for 45 min and then th e pellet was 






2.6  Immunological techniques 
2.6.1 Antibodies 
All antibodies used are listed in Table 2.2 and Table 2.3, with the 
techniques that they were applied and the concentrations at which they 
were utilised.   
Table 2.2  Details of primary antibodies 
Antibody 
Target 
Raised In ICC Western 
Blotting 
IP Dilution Source 
GFAP Chicken    1:200 Chemicon 
GFAP Rabbit    1:500 Dako 
O4 Mouse (IgM)    1:50 R. Reynolds, ICL, 
UK 







Kir2.1 Rabbit    1:100 Alomone 






G. Wilkins, ICL, UK 
Kir4.1 Rabbit    1:400 
1:1000 
Alomone 



















Kir6.2 Rabbit    1:300 Santa Cruz 
Kir7.1 Rabbit    1:300 B Hughes, MN, USA 
β-actin Mouse    1:5000 Sigma 
Na/K 
ATPase α1 





Calnexin Goat    1:300 AbCam 
Prohibitin Rabbit    1:300 AbCam 
SAP-97 Rabbit    1:500 AbCam 












Table 2.3  Details of secondary antibody conjugates 
 
Conjugate Reactivity Dilution Source 
Alexa Fluor® 488 Goat α-Rabbit 1:400 Molecular Probes 
Alexa Fluor® 488 Donkey α-Goat 1:400 Molecular Probes 
Alexa Fluor® 488 Goat α-Mouse 1:400 Molecular Probes 
Alexa Fluor® 568 Donkey α Goat 1:400 Molecular Probes 
Alexa Fluor® 568 Goat α-Rabbit 1:400 Molecular Probes 
Alexa Fluor® 568 Donkey α-Chicken 1:400 Molecular Probes 
Alexa Fluor® 568 Goat α-Mouse 1:400 Molecular Probes 
Alexa Fluor® 568 Goat α-Rat 1:400 Molecular Probes 
FITC Goat α-Mouse IgM 1:100 Sigma 
TRITC Goat α-Mouse IgM 1:100 Sigma 
HRP Rabbit α-Goat 1:10000 Dako 
HRP Goat α-Mouse 1:10000 Dako 
HRP Swine α-Rabbit 1:10000 Dako 
DyLight™ 405 Donkey α Rabbit 1:400 Stratech 
DyLight™ 405 Donkey α Chicken 1:400 Stratech 
DyLight™ 649 Donkey α Rabbit 1:200 Stratech 
DyLight™ 649 Donkey α Mouse 1:200 Stratech 
  
2.6.2 Immunoprecipation 
Brains (n=3) and optic nerves (n=10) obtained from adult wild type mice 
(P16-60) were homogenised as described previously 2.4.2. For the 
precipitation of the proteins µMACS™ Protein A/G MicroBead kit was used 
(Miltenyi Biotec) according to the manufacturers recommendations. In 
brief, homogenised brain or optic nerve samples were first centrifuged at 
4oC with 10 000xg to clean the homogenate from cell debris that can clog 
the column. 5 µl whole antisera, 3 µg polyclonal- or 2 µg monoclonal 
antibody was added to the proteins and incubated overnight at 4oC. In the 
case of negative controls proteins were mixed with the preabsorbed 
antibodies or bare immunoglobulins. The following day Protein G 
MicroBeads were added to the samples to magnetically label the immune 
complex (50 µl if monoclonal antibody was used or 100 µl if whole antisera 
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or polyclonal antibody was used for the precipation). The samples were 
then mixed and incubated for 30 min on ice. The new µ Column were 
placed in the magnetic field of the µMACS™ separator and then prepared 
by rinsing with 200 µl of lysis buffer containing of 150 mM NaCl, 1% Triton 
X-100, 50 mM Tris HCl (pH 8.0) before the cell homogenate was applied 
onto the column. Upon the homogenate run through the columns were 
washed with 200 µl lysis buffer for four times then with 100 µl of low-salt 
wash buffer containing of 1% NP-40, 50 mM Tris HCl (pH 8.0). To prepare 
the elution of the immune complex 20 µl of pre-heated (95 °C) 1× Laemelli 
sample buffer was applied onto the column and incubated for 5 minutes at 
room temperature. Next, 50 µl of pre-heated (95 °C) 1× Laemelli sample 
buffer was applied to the column matrix to elute the immune complex. The 
drop on the column tip containing the eluted immunoprecipitate was 
collected and stored on ice or at -80°C until it wa s analyzed by SDS-
PAGE. 
2.6.3 Immunocytochemistry 
Optic nerve explants cultures grown on 13 mm diameter coverslips were 
fixed at appropriate DIV with room temperature 1 or 4 % 
paraformaldehyde in PBS, pH7.4 for 10 min or ethanol for 1 min with three 
subsequent washes in PBS before proceeding to immunocytochemistry. 
Prior to antibody incubations cells were blocked in 5 % NGS in PBS for 
one hour at room temperature and then permeabilized in 5 % NGS in PBS 
with 0.2 % Triton for 15-30 min (except in the cases of Kir7.1 and O4 
labelling of cells, which did not require permeabilisation hence no Triton X-
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100 was used). All antibodies were diluted in PBS and primary antibodies 
were incubated overnight at 4°C with the cells. Sec ondary antibodies 
conjugates were incubated (with additional 0.2 µg/ml Hoescht Blue 
(Molecular Probes)) at RT for one hour, before coverslips were mounted 
with Vectasheild® (VectorLabs). Washes were carried out in PBS (10 min 
x3) before and after the primary and secondary antibody incubations. 
During double or triple immunolabelling the antibodies were cocktailed for 
both incubation steps, as long as they were each raised in different hosts. 
Images were acquired using confocal microscopy. Negative controls were 
carried out in all experiments. If it was possible antibodies were pre-
incubated with their appropriate antigens from 1 to 3 hours according to 
the manufacturer’s recommendations and the preabsorbed antibody was 
used for the negative control. If the appropriate peptide was not available 
the omission of the primary antibody or in the case of Kir4.1 subunit knock 
out mice also served as a negative control.  
2.7 Microscopy techniques 
2.7.1 Image capture  
Confocal images were captured using the x20 (air) or x40, x63, x100 (oil 
immersed) (numerical aperture 0.5, 1.3, 1.4 respectively) objective of a 
Zeiss meta LSM 510, LSM 710 or LSM 5 Pascal Axioskop2 confocal or 
microscope (Zeiss). Fluorescence was detected using excitation 
wavelengths of 488nm (green), 568nm (red), 633nm (far red) and 405nm 
(blue), with an argon, HeNe1 and diode laser respectively. Three 
dimentional images were taken for the using optimal settings for pinhole 
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diameter (0.13-0.3 µm), detector gain and offset acquisition to detect the 
positive signal with minimal background. Z-stacks contained 4-15 series of 
1024x1024 pixel images that were used the generation of the three 
dimentional images (voxel size 43-76 nm xy/ 76-283 nm z). Multi track 
image capture was used with 2, 3 and 4 channels so that separate 
channels could image different colours to help prevent bleed from any 
overlap in excitation spectra. Identical settings were then used to image 
negative controls in which the primary antibody had been omitted or in the 
case of antibodies from Alomone Laboratories, following the 
manufacturers guidelines, primary antibodies had been preincubated with 
control peptides prior to incubation steps. For the comparison of the Kir4.1, 
Kir5.1, Kir6.1 and Na+/K+ ATPase proteins levels in the wild type, Kir4.1 
knock out and Kir4.1 knock down optic nerve glia they were imaged with 
identical settings. 
2.7.2 Image analysis 
The majority of images were projected in the LSM Image Examiner or Zen 
2009 Light software (Zeiss), but those required for high resolution or co 
analysis were imported to Volocity 4.0 (Improvision Ltd) image analysis 
software. Here background noise within images can be removed by 
iterative restoration (deconvolution), which removes out of focus 
fluorescent scatter from labelled structures that are above and below the 
focal plane. The software can also carry out 3D rendering of images to 
improve visualisation of cellular characteristics and interactions. Isosurface 
rendering does this by giving all voxels (3D pixels) an identical intensity 
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value, and was used occasionally to illustrate immunolabelling 
characteristics in tissue preparations. For co analysis, the software creates 
a scatter plot of intensity values for each voxel in one channel against that 
of voxels from the other channel. So with green and red channels for 
example, central yellow areas of interest can be selected on the plot, and 
a channel of just these voxels created (a co channel). This channel is 
coloured on a scale of red to green, depicting yellow colour where voxels 
occupying the same space are both green and red. For the co-localisation 
analysis that was performed at 2 µm3 or 9 µm3 selected areas at the 
processes, cell somata or on the whole cell (analysis repeated 3 times in 
different selected areas on each analysed cell) these central yellow areas 
(in the case of red and green) were selected using the software Volocity. 
Using the object measurement application of the Volocity software the 
number of voxels for each object in the analysed area were obtained (in 
the red, green or co yellow channel) then transferred into Microsoft Excel 
and summerised, finally the 3 separate measurements (obtained from the 
different parts of the processes or cell somata of the same cell) were 
averaged. This number was then compared to the total number of green 
and/or red voxels in the analysed area. 
Three dimentional images were also analysed with line analysis using the 
LSM Image Examiner software. In line analysis the intensity of the voxels 
were analysed along a line and these intensity values are represented on 
the y axis while the distance of voxels from the starting point is illustrated 






Expression of Kir 4.1, Kir5.1 and Kir2.1 subunits in 





In CNS glia, Kir are predominantly responsible for the high selective 
membrane permeability to K+ and the maintenance of the RMP close to 
the EK (Kofuji et al., 2000, Kofuji and Newman, 2004, Müller et al., 1994, 
Newman et al., 1984, Newman, 1986, Newman, 1993, Sontheimer, 1994, 
Sontheimer, 1994, ). Kir channels are divided by the degree of rectification 
into “strong” (Kir2.x and Kir3.x),“intermediate” (Kir4.x), and “weak” (Kir1.1 
and Kir6.x) rectifiers. Kir channels and their different rectification properties 
play a key role in the glial regulation of [K+]o by the processes of “K+ spatial 
buffering” or “K+ siphoning” (Kofuji and Newman, 2004, Newman et al., 
1984, Newman, 1986, Newman, 1993, Orkand et al., 1966, ). In the main 
macroglial cell types, namely astrocytes and oligodendrocytes, as well as 
in retinal Müller glia and cerebellar Bergmann glia, the Kir4.1 channel 
subtype is proven to be the main K+ conductance (Newman et al., 1984, 
Sontheimer, 1994, Sontheimer, 1994). Kir4.1 channel subunit controls the 
glial membrane potential, K+ homeostasis and myelination (Chever et al., 
2010, Djukic et al., 2007, Neusch et al., 2001, Neusch et al., 2006 ). The 
loss of Kir4.1 has been implicated in wide range of neurological diseases, 
including epilepsy, MS and brain tumors (Heuser et al., 2010, Reichold et 
al., 2010, Shang et al., 2005, Warth et al., 2005, Srivastava et al., 2012) 
while the gain of function of Kir4.1 channel is associated with autism 
(Sicca et al., 2011). Astrocytes in the hippocampus, optic nerve, retina, 
spinal cord and deep cerebellar nuclei have all been shown to express 
Kir4.1 (Kalsi et al., 2004, Olsen et al., 2006, Poopalasundaram et al., 
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2000, Seifert et al., 2009). Optic nerve and spinal cord oligodendrocytes 
also strongly express Kir4.1 (Kalsi et al., 2004, Neusch et al., 2000) but 
the expression elsewhere may be variable (Poopalasundram et al., 2000). 
There is also evidence that astrocytes in various preparations may 
express Kir5.1 and members of the Kir2.x family, which are believed to be 
important for the redistribution of K+ from sites of high activity to low 
activity (Butt and Kalsi, 2005). The Kir5.1 subunit is known to be 
expressed in the retinal Müller glia cell (Ishii et al., 2003b) and has a 
proposed role in spatial potassium buffering (Kofuji et al., 2002, Kofuji and 
Newman, 2004). Recently, electrophysiological studies on the 
retrotrapezoid nucleus astrocytes implicated Kir5.1 subunit in the 
astrocytic chemoreption (Wenker et al., 2010, Mulkey and Wenker, 2011). 
The strongly inward rectifying Kir2.x potassium channels carry very little 
outward current at all, and are mainly active at voltages negative to the Ek, 
where they carry inward current (Hille, 2001). Astrocytes in the retina, 
piriform complex (cerebral cortex) and hippocampus are known to express 
Kir2.1, the last only under pathophysiological conditions (Kofuji et al., 
2002, Tian et al., 2003, Howe et al., 2008, Kang et al., 2008). In the retina, 
due to the rectification properties, Kir2.1 channel has a role of in the 
spatial potassium buffering (Kofuji et al., 2002). However, previous studies 
have not examined Kir5.1 or Kir2.1 in optic nerve astrocytes, and little is 
known about these channels in oligodendrocytes anywhere in the CNS. 
The aim of this chapter was to provide a detailed examination of Kir4.1, 
Kir5.1 and Kir2.1 channel subtypes in optic nerve astrocytes and 
oligodendrocytes, using explant cultures. In order to achieve this, I first 
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compared a range of different immunolabeling protocols that have been 
reported as optimal protocols for ion channel immunocytochemistry, and 
then compared a number of available antibodies and their specificity. The 
results show that optic nerve glia strongly express Kir4.1 and Kir5.1 





3.2 Optimisation of immunocytochemical detection of Kir 
channels in the optic nerve explants cultures 
3.2.1 Comparison of different fixation techniques  
To optimise the immunocytochemistry protocol for the Kir channels, I 
compared 3 different fixation techniques, using a rabbit anti-Kir4.1 
antibody, which has been fully validated in previous studies 
(Poopalasandurum et al., 2000; Kalsi et al., 2004). The compared fixatives 
were 1% PFA with 15% picric acid, 4% PFA, and methanol (with 10 min 
incubation period), since methanol was previously described as the 
optimal fixative for the Kir4.1 subunit immunohistochemistry in brain and 
optic nerve sections (Poopalasdurum et al., 2000; Kalsi et al., 2004). 
Figure 3.1 compares immunocytochemistry for Kir4.1, Kir5.1 and Kir2.1 in 
explants cultures of wild type optic nerves at DIV10-12. The images were 
captured as z-stacks by confocal microscopy, and are illustrated as two-
dimensional flattened images of the single channels. Comparison of Kir4.1 
immunolabelling after 4% PFA or methanol fixation indicated 
immunostaining throughout the cell, appearing intracellular as well as 
membranous; Kir2.1 appeared cytoskeletal in methanol fixation. In the 
case of 1% PFA and picric acid, there was significantly decreased 
immunopositivity for all three Kir subunits within the glial cell somata; 
Kir4.1 and Kir5.1 immunolabelling appeared punctate and membranous, 
whereas the Kir2.1 subunit was localised to the processes. On this basis, 
1% PFA with picric acid provided immunolabelling that was predicted for 
membranous potassium channels, and appeared the optimal fixative for 
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the immunocytochemistry of the Kir subunits in optic nerve explants. The 
reason why 1% PFA with picric acid was the optimal fixative for Kir 
channels is because picric acid enchances the preservation of antigens 
and tissue morphology therefore is widely used for electron microscopy 
studies whereas methanol fixation is generally used for cytosceletal 
components but not for membrane bound proteins as it frequently 
solubilizes and removes membrane bound antigens.  
  
 Figure 3.1 Comparison of the different fixation protocols for Kir channel 
immunocytochemisty: 
12 DIV and fixed with 1% PFA and 15% picric acid, 4% PFA or methanol, and 
immunolabelled for the Kir5.1 subunit (
or Kir2.1 subunit (Ci, Cii
 
Optic nerve explants from P7-P11 wild type mice cultured for 10
Ai, Aii and Aiii), Kir4.1 subunit (





Bi, Bii and Biii), 
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3.2.2 Optimisation of the concentration of the serum for the 
immunocytochemical detection of Kir channels 
Although serum is applied during immunocytochemistry to reduce non-
specific binding of the antibody (background), the overuse of serum can 
have a reverse effect and the concentration used must be optimised. I 
therefore tested this using Kir5.1 immunolablling in optic nerve explant 
cultures, using 2 or 5% normal goat serum (NGS) for blocking and dilution 
of the antibodies (Figure 3.2). In these experiments, I used optic nerves 
from GFAP-EGFP mice and coverslips were derived from the same 
cultures and immunocytochemistry was performed simultaneously. The 
results indicate serum concentration markedly affected Kir5.1 
immunolabelling, whereby background was much reduced and 
immunostaining appeared more membranous and clustered in 2% serum 
(Fig. 3.2A). In 5% serum, there was increased intracellular Kir5.1 
immunolabelling (Fig. 3.2B).   
 
 Figure 3.2 Comparison of Kir5.1 subunit immunocytochemistry in optic nerve 
astrocytes performed with 2% serum (A, C) or 5% serum (B, D). 
immunocytochemistry was performed in P11 transgenic GFAP
explants cultured for 11 DIV. Scale bars = 20 







3.2.3 Comparison of in-house Kir4.1 and Alomone Kir4.1 antibodies 
To verify the specificity of an antibody the number one choice is the use of 
the conventional knock out animals (Lorincz and Nusser, 2008). Here, I 
tested the specificity of our in-house rabbit polyclonal anti-Kir4.1 antibody, 
directed against the intracellular C-terminus of rat Kir4.1 (raised against 
the peptide (C)-G-D-P-E-K-L-K-L-E-E-S-L-R-E-Q-A-E-K-E, corresponding 
to amino acid residues 350-368 of murine Kir4.1) (Poopalasunduram et al., 
2000; Kalsi et al., 2004), using immunocytochemical analysis on Kir4.1 
knock out optic nerve explant cultures in comparison with the wild type 
optic nerve explants. I also compared the Kir4.1 immunocytochemical 
labelling of the wild type optic nerve astrocytes obtained with the in-house 
Kir4.1 and the commercially available Alomone rabbit polyclonal anti-
Kir4.1 antibody that is raised against the intracellular C-terminus of the rat 
Kir4.1 ((C)-K-L-E-E-S-L-R-E-Q-A-E-K-E-G-S-A-L-S-V-R peptide, 
corresponding to amino acid residues 356-375 of murine Kir4.1 (Accession 
BAA92432.1 Kir4.1)), (Fig 3.3); hence the two antibodies are directed 
against over-lapping but non-identical sequences. Western blot analysis 
confirmed the antibodies recognise a protein with the predicted size of 42 
kDa, which was absent in tissue from Kir4.1 KO mouse (Fig. 3.20). 
Astroglial expression of the Kir4.1 subunit is identified by immunolabelling 
for GFAP in wild-type and Kir4.1-/- explants (Fig. 3.3), whereas 
oligodenrocytes were examined in optic nerve explants from PLP-DsRed 
mice (3.8). Astrocytes and oligodendrocytes were strongly immunopositive 
using both Kir4.1 antibodies, but the pattern of immunostaining differed in 
astrocytes. Astrocytes immunolabelled with the in house Kir4.1 antibody 
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displayed punctate, plasmalemmal staining, which was particularly 
enriched at the astroglial membrane edges (Fig. 3.3A). Alomone Kir4.1 
antibody labelled very similarly the optic nerve astrocytes as the in-house 
Kir4.1 (Fig. 3.3B). In both cases, negative controls in which the primary 
antibody was omitted or in the presence of the appropriate blocking 
peptide, displayed no immunostaining (Fig. 3.7 and 3.8). As predicted, 
there was no immunoreactivity in Kir4.1 knock out optic nerve explants 
with the in house Kir4.1 antibody (Fig. 3.3C) therefore the specificity of the 
in-house antibody was verified. Furthermore, in wild type optic nerve 
explants the in house and the Alomone Kir4.1 antibody labelled very 
similarly the optic nerve astrocytes.  
  
 Figure 3.3 Antibody specificity test and comparison of Kir4.1 immunolabelling in optic nerve astrocytes executed with in
Alomone Kir4.1 antibodies: Kir4.1 subunit immunocytochemistry (
P10 Kir4.1 knock out (Ci) optic nerve explants cultured for 10 DIV. For the Kir4.1 immunocytochemistry in
Astrocytic expression is demonstrated by double labelling of 
marker) whereas Hoechst staining was used to visualize cell nuclei (
Ai, Bi and Ci) of P10 wild type (Ai and Bi) optic nerve explants c
-house (Ai, Ci
wild type (Aii) and Kir4.1 knock out optic nerve explants (Cii
Bii). Scale bars = 20 µm 
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-house Kir4.1 and 
ultured for 11 DIV and 
) or Alomone Kir4.1 were used (Bi). 
) for GFAP (astrocytic cell specific 
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3.2.4 Comparison of Alomone and Santa Cruz anti-Kir5.1 antibodies 
In the absence of Kir5.1 knock out mouse, a further appropriate test of 
specificity is to use at least antibodies raised against the different, 
nonoverlapping parts of the same protein (Lorincz and Nusser, 2008). 
Here, I compared the Alomone rabbit polyclonal anti-Kir5.1 antibody 
directed against an epitope located at the intracellular C-terminal domain 
of the rat Kir5.1 channel (raised against the peptide (C)-H-D-V-L-E-V-K-R-
K-Y-Y-K-V-N-C, corresponding to amino acid residues 311-325 of murine 
Kir5.1 (Accession NP_001239139.1)), and the Santa Cruz goat anti-Kir5.1 
antibody (T-14) directed at an epitope mapping near the C-terminus of 
human Kir5.1 (raised against amino acid residues between 369-418 
(Accession NP_001239139.1), information provided by the manufacturer), 
in explant cultures from P10 optic nerves (Fig 3.4). Western blot analysis 
demonstrated that the antibodies recognised a protein with the appropriate 
molecular weight, 48kDa (Figure 3.25). The pattern of immunolabelling 
was almost identical using the two antibodies, with both punctate, 
plasmalemmal staining, as well as intracellular staining, which was 
particularly enriched in a ring shape at the edge of the astrocytic cell 
somata. In astrocytes, the only difference identified between Alomone 
Kir5.1 and Santa Cruz Kir5.1 antibodies was the nuclear staining obtained 
with the latter, which was not prominent with the Alomone Kir5.1 antibody 
(Fig. 3.4 A, B). In oligodendrocytes, the pattern of immunostaining was 
almost identical with both antibodies, although the labelling of the distal 
processes appeared stronger with the Santa Cruz anti-Kir5.1 antibody 
(Fig.3.4 C, D). Overall, despite the two Kir5.1 antibodies being raised in 
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two different species, against a different, not overlapping part of the same 
protein they displayed an almost identical immunolabelling, proving the the 
specificity of the antibodies, both of which were used subsequently in the 
project. No immunolabelling was observed in negative controls using the 
blocking peptide or by omission of the primary antibody (see Figures 3.11 
and 3.12). 
  
Figure 3.4 Antibody specificity test and comparison of Kir5.1 immunolabelling in 
optic nerve astrocytes executed with the Alomone Kir5.1 and Santa Cruz Kir5.1 
antibody: Kir5.1 subunit immunocytochemistry (
nerve explanted astrocyt
Alomone anti-Kir5.1 antibody (
staining was used to visualize the nuclei of the optic nerve astrocytes (
20 µm 
 
A, B, C and D) of P10 wild type optic 
es (A, B) and oligodendrocytes(C, D) cultured for 11 DIV, for the 




B, D). Hoechst 
, B). Scale bars = 
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3.2.5 Comparison of Alomone and Santa Cruz anti-Kir2.1 antibodies 
Alomone rabbit polyclonal anti-Kir2.1 antibody directed against the 
intracellular C-terminal of the human Kir2.1 (raised against peptide (C)-N-
G-V-P-E-S-T-S-T-D-T-P-P-D-I-D-L-H-N, corresponding to amino acid 
residues 393-411 of murine Kir2.1 (C)-N-G-V-P-E-S-T-S-T-D-S-P-P-G-I-D-
L-H-N (Accession AAI37842.1), or Santa Cruz goat polyclonal anti-Kir2.1 
antibody (C-20) directed against an epitope near the C-terminus of human 
Kir2.1 (raised against amino acid between 378-427 of human Kir2.1 
(Accession P63252) information provided by manufacturer) were 
compared in P10 wild type and PLP-Ds-Red optic nerve explant cultures 
(Figs 3.5 and 3.6). Western blot confirmed the antibodies recognise a 
protein of the predicted molecular weight, 45kDa (Figure 3.26). The 
immunostaining in oligodendrocytes, but not in astrocytes, was almost 
identical with the two anti-Kir2.1 antibodies (Figure 3.6). Single Kir2.1 
subunit immunocytochemical analysis showed distinct labelling in 
astrocytes (Figure 3.5). The Sant Cruz antibody localised to what 
appeared to be intracellular cytoskeletal elements in astrocytes (Fig. 3.5B), 
and in oligodendrocytes there was evident nuclear staining with the Santa 
Cruz antibody (Fig. 3.6B), which was not observed with the Alomone 
antibody, where immunostaining appeared punctate and plasmalemmal in 
both astrocytes and oligodendrocytes. The Santa Cruz antibody was 
preferred in subsequent analyses. No immunolabelling was observed in 
negative controls using the blocking peptide or by omission of the primary 
antibody (see Figures 3.14 and 3.15). 
  
Figure 3.5 Antibody specificity test and comparison of Kir2.1 immunolabelling in 
optic nerve astrocytes executed with the Alomone Kir2.1 and Santa Cruz Kir2.1 
antibody: Single Kir2.1 subunit immunocytochemistry (
optic nerve explants cult
Cruz Kir2.1 antibody (B
nerve astrocytes (A, B). Scale bars = 20 
A and B) of the P10 wild type 
ured for 11 DIV executed with the Alomone Kir2.1 (




A) and Santa 
 
 Figure 3.6 Antibody specificity test and comparison of Kir2.1 immunolabelling in 
optic nerve oligodendroglia executed with the Alomone Kir2.1 and Santa Kir2.1 
antibody:  Kir2.1 subunit immunocytochemistry (
explants cultured for 11 DIV (
10 DIV (Bi). Oligodendroglial expression is shown by immunocytochemical double 
labelling of wild type optic nerve explanted glia for O4 (
immunocytochemical Kir2.1 labell
oligodendroglia (Bii). Scale bars = 20 
Ai and Bi) of P11 wild type optic nerve 
Ai) and P10 PLP-DsRED optic nerve explants cultured for 
Aiii) and Kir2.1,  or 







3.3 Expression patterns of Kir4.1, Kir5.1 and Kir2.1 
immunostaining in optic nerve glia 
3.3.1 Kir4.1 in optic nerve astrocytes and oligodendrocytes 
Expression of Kir4.1 subunit in astrocytes is shown by double 
immunolabelling with GFAP (Figure 3.7), and in oligodendrocytes using 
PLPDsRed expression (Fig. 3.8). Astrocytes displayed punctate, 
plasmalemmal staining, which was particularly enriched at the end of the 
processes, but there was a degree of heterogeneity in the overall level of 
immunostaining (Figure 3.7A-C). The orthographic projection (Figure 3.7B) 
demonstrates very little intracellular Kir4.1 immunolabelling in the optic 
nerve astrocytes. No immunostaining was observed in the Kir4.1 KO 
astrocytes that were used as a negative control (Figure 3.7D). Optic nerve 
oligodendroglia were also stongly immunopositive for Kir4.1 (Fig. 3.8), and 
displayed punctate on the cell somata and primary processes, with 
apparently weaker immunopositivity on the distal processes. The 
orthographic projection (Figure 3.8B) demonstrates some intracellular 
Kir4.1 immunolabelling in the optic nerve oligodendrocytes. 
 
 The number of Kir4.1+ voxels was quantified in a 9 µm3 area on the 
processes and cell somata of optic nerve astrocytes (n=15 cells) and 
oligodendrocytes (n=14), using Volocity software (Figure 3.9). In 
astrocytes, the density of Kir4.1+ voxels was significantly greater (p<0.05, 
unpaired t-test) on cell process (7741 ± 2248) than on the cell somata 
(2456 ± 1088), indicating a concentration of the channels on astroglial 
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processes. Whereas oligodendroglia displayed significantly greater 
(p<0.001, unpaired t-test) expression on cell somata (6673 ± 2917) than 
on the processes (1129 ± 557) (Fig. 3.9).  
 
Previous studies have indicated heterogeneous Kir4.1 expression in 
astrocytes (Poopalasandurum et al., 2000; Tang et al., 2009), and this was 
also observed in astrocytes from P10 wild type optic nerves, where I 
observed 4 different Kir4.1 expression patterns (Fig 3.10): A, Kir4.1 is 
highly enriched at edge of the cell and the end of the processes; B, Kir4.1 
is punctate on the processes; C, the cell somata and the end of processes 
are strongly immunopositive; D astrocytes displaying weak Kir4.1 
immunolabelling. 
 
 Figure 3.7: Expression pattern of Kir4.1 in optic nerve astrocytes
for GFAP (red) and Kir4.1(green) in 
and DIV15 DIV (B). (A
orthographic projection
in Kir4.1 KO astrocytes
explants cultures from P7-P8 nerves at DIV10 (
),(C) and (D) are the three dimentional projections, (
 of the thee dimentional confocal images; Kir4.1 immunolabbeling 
 (Di) that were used as a negative control. Scale bars = 20 
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: Double labelling 
A, D) 
B) is the 
µm 
 Figure 3.8: Expression pattern of the Kir4.1 subunit in optic nerve 
oligodendrocytes: Kir4.1 subunit immunocytochemistry (
DsRED-PLP optic nerve explants cultured for 10 DIV; 
projections, (B) orthographic projection
antibody was omitted in the negative control (
Ai, Bi, Ci and 
(A),(C) and (D) three dimentional 
 of the thee dimentional confocal images 
Di). Scale bars = 20 µm 
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Di) of the P10 
Kir4.1 
 
 Figure 3.9 Number of Kir4.
processes and cell somata of optic nerve astrocytes and oligodendrocytes:
(+SEM) number of Kir4.1
PLP-DsRED+ oligodendrocytes (n=14), from 3 different measurement on processes and 
cell somata. Results obtained 3 independent experiments from 24 wild type 
DsRED mice.  
 
1 immunopositive voxels per 9 µm3 constant area on the 







 Figure 3.10: Heterogeneity in the expression pattern of Kir4.1 in optic nerv
astrocytes: Single Kir4.1 subunit immunocytochemistry (
type optic nerve explants cultured for 12 DIV. Astrocytic nuclei visualized with Hoescht 
staining. Representation of 4 different expression patterns of Kir4.1: (
enriched at the plasma membrane and at the end
displays a punctate staining on the astrocytic processes; (
the end of processes 
weak Kir4.1 immunopositivity next to an astrocyte showing strong Kir4.1 
immunopositivity. Astrocytes were identified by cellular morphology. 
 
Ai, Bi, Ci and 
A)
 of the astrocytic processes; (
C) astrocytic cell somata and 
are strongly immunopositive for Kir4.1; (D) astrocyte displaying 





Di) of P10 wild 





3.3.2 Kir5.1 in optic nerve astrocytes and oligodendrocytes 
Kir5.1 have been reported in astroglia, where they are believed to be 
important for K+ uptake. In contrast, oligodenroglial expression of Kir5.1 
has not previously been examined. Expression of Kir5.1 subunit in 
astrocytes is shown by double immunolabelling of the P10 wild type optic 
nerve explants cultured for 11 DIV with GFAP and in oligodendrocytes by 
using PLP-DsRED P11 optic nerve explants cultured for 11 DIV. Punctate 
plasmalemmal Kir5.1 immunolabelling was evident in astrocytes, but the 
orthographic projection (Figure 3.11B) demonstrates that Kir5.1 
immunostaining appeared mainly intracellular; no immunopositivity was 
detected in negative control (Fig. 3.11D). Oligodendrocytes were stongly 
immunopositive for Kir5.1, with punctate staining on the cell somata, and 
weaker immunopositivity on the primary and distal processes (Fig. 3.12); 
the orthographic projection (Figure 3.12B) demonstrates no intracellular 
Kir5.1 immunolabelling in the optic nerve oligodendrocytes, no 
immunopositivity was detected in the negative control. 
Quanitification of Kir5.1 immunostaining from constant areas revealed far 
greater (p<0.001, unpaired t-test) expression of Kir5.1 on astrocyte 
somata (10452 ± 4574) than on the processes (1082 ± 850), whereas 
expression levels in oligodendrocyte somata were only slightly greater 
than processes, respectively 2652 ± 1033 and 1816 ± 847. 
In addition, astrocytes displayed a high degree of heterogeneity, as 
observed for Kir4.1, and I identified the 4 different expression pattern that 
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was present in wild type and GFP-GFAP astrocytes as well (Fig. 3.14): A, 
(Fig. 3.14 Ai): punctate, mostly somatal staining, which was particularly 
enriched in a ring around the cell somata, with processes showing weak 
Kir5.1 immunopositivity B while (astrocyte at the bottom) (Fig. 3.14 Ai) 
displays homogenous punctate staining; C, (Fig. 3.14 Bi): punctate 
staining localised almost exclusively to the plasma membrane and 
particularly enriched on the somatal plasmalemma, with minor intracellular 




 Figure 3.11: Expression pattern of Kir5.1 in optic nerve astrocytes
(green) and GFAP (red) double immunolabelling in
cultured for 11 DIV; (
projection of the thee dimentional confocal images
preincubation with the Kir5.1 blocking peptide
 
 P10 wild type optic nerve explants 
A),(C) and (D) three dimentional projections, (
 (D) negative control




: (A-C) Kir5.1 
B) orthographic 
 following 
 Figure 3.12: Expression 
Kir5.1 immunolabelling (green) in oligodenrocytes identified by expression of the PLP
DsRed reporter (P11 DsRED
(D) three dimentional projec
confocal images.(D) negative control
peptide. Scale bars = 20 
pattern of Kir5.1 in optic nerve oligodendrocytes
-PLP optic nerve explants cultured for 11 DIV); 
tion and (B) orthographic projection of the thee dimentional 












Figure 3.13 Number of Kir5.1 
analysed on the processes and cell somata of optic nerve astrocytes and 
oligodendrocytes: Mean (
optic nerve astrocytes (n=22) and PLPDsRED+ oligodendrocytes (n=15), from 3 differen
measurement on processes and cell somata.
subunit positive voxels per 9 µm





 constant area 
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 Figure 3.14: Heterogeneity in the expression pattern of Kir5.1 in the optic nerve astrocytes
optic nerve explants (A, B) cultured for 12 DIV and P11 transgenic GFAP
by GFAP immunolabelling in wild type optic nerve explanted astrocytes (
pattern of the Kir5.1 subunit identified in the optic nerve astrocytes. Scale bars = 20 
:: Kir5.1 subunit immunocytochemistry of the P10 wild type 
-EGFP optic nerve explants (C) cultured for 11 DIV. Astrocytic expression is shown 







3.3.3 Kir2.1 in optic nerve astrocytes and oligodendrocytes 
Kir2.1 have been reported in astroglia, where their strong rectifying 
properties are believed to be important for K+ uptake. In contrast, 
oligodenroglial expression of Kir2.1 has not previously been examined. 
Figures 3.15 and 3.16 illustrate Kir2.1 immunolabelling in astrocytes and 
oligodendrocytes in P10 optic nerve explants cultured for 11 DIV. Optic 
nerve astrocytes showed weak immunopositivity for Kir2.1 (Fig. 3.15), 
consistent with reports in the retina that astroglial Kir2.1 expression was 
12 times lower than Kir4.1 (Ulbricht et al., 2008). Astroglial labelling 
appeared punctate and was predominant in the processes; no 
immunopositivity was detected in the negative control. In 
oligodendrocytes, identified by expression of the PLP-DsRED reporter or 
double immunolabelling for O4, there was weak Kir2.1 immunopositivity, 
with punctate staining on the plasma membrane of the cell somata on the 
processes of the oligodendroglia; no immunopositivity was detected in the 
negative control. 
  
 Figure 3.15: Expression pattern of Kir2.1 in optic nerve astrocytes
(green) and GFAP (red) double immunolabelling of P10 wild type optic nerve explants 
cultured for 11 DIV; (D) negative control in which the Kir2.1 antibody was omitted. Scale 




: (A-C) Kir2.1 
 Figure 3.16: Expression pattern of Kir2.1 in optic nerve o
Kir2.1 immunolabelling (green) of P10 PLP
DIV (A, B), and P11 wild type optic nerve explants cultured for 11 DIV and double 
labelled for O4 (C, D); (
Kir2.1 peptide. Scale bars = 20 
ligodendrocytes
-DsRED optic nerve explants cultured for 10 







3.4 Plasmalemmal localisation of Kir subunits in optic nerve glia 
Na+/K+ ATPase is a plasma membrane-bound protein that establishes and 
maintains the high internal K+ and low internal Na+ concentrations across 
the membrane typical for most animal cells. I used Na+/K+ ATPase α1 
subunit as a plasma membrane marker to determine the functional surface 
expression of the Kir4.1, Kir5.1 and Kir2.1 subunits in vitro, and I used 
western blot analysis of purified plasma membrane fractions to test this in 
vivo. 
 
3.4.1 Purification of plasmalemmal fraction in the optic nerve 
To establish plasmalemmal expression of Kir channels by western blot, I 
needed to purify the plasma membrane fraction. The main problem during 
purification of the plasma membrane fraction is contamination with other 
cell organelle membranes. First, I used western blot to verify the purity of 
the isolated brain plasma membrane fraction (Figure 3.17). To determine 
the level of contamination, I then used organelle specific antibodies 
against the intracellular organelle membranes. Calreticulin antibody, a 
marker for the endoplasmic reticulum, was used to measure the quantity of 
the endoplasmic reticulum membranes in the whole brain lysate and in the 
plasma membrane fraction purified from the whole brains of P19 wild type 
mice. Bands were detected at the predicted 60 kDa molecular weight of 
calreticulin. The results show that compared to the the β actin, the level of 
the ER marker was decreased by 8.52 times in the isolated plasma 
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membrane fraction compared to the ER marker levels measured in the 
whole brain lysate. Next, I used the mitochondrial marker anti-prohibitin 
antibody to measure the quantity of the mitochondrial membranes in the 
whole brain lysate and in the plasma membrane fraction purified from the 
whole brains of P19 wild type mice. A band was detected at 30 kDa at the 
predicted molecular weight of prohibitin, and compared to the β actin, the 
level was decreased by 11.36 times in the isolated plasma membrane 
fraction compared to the mitochondrial marker levels measured in the 
whole brain lysate. Anti-Na+/K+ ATPase antibody was used to measure the 
quantity of the plasma membrane proteins in the whole brain lysate and in 
the plasma membrane fraction purified from the whole brains of P19 wild 
type mice. A band was detected at 112kDa at the predicted molecular 
weight of Na/K ATPase α1 subunit, and compared to the the β actin the 
plasma membrane proteins were enriched 5.64 times in the plasma 
membrane fraction. As the contamination of the plasma membrane 
fraction with endoplasmic reticulum and mitochondrial membranes was 
minor, it was considered an accurate way to examine plasmalemmal 
expression of ion channels. 
  
 Figure 3.17 Verification of the purity of the plasma membrane fraction: 
for the different intracellular organelle markers using total protein extracted (30 
from the whole brain and brain plasma membrane fraction purified from the whole brains 
of P19 wild type mice. 
used to measure the quantity of the endoplasmic reticulum membranes in the whole brain 
lysate and in the plasma membrane fraction;  bands were detected at 60 kDa, the 
predicted molecular weight of calreticulin. 
mitochondria, was used to measure to quantity of the mitochondrial membranes in the 
whole brain lysate and in the plasma membrane fraction; bands were detected at 30 kDa, 
the predicted molecular weight of prohibitin. 
plasma membrane, was used to measure to quantity of the plasma membrane proteins in 
the whole brain lysate and in the plasma membrane fraction; bands were detected at 112 
kDa, the predicted molecular weight of Na/K ATPas 
the bands normalised to the beta actin. The marker protein levels for different intracellular 
organelles from the whole brain are represented by blue bars, and from the brain plasma 
membrane fraction are represented by red bars. The contamination of the plasma 
membrane fraction was minor with endoplasmic reticulum (decreased by 8.52 times) and 
mitochondrial membranes (decreased by 11.36) and the plasma membrane proteins were 
enriched successfully by 5.64 times in the isolated plasma membrane fraction.
A Calreticulin antibody, a marker for endoplasmic reticulum, was 
B prohibitin antibody, a marker for 
C Na/K ATPase antibody, a marker for 









3.4.2 Plasmalemmal localisation of Kir4.1 in astrocytes in vitro 
Figure 3.18 shows Kir4.1, Na+/K+ATPase α1 subunit, and GFAP triple 
immunolabelling of P8 wild type optic nerve explants. Notably, the majority 
of Kir4.1 immunostaining co-localised with the Na+/K+ ATPase α1 subunit 
in astrocytes, indicating plasmalemmal localisation of Kir4.1, consistent 
with a prominent functional role in optic nerve astrocytes and potassium 
buffering. Quantification of the extent of co-localisation between Kir4.1 and 
Na+K+ ATPase was determined using Volocity to create a colocalisation 
channel and determine the number of voxels co-expressing Kir4.1 and 
Na+/K+ ATPase α1 subunit (Fig. 3.19). The results from 8 different wild 
type astrocytes show that from 114733 ± 51385 Kir4.1+ voxels, 48651 ± 
22561 colocalised with the Na+/K+ ATPase α1 subunit per cell. As the 
Na+/K+ ATPase is always located to the plasma membrane, these results 




Figure 3.18: Kir4.1 and Na/K ATPase
nerve astrocytes: (A, B) 
immunocytochemistry of P8 wild type optic nerve explants cultured for 15 DIV; astrocytes 
were identified by GFAP immunolabelling (grey). Pla
and Na/K ATPase α1 subunit appears yellow. Scale bars = 20 
 α1 subunit immmunocytochemistry of optic 
Kir4.1 (green) and Na/K ATPase α









Figure 3.19 Number of Kir4.1 subunit positive voxels co-localising with 
plasmalemmal Na/K ATPase. Volocity software was used to create a co-localisation 
channel and count the total number of Kir4.1 subunit positive voxels and plasma 
membrane bound Kir4.1 subunit voxels per optic nerve astrocytes. Bars represent the 
mean number of Kir4.1 subunit positive voxel and plasma membrane bound Kir4.1 
subunit voxels (co-localised with the plasma membrane marker Na/K ATPase α1 subunit) 
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3.4.3 Plasmelemmal localisation of the Kir4.1 subunit in the optic 
nerve in vivo 
Western blot analysis of total protein extracted from the whole brain of the 
P19 wild type and Kir4.1 knock out mice (Fig. 3.20A), and from total optic 
nerve lysate and optic nerve plasma fraction of wild type mice (Fig. 3.20B), 
revealed bands at ~42 kDa as predicted from the molecular weight of the 
Kir4.1 subunit. Bands were detected from the wild type brain at ~42 kDa 
and ~160 kDa, but not from the Kir4.1 knock out brain, corresponding to 
the monomeric ~42 kDa and tetrameric ~160 Kda Kir4.1 channels. The 
lack of bands corresponding to the Kir4.1 subunit in the Kir4.1 knock out 
brain confirmed the specificity of the in house Kir4.1 antibody. The western 
blot data also indicated that the enrichment of the Kir4.1 subunit in optic 
nerve plasma membrane fraction, compared to the total optic nerve lysate, 
and confirm the plasmalemmal expression of the Kir4.1 subunit in vivo in 
the optic nerve.  
 
  
 Figure 3.20 Antibody specificity test and Kir4.1 subunit protein level in the optic 
nerve plasma membrane fraction and total optic nerve lysate
western blot analysis using (30 
Kir4.1 knock out mice and wild type mice. 
µg/lane) protein extracted from the total optic nerve lysa
membrane fraction of the P20
and ~160 kDa ( tetramer ) as predicted, in the wild type brain, in the total optic nerve 
lysate (ON) and in the optic nerve plasma membrane frac
molecular weight (MW) of the Kir4.1 subunit is 42 kDa. 
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3.4.4 Plasmalemmal localisation of Kir5.1 in astrocytes in vitro 
Figure 3.21 shows Kir5.1 and Na+/K+ ATPase α1 subunit triple 
immunolabelling with GFAP in P8 wild type optic nerve explants. Co-
localisation with the Na+/K+ ATPase α1 subunit identified that the ring of 
Kir5.1 immunostaining on the cell somata was plasmalemmal. Co-
localisation of Kir5.1 and Na+/K+ ATPase α1 subunit was also identified on 
astroglial processes. Quantitation of colocalisation using Volocity from 26 
different astrocytes showed that from 78702 ± 24160 Kir5.1+ voxels, 
11951 ± 8782 colocalised with the Na+/K+ ATPase α1 subunit per cell (Fig. 
3.22). The results confirm plasmalemmal expression of Kir5.1, but also 
indicate substantial intracellular Kir5.1 expression in optic nerve 
astrocytes. However, the significant amount of Kir5.1 + voxels that did not 
co-localise with the Na+/K+ ATPase α1 subunit might be plasma 
membrane bound Kir5.1 subunits that are in the different microdomains of 
the plasma membrane than the Na+/K+ ATPase α1 subunit due to the 
different clustering mechanism or as not all the functional Na+/K+ ATPases 
contain α1 subunit (there are 3 other α subunits) some of the Kir5.1 + 
voxels might co-localise with the other α subunits.  
 Figure 3.21: Kir5.1 and Na/K ATPase 
nerve astrocytes: Kir5.1 (
immunocytochemistry of the P8 wild type optic nerve explants cultured for 10 DIV. 
Astrocytic expression is shown by the immunocytochemical triple labelling of the 
type optic nerve explanted astrocytes for GFAP, (




Aii and Bii) and Na/K ATPase α1 subunit (
Aiv and Biv) (astrocytic cell specific 
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Figure 3.22 Number of Kir5.1 subunit positive voxels and plasma membrane bound 
Kir5.1 voxels per optic nerve astrocyte: Kir5.1 subunit and Na/K ATPase 
immunocytochemical analysis of the P8 wild type optic nerve explants cultured for 10 
DIV. Astrocytic expression is shown by the immunocytochemical triple labelling of the 
wild type optic nerve explanted astrocytes for GFAP, (astrocytic cell specific marker) 
Kir5.1 and Na/K ATPase α1 subunit. Software volocity used to create a co-localisation 
channel and count the total number of Kir5.1 subunit positive voxels and plasma 
membrane bound Kir5.1 subunit voxels per optic nerve astrocytes. Bars represent the 
average number of Kir5.1 subunit positive voxel and plasma membrane bound Kir5.1 
subunit voxels ( co-localised with the plasma membrane marker Na/K ATPase α1 
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3.4.5 Plasmalemmal localisation of Kir5.1 in oligodendrocytes in vitro 
Figure 3.23 shows Kir5.1 and Na+/K+ ATPase α1 subunit double 
immunolabelling in morphologically identified oligodendrocytes from P8 
wild type optic nerve explants. Kir5.1 and Na+/K+ ATPase α1 subunit 
immunolabelling co-localised to a ring of expression on the cell somata 
plasmalemma. In addition, strong co-localised Kir5.1 and Na+/K+ ATPase 
α1 subunit expression was identified on the processes of oligodendroglia, 
including the myelin expansions. Co-localisation was quantified using 
Volocity (n=12 oligodendrocytes), and showed that from 71564 ± 33978 
Kir5.1+ voxels, 6824 ± 2752 colocalised with the Na/K ATPase α1 subunit 
per cell (Fig. 3.24). The results demonstrate plasmalemmal expression of 
Kir5.1 channel subunits, and a high degree of cytoplasmic Kir5.1 in optic 
nerve oligodendrocytes. However, the significant amount of Kir5.1 + 
voxels that did not co-localise with the Na+/K+ ATPase α1 subunit might be 
plasma membrane bound Kir5.1 subunits that are in the different 
microdomains of the plasma membrane than the Na+/K+ ATPase α1 
subunit due to the different clustering mechanism or as not all the 
functional Na+/K+ ATPases contain α1 subunit (there are 3 other α 
subunits) some of the Kir5.1 + voxels might co-localise with the other α 
subunits.  
 Figure 3.23: Kir5.1 and 
nerve oligodendroglia
and Ciii) immunocytochemistry of the P8 wild type optic nerve explants cultured for 10 
DIV. Plasma membrane of the 
ATPase α1 subunit plasma membrane marker. Scale bars = 20 
Na/K ATPase α1 subunit immmunocytochemistry of optic 
: Kir5.1 (Aii, Bii and Cii) and Na/K ATPase α1 subunit (









Figure 3.24 Number of Kir5.1 subunit positive voxels and plasma membrane bound 
Kir5.1 voxels per optic nerve oligodendroglia: Kir5.1 subunit and Na/K ATPase 
immunocytochemical analysis of the P8 wild type optic nerve explants cultured for 10 
DIV. Plasma membrane of the optic nerve oligodendroglia immunolabelled with Na/K 
ATPase α1 subunit plasma membrane marker. Software volocity used to create a co-
localisation channel and count the total number of Kir5.1 subunit positive voxels and 
plasma membrane bound Kir5.1 subunit voxels per optic nerve oligodendroglia. Bars 
represent the average number of Kir5.1 subunit positive voxel and plasma membrane 
bound Kir5.1 subunit voxels ( co-localised with the plasma membrane marker Na/K 
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3.4.6 Plasmalemmal localisation of Kir5.1 in the optic nerve in vivo 
Functional ion channels are transported and inserted into the plasma 
membrane to regulate the voltage gradient across the membrane by 
controlling the ion movement through the channel pore. To establish the in 
vivo plasma membrane expression of the Kir5.1 subunit in the optic nerve, 
I used Western blot (Fig. 3.25). Western blot analysis of protein extracted 
from the wild type P21 total optic nerve lysate and optic nerve plasma 
fraction of the P20-P23 wild type mice demonstrates bands at ~ 48 kDa, 
as predicted from the MW of Kir5.1, and in addition bands at ~70kDa. No 
bands were observed in the negative controls following pre-incubation in 
the blocking peptide (Fig. 3.25). The surface, plasmalemmal expression of 
ion channels is often regulated by glycosylation (Cotella et al., 2012, 
Egenberger et al., 2010, Utsunomiya et al., 2010, Zhu et al., 2012), and 
the band detected at ~70 kDa was more enriched in the optic nerve 
plasma membrane fraction compared to the total optic nerve lysate, hence 
presumably is the membrane bounded, fully glycosylated form of the 
Kir5.1 subunit. The integrated density of the 48 kDa and 70 kDa bands 
were measured and normalised to the beta actin which demonstrated the 
2.26 times enrichment of the Kir5.1 and 3.93 time enrichment of the fully 
glycosylated Kir5.1 in optic nerve plasma membrane fraction. Overall, the 
Western blot data showed expression of the Kir5.1 subunit in optic nerve 
plasma membrane fraction and the enrichment of the Kir5.1 subunit in 
plasma membrane in vivo in the optic nerve, furthermore, suggesting that 
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Figure 3.25 Kir5.1 subunit protein level in 
fraction and total optic nerve lysate
30 µg/lane) protein extracted from the P21 wild type total optic nerve lysate and optic 
nerve plasma membrane fraction of the P20
kDa as predicted, in the wild in the total optic nerve lysate (ON) and in the optic nerve 
plasma membrane fraction (ON PMF),as the molecular weight (MW) of the Kir5.1 subunit 
is 48 kDa.. Bands also detected at ~
subunit. Immunoblotting was absent in negative control where Kir5.1 antibody 
preincubated with the blocking peptide
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3.4.7 Plasmalemmal localisation of Kir2.1 in the optic nerve in vivo 
Plasmalemmal localisation of Kir2.1 was examined by western blot (Fig. 
3.26). In protein extracted from the wild type P21 total optic nerve lysate 
and optic nerve plasma fraction of the P20-P23 wild type mice, bands 
were detected at ~ 45 kDa as predicted, together with a second band at 
~60 kDa. No bands were observed in the negative controls following pre-
incubation in the blocking peptide (Fig. 3.26A). The 60 kDa band was 
more enriched in the optic nerve plasma membrane fraction compared to 
the total optic nerve lysate, hence presumably is the membrane bounded, 
fully glycosylated form of the Kir2.1 subunit. The integrated density of the 
45 kDa and 60 kDa bands were measured and normalised to the beta 
actin which demonstrated the 2.91 times enrichment of the Kir2.1 and 6.28 
time enrichment of the fully glycosylated Kir2.1 in optic nerve plasma 
membrane fraction. The results demonstrate expression and the 
enrichment of the Kir2.1 subunit in optic nerve plasma membrane fraction, 




Figure 3.26 Kir2.1 subunit protein level in the 
fraction and total optic nerve lysate
30 µg/lane) protein extracted from the P21 wild type total optic nerve lysate and optic 
nerve plasma membrane fraction of the P20
kDa as predicted, in the wild in the total optic nerve lysate (ON) and in the optic nerve 
plasma membrane fraction (ON PMF),as the molecular weight (MW) of the Kir2.1 subunit 
is 45 kDa. Bands also detected at ~
subunit. Immunoblotting was absent in negative controls where Kir2.1 antibody was 
preincubated with the blocking peptide.
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Glia in the CNS have been reported to express predominantly Kir4.1 
channels (Kalsi et al., 2004, Olsen et al., 2006, Poopalasundaram et al., 
2000, Seifert et al., 2009). In addition, Kir4.1 form functional heteromeric 
channels with Kir5.1 subunits, which have a major role in chemoreception 
in retrotrapezoid nucleus astrocytes, and are also reported to be 
expressed widely by astrocytes in the retina, hippocampus, neocortex, and 
olfactory bulb (Hibino et al., 2004, Ishii et al., 2003, Mulkey and Wenker, 
2011, Wenker et al., 2010). Furthermore, strongly rectifying Kir2.1 are 
proposed to be important for K+ uptake by astrocytes, and their expression 
has been demonstrated in the retina, cerebral cortex and hippocampus, 
the latter only under pathophysiological conditions (Howe et al., 2008, 
Kang et al., 2008, Kofuji et al., 2002). The primary astrocyte function of 
brain [K+]o homeostasis is believed to involve uptake at sites of high 
activity through strongly rectifying Kir2.1 and Kir4.1/Kir5.1 heteromeric 
channels, and release of K+ via weakly rectifying Kir4.1 homomeric 
channels at sites of low activity, such as blood vessels. However, few 
studies have examined co-localisation of Kir subunits in astrocytes, and 
very little is known about oligodendrocytes, where there is even 
controversy over their expression of Kir4.1 channels, and no reports on 
their expression of other Kir subunits (Butt and Kalsi, 2006). Here, I 
demonstrate strong plasmalemmal expression of Kir4.1 and Kir5.1 in 
astrocytes and, for the first time, oligodendrocytes. In contrast, expression 
of Kir2.1 subunits was weaker, although there was clear expression in 
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optic nerve glia, detected by immunocytochemistry in vitro and western 
blot in vivo. Furthermore, my results demonstrate the in vivo 
plasmalemmal expression of the three Kir subunits, consistent with roles 
for these channels in setting the membrane properties of astrocytes and 
oligodendrocytes, and involvement in their respective primary functions of 
potassium homeostasis and myelination. 
 
3.5.1 Optimisation and validation of Kir immunolabelling 
To establish the expression pattern of the Kir subunits in glia, it was 
essential to optimise the immunocytochemical methods and validate the 
antibodies, using western blot and, in the case of Kir4.1, tissue from the 
knock out mouse. Comparison of fixation with 1% PFA+15% picric acid, 
conventional 4% PFA or methanol, confirmed previous reports that 
methanol is an optimal fixative for Kir immunocytochemistry (Kalsi et al., 
2004). However, methanol fixation was not suitable for cells that express 
fluorescent reporters (whether by transfection or isolation from transgenic 
mice), since methanol caused the formation of plasmalemmal pores 
resulting in the loss of cytoplasmic fluorophore. Nonetheless, 1%PFA and 
picric acid proved to be as favourable as methanol for correct 
plasmalemmal clustering of Kir immunostaining, and it was suitable for the 
fixation of cells expressing fluorescent reporters. In addition, I examined 
the use of 2% or 5% serum in the antibody cocktail, to reduce non-specific 
labelling. It is conventional to use 4-5% serum, but this resulted in 
intracellular and nuclear immunostaining of Kir in cultured cells, which is 
147 
 
inconsistent with the localisation of plasmalemmal ion channels. In 
contrast, the use of 2% serum resulted in plasmalemmal and clustered 
immunostaining, as predicted for ion channels. Hence, I routinely used 
1%PFA+PA in 2% serum for Kir immunolabelling. 
  
The standard techniques for verifying antibody specificity are by western 
blot and immunocytochemistry, using the appropriate knock out animal or 
blocking peptide which the antibody was raised against. We have a Kir4.1 
knock-out mouse colony, and so it was possible to validate the anti-Kir4.1 
antibodies using these mice. Western blot analysis confirmed a band at 
the predicted size of 42kDa, which was absent in Kir4.1 knock-out tissue. 
Wild type optic nerve astrocytes, as predicted, showed immunopositivity 
for the Kir4.1 subunit using both in-house (Kalsi et al., 2004, 
Poopalasundaram et al., 2000) and Alomone rabbit polyclonal anti-Kir4.1 
antibody antibodies. The Alomone Kir4.1 antibody and the in house Kir4.1 
antibody labelled the optic nerve astrocytes identically with punctate 
staining displayed at the plasmalemma which was particularly enriched at 
the astroglial membrane edges. The two Kir4.1 antibodies are directed 
against over-lapping but non-identical sequences of the intracellular C-
terminus of rat Kir4.1, corresponding to amino acid residues 350-368 for 
the in-house antibody (peptide sequence (C)-G-D-P-E-K-L-K-L-E-E-S-L-R-
E-Q-A-E-K-E), and amino acid residues 356-375 for the Alomone antibody 
(peptide sequence (C)-K-L-E-E-S-L-R-E-Q-A-E-K-E-G-S-A-L-S-V-R), 
overlapping peptides highlighted. The knock-out mouse was generated 
using a 6 kb fragment, which contained the entire coding sequence exon 
148 
 
and the deleted fragment encodes the amino acids 33–266 in the Kir4.1 
deduced primary sequence and thus contains the putative transmembrane 
domains and part of the C terminus of the Kir4.1 polypeptide (Kofuji et al., 
2000). The knock-out mouse has been validated previously using RT-PCR 
and rabbit polyclonal antibodies directed against a synthetic peptide (C)R-
E-Q-A-E-K-E-G-S-A-L-S-V-R-I-S-N-V (peptides overlapping with our in-
house antibody and the Alomone antibody highlighted in yellow and red), 
corresponding to the amino acids 362–379 in the C terminus of mouse 
Kir4.1 (Kofuji et al., 2000). My results using the Kir4.1 knock out mouse 
confirmed that our in-house antibody is specific to the deleted Kir4.1 
channel, and supports the previous studies using a different antibody 
(Kofuji et al., 2000; Neusch et al., 2001). The Alomone antibody is directed 
against a peptide sequence that overlaps with our antibody and that of 
(Kofuji et al., 2000) (G-D-P-E-K-L-K-L-E-E-S-L-R-E-Q-A-E-K-E-G-S-A-L-S-
V-R-I-S-N-V), and so the specificity can not be in doubt.  
 
In the case of Kir5.1 and Kir2.1, I did not have knock-out mice available, 
and so I confirmed the specificity of these antibodies using blocking 
peptides and by comparing two commercially available antibodies from 
Alomone and Santa Cruz. Western blot analysis confirmed a band at the 
predicted size of 48kDa, which was absent following pre-incubation with 
the blocking peptide. Comparison of immunolabelling with the Alomone 
rabbit polyclonal anti-rat Kir5.1 antibody and the Santa Cruz polyclonal 
goat anti-mouse Kir5.1 antibody, two different, non overlapping antibodies 
both directed at epitopes in the C-terminus, provided almost identical 
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results in optic neve glia, and immunostaining was absent following pre-
incubation with the appropriate blocking peptide. However, in the case of 
Kir2.1, immunostaining patterns of astrocytes but not oligodendrocytes 
were markedly different using the two different but overlapping Alomone 
rabbit polyclonal anti-human Kir2.1  and Santa Cruz goat polyclonal anti-
human Kir2.1 antibodies. In astrocytes, the Alomone anti-Kir2.1 antibody 
showed heavy intracellular labelling of the processes, whereas the Santa 
Cruz anti-Kir2.1 antibody displayed plasmalemmal punctate staining over 
the entire cell. No immunolabelling was observed in negative controls, and 
western blot analysis confirmed a band at the predicted size of 45kDa, 
which was absent following pre-incubation with the blocking peptide. The 
difference in the pattern of immunostaining in astrocytes detected using 
the two antibodies is difficult to explain, especially since this was not 
observed in oligodendrocytes, indicating it was not a methodological issue. 
The results raise the possibility that Kir2.1 immunolabelling using the 
Alomone antibody resulted in non-specific binding to intracellular 
elements, and so the Santa Cruz anti-Kir2.1 antibody was preferred, due 
to its preferential plasmalemmal immunostaining, as predicted for 
membranous potassium channels. 
  
3.5.2 Plasmalemmal localisation of Kir subunits 
Western blot and immunocytochemical analyses demonstrated 
plasmalemmal localisation of the Kir subunits in optic nerve glia. Western 
blot analysis of optic nerve plasma membrane and total optic nerve lysate 
demonstrated robust bands as predicted according to the homomer 
150 
 
molecular weights, 40kDa for Kir4.1, 48 kDa for Kir5.1 and 45 kDa for 
Kir2.1. In addition, a strong band for Kir4.1 was indicated at 160 kDa, 
which corresponds to the homo-tetrameric channel as observed previously 
in the brain and retina (Kofuji et al., 2000, Ulbricht et al., 2008). 
Furthermore, bands were detected at 60 kDa for Kir2.1 and 70 kDa for 
Kir5.1, which were more enriched in the optic nerve plasma membrane 
fraction, and are consistent with previous findings that surface expression 
of the ion channels is regulated by glycosylation (Cotella et al., 2012, 
Egenberger et al., 2010, Utsunomiya et al., 2010, Zhu et al., 2012). The 
western blot data indicated enrichment of the Kir4.1, Kir5.1 and Kir2.1 
subunits in the plasma membrane fractions of the optic nerve, and 
immunocytochemical analysis confirmed plasmmalemmal punctate 
localisation of the channels in astrocytes and oligodendrocytes. Co-
localisation analysis with Na-K-ATPase, a plasma membrane-bound 
protein, established that Kir4.1 and Kir5.1 were localised at the 
plasmalemma; this analysis was not performed for Kir2.1, but labeling 
appeared localised to the cell membranes in astrocytes and 
oligodendrocytes, consistent with the western blot findings. The 
plasmalemmel expression of Kir2.1 channels in optic nerve glia and their 
known strong rectifying properties are consistent with their playing a role in 
setting the membrane potential and possibly in potassium buffering (Brew 
et al., 1986, Karwoski et al., 1989, Kofuji et al., 2002, Oakley et al., 1992, 
Nilius and Reichenbach, 1988, Skatchkov et al., 1999). However, the far 
greater expression of Kir4.1 and Kir5.1, suggested by the diminished Kir 
currents in the Kir4.1 knock out mouse indicates far more important roles 
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for these subunits, consistent with electrophysiological and histological 
findings in the Kir4.1 knock out mouse optic nerve (Bay and Butt, 2012, 
Neusch et al., 2001). 
 
3.5.3 Functional implications of glial Kir subunit expression 
The apparent enrichment of Kir4.1 subunit at the cytoplasmic edges of 
astrocytes and along processes corresponds to reported localisation at 
perivascular processes in Müller glia (Connors and Kofuji, 2002, Masaki et 
al., 2010). Furthermore, the heterogeneity I observed in the pattern of 
immunostaining in optic nerve asytrocytes indicated that the majority of 
astrocytes expressed Kir4.1 to a high degree, but a subpopulation were 
only weakly immunopositive for Kir4.1, consistent with findings in vivo 
obtained by immunostaining and using the Kir4.1-EGFP mouse 
(Poopalasundaram et al., 2000, Tang et al., 2009). The analysis of Kir 
immunostaining measured using Volocity Software confirmed the 
qualitative observations that Kir4.1 expression was 3-times more dense on 
the cell processes of optic nerve astrocytes, consistent with preferential 
targeting of these ion channels to the processes, the sites of K+ uptake in 
vivo. Similarly, optic nerve astrocytes exhibited strong immunopositivity for 
the Kir5.1 subunit, although there was again a subpopulation of weakly 
Kir5.1 immunopostive astrocytes. This variation was not evident in 
oligodendrocytes, which were strongly immunopositive for Kir4.1 and 





Quantification confirmed that, overall, the density of Kir4.1 was 3-times 
greater on the processes than cell somata in astrocytes. However, a key 
observation was that Kir5.1 subunits in astrocytes were intensely 
concentrated on cell somata, 10-fold greater than on the processes, and 
over 3-fold greater than observed for Kir4.1 subunits on astroglial somata. 
Immunolabelling demonstrated the plasmalemmal expression of the Kir5.1 
subunit around the astrocytic cell somata where it co-localised with Na-K-
ATPase plasma membrane marker. Kir5.1 subunits do not normally form 
homomeric channels, and preferentially form heteromeric channels with 
Kir4.1, which are more strongly rectifying and more active at physiological 
pH than homomeric Kir4.1 channels, which have a pKa=6 (Pessia et al., 
1996, Tanemoto et al., 2000, Yang et al., 2000). Furthermore, Kir5.1 
subunits are known to display intracellular localisation, whereas 
phosphorylation dependent interactions result in the targetting of 
Kir5.1/Kir4.1 heteromeric channels to the membrane (Tanemoto et al., 
2004, Tanemoto et al., 2008). The transport of Kir to the plasmamembrane 
is regulated by multiple factors, including PKA and PIP2. The cytoplasmic 
and somatal Kir5.1 subunits in glia would provide a pool by which 
Kir4.1/Kir5.1 channels could be dynamically regulated, such as in 
response to metabolic changes, for example, and under the control of 
intracellular pH and PIP2. In addition, the close association of the Kir4.1 
channels with the Na/K-ATPase furthermore the targeting of these 
channels to the same membrane macrodomains suggests they may help 
provide extracellular K+ for the activity of the pumps, as observed for 
H+/K+-pumps in parietal cells (Fujita et al., 2002, Kaufhold et al., 2008).    
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Quantification of Kir expression in oligodendrocytes revealed 6-fold greater 
expression of Kir4.1 on cell somata, compared to the processes, while in 
astrocytes Kir4.1 was marginally more concentrated on processes. This is 
entirely consistent with our in vivo observations, where Kir4.1 
immunolabelling identified rows of strongly immunopositive 
oligodendrocyte somata (Kalsi et al., 2004). In contrast, Kir5.1 
immunostaining was uniform in oligodendrocyte somata and processes, 
and 4-fold less than observed in astrocyte somata. The results indicate 
potential differences in the functional expression of Kir4.1 homomeric and 
Kir4.1/Kir5.1 heteromeric channels in oligodendrocytes and astrocytes. As 
noted above, Kir5.1 do not usually form homomeric channels and so 
strong expression of these subunits in astrocytes is indicative of an 
important role for these channels in astroglial functions, most notably K+ 
uptake. In contrast, stronger expression of Kir4.1 in oligodendrocytes 
suggests a prominent role for homomeric Kir4.1 channels in 
oligodendrocyte functions, most notably myelination, which is severely 
retarded following genetic ablation of Kir4.1 (Neusch et al., 2001). Notably 
the hypomyelination, accompanied by the severe spongiform vacuolation 
identified in the spinal cord and brain stem in the Kir4.1 knock out mouse 
(Neusch et al., 2001) was not detected in the EAST/SeSaME syndrome 
described by the loss of the function of the Kir4.1 channel in humans (U. I. 
Scholl et al., 2009), reminding us of the importance of the human biopsies. 
 
Kir5.1 co-assembles with Kir4.1 to form functional pH-sensitive potassium 
channels (Cui et al., 2001, Pessia et al., 1996, Yang et al., 2000), which 
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recently have been identified as astroglial CO2 chemoreceptors in the 
chemosensitive nuclei of the brainstem (Mulkey and Wenker, 2011, 
Wenker et al., 2010, Wu et al., 2004). It is possible Kir5.1 subunit 
expression in optic nerve astrocytes and oligodendrocytes is involved in 
sensing changes in pH, which could be important in maintaining their RMP 
during metaboilic stress.  
 
3.5.4  Summary and conclusions 
In this chapter, I validated the Kir antibodies for use in the optic nerve and 
demonstrated robust expression of Kir4.1, Kir5.1, Kir2.1 in optic nerve glia. 
The findings in astrocytes are consistent with reports in various regions 
throughout the CNS, and show for the first time that astrocytes co-express 
these subunits. The results confirm strong expression of Kir4.1 in 
oligodendrocytes, which has been controversial, and demonstrate for the 
first time that oligodenrocytes strongly express Kir5.1 and to a lesser 
extent Kir2.1. In astrocytes, these channels are believed to be key to the 
astroglial function of K+ homeostasis, and co-assembly of Kir4.1 with 
Kir5.1 or Kir2.1 markedly alters their inwardly rectifying properties (Fakler 
et al., 1996, Kofuji et al., 2002). Expression of these channels by 
oligodendrocyte processes and mylin sheets suggests they may also be 
involved in potassium buffering at nodes of Ranvier, the sites of K+ release 
during action potential propagation, as observed in myelinating Schwann 
cells in the PNS. However, greater expression of Kir4.1 in oligodendrocyte 
somata suggests a role other than K+ reguation at nodes, and their 
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function in setting the strongly negative RMP is critical for myelination 







Evidence for heteromeric Kir4.1, Kir5.1 and Kir2.1 





In the previous chapter, I demonstrated expression of Kir4.1, Kir5.1 and 
Kir2.1 subunits in optic nerve astrocytes and oligodendrocytes. The strong 
expression of Kir4.1 I observed in astrocytes is consistent with the 
proposed role of these channels in the key astroglial function of K+ spatial 
buffering (Bay and Butt, 2012). My findings demonstrate that 
oligodendrocytes strongly express Kir4.1 and resolve the controversy in 
the literature about the expression of oligodendroglial Kir4.1 channels 
(Higashi et al., 2001), furthermore support evidence that these channels 
have a direct function in myelination (Neusch et al., 2001). A novel finding 
was the extensive expression of Kir5.1 in optic nerve glia, and the 
demonstration of this subunit in oligodendrocytes for the first time. Despite 
the abundance of Kir5.1 in the optic nerve, homomeric channels formed by 
Kir5.1 subunits are thought to be nonfunctional. To form functional 
channels, Kir5.1 subunits most co-assemble with other subunits, most 
notably Kir4.1 (Pessia et al., 1996, Yang et al., 2000, Cui et al., 2001). 
Heteromeric Kir4.1/Kir5.1 channels have been indentified in renal tubular 
epithelia, brainstem neurons from the cardio-respiratory nuclei, in addition 
to retinal Müller cells, cortical astrocytes and specialised astrocytes of the 
central respiratory centre (Tanemoto et al., 2000, Tucker et al., 2000, Ishii 
et al., 2003, Hibino et al., 2004, Wu et al., 2004, Yamamoto et al., 2008). It 
is not known whether heteromeric Kir4.1/Kir5.1 channels may be a general 
feature of astrocytes, and the possibility that oligodenrocytes express 




In addition, Kir2.1 subunits are implicated in potassium spatial buffering in 
the form of both homomeric Kir2.1 and heteromeric Kir4.1/Kir2.1channels 
(Fakler et al., 1996, Kofuji et al., 2002). Furthermore, a functional linkage 
between Kir5.1 and Kir2.1 subunits has been established, whereby co-
expression of the two subunits in Xenopus oocytes resulted in the 
formation of electrically silent channels (Derst et al., 2001). My results 
demonstrating expression of both Kir5.1 and Kir2.1 subunits in optic nerve 
glia raises the possibility that formation of electrically silent Kir5.1/Kir2.1 
heteromers may negatively regulate the expression of strongly rectifying 
Kir4.1/Kir2.1 heteromeric channels, with implications for potassium 
clearance. 
 
In this chapter, I have examined the colocalisation and potential 
interactions between the Kir4.1, Kir5.1 and Kir2.1 subunits in optic nerve 
glia, using immunocytochemical, co-immunoprecipitation, and shRNA 
approaches. The results provide evidence of heterogeneous expression of 
homomeric and heteromeric channels formed by combinations of the 





4. 2 Controls for combined use of anti-Kir4.1, -Kir5.1 and -Kir2.1 
antibodies 
In Chapter 3, I demonstrated the specificity of antibodies used in this study 
against Kir4.1, Kir5.1 and Kir2.1. In this chapter, I will use combinations of 
the in house polyclonal rabbit Kir4.1 antibody, Alomone rabbit polyclonal 
anti-Kir4.1 antibody, the Santa Cruz polyclonal goat anti-Kir5.1 antibody 
(T-14), and Santa Cruz goat polyclonal anti-Kir2.1 antibody (C-20). 
Negative controls for immuncytochemistry (Fig. 4.1) and Western blot (see 
below), demonstrated the absence of non-specific immunostaining and 
immunoblotting using these combinations of antibodies.  
  
         
Figure 4.1 : Controls for the combined use of anti
antibodies and Kir4.1, Kir5.1 and Kir2.1 Western blot analysis of the brain
Kir4.1 and Kir5.1 in (Aii
cultured for 10 DIV with preincubated Kir5.1 and omitted Kir4.1 antibody. 
Kir2.1 and (Ci) Kir5.1 and Kir2.1 in 
cultured for 10 DIV with preincubated Kir2.1 and omitted Kir4.1 antibody or preincubated 
Kir5.1 and Kir2.1 antibodies. Immunolabelling was absent in all negative controls. 
Kir4.1, (E) Kir5.1 and (
were detected at ~42, 80 and 160 kDa that presumably represent
heteromeric and tetrameric Kir4.1 channels, or (
Kir5.1 and (F) at ~45 and 6
controls where the Kir4.1, Kir5.1 and Kir2.1 antibodies were preincubated.
 
-Kir4.1, Kir5.1 and Kir2.1 
) PLP+ oligodendrocyte, from PLP-dsRED optic nerve explants 
(Bii, Cii) GFAP+ wild type optic nerve 
F) Kir2.1 Western blot analysis of the wild type brain. (
E) at ~ 48 and 70 kDa as predicted for 




 (Ai)  




 the monomeric, 
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4. 3 Evidence for heteromeric Kir4.1/Kir5.1 channels in optic 
nerve glia 
4.3.1 Immunocytochemical colocalisation of Kir4.1 and Kir5.1 in 
oligodendrocytes 
In oligodendrocytes, Kir4.1 and Kir5.1 were co-expressed on the somata 
and primary processes (Fig. 4.2Ai). A colocalisation channel was 
generated using Volocity  software, which illustrates only those voxels that 
express equal levels of the red and white channels, i.e. Kir4.1 and Kir5.1 
(Fig. 4.2Bi). Quantification showed 12644 ± 5163 colocalised 
Kir4.1+/Kir5.1+ voxels in 13 oligodendrocytes, compared to a total of 
152337±36694 Kir4.1+ voxels and 36654 ± 1621 Kir5.1+ voxels per cell 
(Fig. 4.2C), suggesting 30% of Kir5.1 are present as heteromeric 
Kir4.1/Kir5.1 channels, compared to <10% of Kir4.1, which presumably 
form homomeric Kir4.1 channels; notably, over 60% of Kir5.1 were not co-
localised with Kir4.1, and since they do not form homomeric channels, this 
suggests they are either not functional plasmalemmal channels or form 
heteromers with other subunits. A line analysis (Fig. 4.3A) and 
isosurfacing (Fig. 4.3B), in which Kir4.1+ and Kir5.1+ voxels are given the 
same intensity, demonstrated the correspondence of Kir5.1 with Kir4.1, on 
the somata and processes. In line analysis the intensity of the Kir4.1 
(green) and Kir5.1 (white) voxels are analysed along a line and these 
intensity values are represented on the y axis while the distance of voxels 
from the starting point is illustrated in µm-s on the x axis.  
 C
Figure 4.2 Co-expression of Kir4.1 and Kir5.1 subunits in optic nerve 
oligodendroglia: Double immunolabelling for 
oligodendroglia, from PLP
channels presented illustrating the 
PLP. (Bi) A colocalisation
in which Kir5.1 and Kir4.1 are 
Kir4.1+, Kir5.1+, and Kir4.1+/Kir4.1+ 












Number  of voxels per optic nerve oligodendroglia
Kir4.1 and Kir5.1 
-dsRED optic nerve explants cultured for 10 DIV.
(Aii) Kir4.1, (Aiii) Kir5.1 immunolabelling and 
 channel was created using Volocity software, illustrating 
expressed at the same intensity (C) and the number of 
voxels quantified per oligodendroglia












 (data are 
 = 20 µm   
    
Figure 4.3 Analysis of Kir4.1 and Kir5.1 subunit expression in optic nerve oligodendrocytes: 
immunocytochemistry of the PLP-dsRED optic nerve explants culture
presentation of the results on oligodendroglial somata (Aii, 
Kir5.1 (grey) with Kir4.1 (green). (B) Isosurface imaging of oligodendrocyte processes, in which Kir4.1+ (green) and Kir5.1+ (red) 
intensity (Bi and Bii), illustrating the close apposition of Kir5.1 
(Ai) double Kir4.1 
d for 10 DIV. (Aii) line analysis of the Kir4.1+ and Kir5.1+
1), primary processes (Aii, 2,3,4), and distal processes (Aiii 5




(green) and Kir5.1 (white) 
 voxels, with graphic 
), illustrating the correspondence of 




4.3.2 Immunocytochemical colocalisation of Kir4.1 and Kir5.1 in 
astrocytes 
Expression of Kir4.1 and Kir5.1 were examined in astrocytes using triple 
immunocytochemistry with GFAP (Fig. 4.4). Optic nerve astocytes 
displayed strong immunopositivity for Kir4.1 and Kir5.1, and appeared 
particularly enriched on their plasmalemma and processes (Fig. 4.4A); 
Kir5.1 immunolabelling also appeared in astroglia nuclei, but this is likely 
to be artefactual, although it was not observed in negative controls or in 
oligodendrocytes (see above). The colocalisation channel suggested a 
high degree of co-localisation between Kir4.1 and Kir5.1 subunits (Fig. 
4.4B), and quantification showed 31575 ± 12053 colocalised 
Kir4.1+/Kir5.1+ voxels in 15 astrocytes, compared to a total of 240124 ± 
78395 Kir4.1+ voxels and 72417 ± 20838 Kir5.1+ voxels per cell (Fig. 
4.4C), suggesting 43.6% of Kir5.1 are present as heteromeric Kir4.1/Kir5.1 
channels, compared to 13% of Kir4.1, which presumably form homomeric 
Kir4.1 channels; notably, over 56% of Kir5.1 were not co-localised with 
Kir4.1, and since they do not form homomeric channels, they might be 
either not functional plasmalemmal channels or form heteromers with 
other subunits. A line analysis (Fig. 4.4D) and isosurfacing (Fig. 4.4E), 
demonstrated the immediate correspondence of Kir5.1 with Kir4.1. 
  
 D
Figure 4.4 Analysis of Kir4.1 and Kir5.1 subunit expression in optic nerve 
astrocytes: (A) Double immunolabelling for Kir4.1 (red) and Kir5.1 (green) in GFAP+ 
astrocytes (white, insert), from optic nerve explants cultured for 10 DIV. (B) A 
colocalisation channel was created using Volocity software, illustrating 
Kir5.1 and Kir4.1 are expressed at the same intensity, and (C) the number of Kir4.1+, 
Kir5.1+, and Kir4.1+/Kir4.1+ 
Line analysis of Kir4.1 and Kir5.1 subunit immunocytochemistry (lines in A), illustrating 
the correspondence of Kir5.1 (green) with Kir4.1 (red), and lack of Kir5.1 peaks in the 
absence of Kir4.1. (E) Isosurface imaging of astrocyte processes, in which Kir4.1+ (
and Kir5.1+ (green) voxel
apposition of Kir5.1 subunits with Kir4.1 subunits. 
1unit=3.9 μm in Ei and 3.2
voxels quantified per cell (data are means 
s are given the same intensity, illustrating the immediate 
Scale bars = 20 




voxels in which 
+ SEM, n=15. (D) 
red) 
µm in A and B, 
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4.3.3 Heteromerisation of Kir4.1 and Kir5.1 in vivo in the optic nerve 
The results above suggest overlapping expression of Kir4.1 and Kir5.1 in 
optic nerve glia, supporting the possibility they form heteromeric 
Kir4.1/Kir5.1 channels. To examine the heteromerisation of Kir4.1/Kir5.1 
proteins directly in vivo, I carried out co-immunoprecipitation experiments 
in the brain and optic nerve of P20-30 mice with affinity-purified Alomone 
rabbit polyclonal anti-Kir4.1 antibody and Santa Cruz polyclonal goat anti-
Kir5.1 antibody (Fig. 4.5). Immunolabelling and Western analysis showed 
that the antibodies were specific in brain and optic nerve extracts (see 
Chapter 3). Figure 4.5 shows that Kir4.1 and Kir5.1 subunits could be co-
immunoprecipitated from brain and optic nerve extracts, in either direction, 
with Kir5.1 protein being detected in the Kir4.1 immunoprecipitate (Fig. 
4.5A), and Kir4.1 being detected in the Kir5.1 immunoprecipate (Fig. 
4.5C). Specificity was confirmed by detection of bands at ~48 kDa for 
Kir5.1 and  ~ 42 kDa for Kir4.1, as predicted from their molecular weights 
(Fig. 4.5B, D), and absence of immunoblotting in negative controls 
following preincubation with the appropriate blocking peptides (Fig. 4.5A-
D, left-hand lanes). This was confirmed in 5 experiments, all unequivocaly 
demonstrating the same result, and confirming the idea that Kir4.1 and 
Kir5.1 subunits can coassemble in glia in vivo. 
 
 
 Figure 4.5 Co-immunoprecipitation of Kir4.1 and Kir5.1 subunits from the brain and 
optic nerve. Brain and optic
with anti-Kir4.1 antibody (A, D; Alomone) and anti
Immunoprecipitates (IP) were then subjected to western blot (wb) analysis using 
corresponding antibodies (B,C)
immunoprecipitation of the two subunits (A, C). Immunoblotting was absent in negative 
controls preincubated with the appropriate blocking peptide (A
 nerve protein extracts from P20-30 mice were precipitated 
-Kir5.1 antibody (B, C; Santa Cruz). 









4.4 Interactions between Kir4.1 and Kir5.1 in optic nerve glia 
The immunocytochemical and co-immunprecipitation results above 
provide evidence that Kir4.1 and Kir5.1 subunits form heteromeric 
channels in optic nerve glia. Since, Kir5.1 subunit preferentially combine 
with Kir4.1 subunits to form heteromeric channels, I examined whether 
ablation of Kir4.1 resulted in altered expression of Kir5.1 subunits. 
 
4.4.1 shRNA knock down of Kir4.1 in optic nerve glia 
Explants of optic nerve glia were maintained in vitro for 10 days and then 
transfected with Kir4.1 shRNA or scrambled shRNA vector in controls 
(Figure 4.6). Cell cultures were immunolabelled for Kir4.1 at 2 days post 
transfection and immunolabelling compared in non-transfected cells and 
transfected cells, identified by GFP expression. The results demonstrate 
extensive immunolabelling of Kir4.1 in non-transfected cells and in cells 
transfected with scrambled shRNA on the same coverslips (Fig. 4.6 C). In 
comparison, transfection with Kir4.1 shRNA resulted in a marked reduction 
in Kir4.1 immunolabelling compared to non-transfected cells on the same 
coverslips (Fig. 4.6A, B). Quantitation of Kir4.1 immunofluorescence was 
performed on confocal z-stacks, using Volocity software to determine the 
mean (+SEM) number of Kir4.1+ voxels (red channel) within three fields of 
2 µm3 in each cell (n=10-12 cells per experimental group) (Figure 4.7). 
There was no significant difference in Kir4.1 expression between non-
transfected cells (13000 + 2000) and those transfected with scrambled 
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shRNA (13000 + 1000), whereas there was a marked and statistically 
significant loss of Kir4.1 in cells transfected with Kir4.1 shRNA (800+100; 
p<0.001, one-tailed t-test).  
  
 Figure 4.6 Transfection of optic nerve glia shRNA to knock down Kir4.1. 
optic nerve glia 10 DIV were transfected with either Kir4.1 shRNA (A, B), or the 
scrambled shRNA in controls (C). Transfected cells were identified by co
GFP (transfected cells appear green) and Kir4.1 immunocytochemistry (appears red) was 














Figure 4.7 Analysis of Kir4.1 immunolabelling following shRNA knock down of 
Kir4.1 in cultured optic nerve glia. Cultured optic nerve glia were transfected with the 
Kir4.1 shRNA vector or scrambled control shRNA plasmid at 10 DIV and examined by 
Kir4.1 immunocytochemistry at 2 days post transfection. Transfected cells were identified 
by co-transfection with GFP expression and Kir4.1 immunofluorescence was analysed 
from confocal images using Volocity software; confocal image capture parameters were 
kept constant for all groups. Analysis was performed on 10-12 cells in each group, and 






























shRNA knock-down of  the inwardly rectifying 







4.4.2 Kir4.1 ablation decreases Kir5.1 expression in optic nerve glia 
I have established the absence of Kir4.1 in the global knock out mouse 
(Chapter 3), and in the absence of Kir4.1 there was a marked decrease in 
Kir5.1 immunolabelling compared to wild-type controls (Fig. 4.8A, B). 
However, Kir4.1 is never expressed in the global KO mouse, and so 
differences in Kir5.1 expression may be related to developmental defects. 
To test for this, I examined the effects of shRNA knock down of Kir4.1 on 
Kir5.1 expression in wild-type cells (Fig. 4.8C, D). Transfection with 
scrambled shRNA vector in controls did not alter Kir5.1 expression (Fig. 
4.8C). In contrast, Kir5.1 immunolabelling appeared markedly decreased 
following transfection with Kir4.1 shRNA (Fig. 4.8D) in optic nerve 
astrocytes, which is shown above to effective knock-down Kir4.1 (Fig. 4.6). 
Quantitation confirmed a marked and statistically significant decrease 
(p<0.001, one-tailed t-test) in Kir5.1 immunolabelling of the optic nerve 
astrocytes in the absence of Kir4.1 (Fig. 4.9), from 13442 + 2313 in wild-
type cells, to 3039 + 1468 in Kir4.1 KO cells, and from 12521 + 1589 in 
scrambled controls to 4097 + 806 in Kir4.1 shRNA transfected cells; Kir5.1 
expression was not significantly different between wild-type and scrambled 
controls, or between Kir4.1 KO and Kir4.1 shRNA cells. Oligodendrocytes 
were very rarely transfected and so were not analysed. Western blot 
analysis demonstrated genetic ablation of Kir4.1 resulted in a significant 
decrease in Kir5.1 levels in vivo in brain and optic nerve lysates from age-
matched wild-type and Kir4.1 knock out mice (p<0.001, unrelated t-test), 
by 33.5 ± 3.5% in nerves and 53 ± 0.4% in brains (Fig. 4.10)  
 Figure 4.8 Kir5.1 immunolabelling in the optic nerve astrocytes is decreased in the 
absense of Kir4.1. Optic nerve explants cultured for
for GFAP (blue) and Kir5.1 (red), from wild type
following transfection with scrambled shRNAs in controls (




 DIV10 anddouble immunolabelled 
 mouse (A), Kir4.1 knockout mice (
Cii), or Kir4.1 shRNA (









Figure 4.9 Analysis of Kir5.1 immunolabelling following ablation of Kir4.1 in optic 
nerve astrocytes. Kir5.1 immunocytochemistry was performed on oultured optic nerve 
glia from wild-type or Ki4.1 KO mice were cultured for 10 DIV, and transfection of Kir4.1 
shRNA vector or scrambled control. Transfected cells were identified by co-transfection 
with GFP expression. Kir5.1 immunofluorescence was analysed from confocal images 
using Volocity software; confocal image capture parameters were kept constant for all 
groups. Analysis was performed on 10-12 cells in each group, and data is expressed as 






Figure 4.10 Kir5.1 protein level is decreased in the absence of Kir4.1.
blot for Kir5.1 in P19  optic nerve 
knock out (KO) mice, illustrating a band ~48 kDa, the predicted MW for the Kir5.1 subunit.  
Wild type or Kir4.1 knock out  optic nerve ( WT or KO ON) and wild type or Kir4.1 knock 
out (WT or KO brain). (B) Mean (
normalised against beta actin in the same samples
 
 
and brain (B) lysate from wild-type (WT) and Kir4.1 






 (A) Western 
176 
 
4.4.3 Plasmalemmal localisation of Kir5.1 is dependent on Kir4.1 
The expression of plasma membrane bound Kir5.1 was examined in the 
presence and absence of Kir4.1, in the purified plasma membrane fraction 
from whole brains of age-matched wild type and Kir4.1 knock out mice 
(Fig. 4.11). The purification of the plasma membrane fraction and its 
expression of membrane bound Kir5.1has been demonstrated in Chapter 
3, with little contamination from intracellular organelles, ER and 
mitochondria, and high expression of Na/K ATPase, a marker for plasma 
membranes. Western blot of the brain plasma membrane fraction (PMF) 
identified bands at the predicted 48 kDa molecular weight for Kir5.1 which 
was significantly reduced by 60 ± 14% in Kir4.1 knock out compared to 
wild-type brain lysates, normalised to β-actin levels (Fig. 4.11); western 
blot results were verified using two different antibodies, from Alomone and 
Santa Cruz (not illustrated; see Chapter 3). 
 
Regrettably, due to the large number of optic nerves (~ 40) required, I 
could not use the western blot technique to compare membrane bound 
levels of Kir5.1 in absence of Kir4.1. In this case, I used an 
immunocytochemical approach to quantify plasmalemmal Kir5.1 in wild 
type, Kir4.1 knock out and Kir4.1 knock down optic nerve astrocytes (Figs. 
4.12-4.14). Plasmalemmal Kir5.1 was measured using immunolabelling for 
the plasma membrane marker, Na/K ATPase, and generation of 
co-localisation channels for subsequent quantification (Fig. 4.12). As 
demonstrated in Chapter 3, Kir5.1 and Na/K ATPase double 
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immunolabelling showed marked co-expression in wild-type astrocytes 
(Fig. 4.12A), and in controls transfected with scrambles shRNA (Fig. 
4.12B), whereas colocalisation was reduced following transfection with 
Kir4.1 shRNA (Fig. 4.12C). Quantification showed that knock down of 
Kir4.1 resulted in a 2.13-fold decrease in plasmalemmal Kir5.1, from 15.18 
% in controls to 7.1% in the absence of the Kir4.1 (Fig. 4.12D). 
 
These results indicated reduced translocation of Kir5.1 to the 
plasmalemma in the absence of Kir4.1, although Kir5.1 immunolabelling 
was evident in these cells (Fig. 4.12Ci). The results demonstrate that 
levels of Kir5.1 are decreased overall in the absence of Kir4.1, and that 
remaining Kir5.1 subunits are mostly retained intracellulary and do not 







Figure 4.11 Reduced Kir5.1 in the plasma membrane fraction in the absence of 
Kir4.1 channel. Western blot analysis 
fraction (PMF) from brain lysate from P19 wild type 
was detected at ~ 48 kDa, the predicted molecular weight of the Kir5.1 channel (
Integrated density of the 48 kDa band (n=3) normalised to beta actin.
3 different aged matched wild type and Kir4.1
0.001, unpaired t-test. 
 
(n=3) of Kir5.1 subunit in the plasma membrane 
and Kir4.1 knock out mice
 For this experiment 





 (A); a band 
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 *** p < 
 Figure 4.12 Reduced 
Kir4.1. Colocalisation channel of
immunocytochemistry of optic nerve 
(B), shRNAKir4.1 transfected, Kir4.1 knock down (
illustrated. Scale bars = 20 
co-localisation (n=11-13 cells analysed per group).
localisation of Kir5.1 to the plasmalemma in the absence of 
 Kir5.1 and Na/K ATPase alpha 1 subunit 
strocytes in untransfected (A) scrambled transfected 
C); individual channels are also 
µm (D) Quantification  of the percentage of Kir5.1/NaKATPase 







4. 5 Evidence Kir2.1 form heteromeric channels in optic nerve 
glia 
4. 5.1 Heteromeric Kir4.1/Kir2.1 channels in optic nerve glia 
There was little expression of Kir2.1 in oligodenrocytes (Fig. 4.13A), and 
astrocytes (Fig. 4.15A). Generation of the colocalisation channel in 
oligodenrocytes and quantitfication shows that almost all Kir2.1 was 
colocalised with Kir4.1 on the terminals of oligodendroglial processes (Fig. 
4.13B); line analysis (Fig. 4.14A) and isosurfacing (Fig. 4.14B) confirmed 
the correspondence of Kir2.1 with Kir4.1 subunits. In oligodendroglia the 
quantification showed a high degree of colocalisation between Kir4.1 and 
Kir2.1 subunits (Fig.4.13B)  24839 ± 11445 colocalised Kir2.1/Kir4.1 
voxels per cell from totals of Kir2.1+ voxels 47152 ± 22079 per cell (n=13) 
and 149541 ± 58462 Kir4.1+ voxels. Kir2.1 subunit expression in astrocyte 
and also showed high degree (>50%) of co-localisation between Kir4.1 
and Kir2.1 subunits (Fig. 4.15B); 32755 ± 15080 colocalised Kir4.1/Kir2.1 
voxels per cell, from totals of 68294 ± 34663 Kir2.1+ voxels and 189959 ± 
100143 Kir4.1+ voxels (Fig. 4.15C). Line analysis (Fig. 4.15D) and 
isosurfacing (Fig. 4.15E), demonstrated the immediate correspondence of 
Kir2.1 with Kir4.1 in astrocytes. 
 
Heteromerisation of Kir4.1 and Kir2.1 was confirmed in vivo, by 
coimmunoprecipitation experiments in the brain and optic nerve of P20-30 
mice (Fig. 4.16). Specificity of the antibodies was confirmed in Chapter 3, 
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and Figure 4.17 shows that Kir4.1 and Kir2.1 subunits were 
coimmunoprecipitated from brain and optic nerve extracts, with Kir2.1 
protein being detected in the Kir4.1 immunoprecipitate (Fig. 4.16A), and 
Kir4.1 being detected in the Kir2.1 immunoprecipate (Fig. 4.16C); 
immunoblotting was absent in negative controls following preincubation 
with the appropriate blocking peptides (Fig. 4.16A-C, left-hand lanes). This 
was confirmed in 3 experiments, all unequivocally demonstrating the same 
result, and confirming that Kir4.1 and Kir2.1 subunits coassemble in glia in 
vivo. 
 
The expression of plasma membrane bound Kir2.1 was examined in the 
presence and absence of Kir4.1, in the purified plasma membrane fraction 
from whole brains and optic nerves of age-matched wild type and Kir4.1 
knock out mice (Fig. 4.17). Western blot of total brain and optic lysate 
identified a band at the predicted 45 kDa molecular weight for Kir2.1, with 
levels relative to β-actin significantly reduced overall in the absence of 
Kir4.1 (p<0.001, one-tailed t-test); 1.05 ± 0.09 and 0.67 ± 0.04 in brain 
lysate from age-matched P19 wild-type and Kir4.1 knock out mice, 
respectively, and 1.02 ± 0.10 and 0.43 ± 0.11 in optic nerve lysate from 
age-matched P19 wild-type and Kir4.1 knock out mice, respectively  (Fig. 
4.18; p<0.01, one-tailed t-test); results were verified using two different 
antibodies, from Alomone and Santa Cruz (not illustrated; see Chapter 3). 
In the plasma membrane fraction, a band was detected at ~60 kDa, which 
is the predicted molecular weight for plasmalemmal gycosyalted Kir2.1 
channels.  Notably, the level of the Kir2.1 subunit in the plasma membrane 
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fraction was significantly increased in the absence of Kir4.1, from 0.95 ± 
0.098 in wild-type to 1.47 ± 0.52 in Kir4.1 knock out brains, indicating 
plasmalemmal expression of the Kir2.1 subunit is significantly upregulated 
in the absence of Kir4.1 (p<0.05, one-tailed t-test). Optic nerves and 
brains for this experiment were obtained from 3 different Kir4.1 knock out 
or wild type animals and the result were verified in 3 different experiments.  
 
  
 Figure 4.13 Co-expression of Kir4.1 and Kir2.1 subunits in the optic nerve 
oligodendroglia: Double immunolabelling for
oligodendrocyte (Aiii), from PLP
squared regions on the (
colocalisation channel was created using Volocity software, illustrating 
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Figure 4.14 Analysis of Kir4.1 and Kir2.1 subunit expression in optic nerve 
oligodendrocytes: (A) Line analysis of the intensity of Kir4.1 and Kir2.1 subunit 
immunocytochemistry of PLP
arrows),  with graphic pres
(B), illustrating the correspondence of Kir2.1 (green) with Kir4.1 (black), and lack of Kir2.1 
peaks in the absence of Kir4.1. 
which Kir4.1+ (red) and Kir2.1+ (green) 
illustrating the immediate apposition of Kir2.1 subuni
-dsRED optic nerve explants cultured for 10 DIV (A,blue 
entation of the results on cell somata and primary processes 
(C) Isosurface imaging of oligodendrocyte processes, in 
voxels are given the same intensity (Ci and Cii), 





 µm.  
 Figure 4.15 Analysis of Kir4.1 and Kir2.1 subunit expression in optic nerve 
astrocytes: (A) Double immunolabelling for Kir4.1 (red) and Kir2.1 (green) in GFAP+ 
astrocytes (white, insert), from optic nerve explants cultured for 10 DIV. (B) A 
colocalisation channel was created using Volocity software, illustrating 
Kir2.1 and Kir4.1 are expressed at the same intensity, and (C) 
and Kir2.1 subunit immunocytochemistry, and graphical illustration of the correspondence 
of Kir2.1 (green) with Kir4.1 (red), (D) 
and somata (F) in which Kir4.1+ (red) and Kir2.1+ (green) 
intensity, illustrating the immediate apposition of Kir2.1 subunits with Kir4.1 subunits. 
Scale bars = 20 µm in A and B, 
Kir4.1+, Kir2.1+, and Kir4.1+/Kir2.1+ 
per cell (data are means 
Line analysis of 
(D, E) Isosurface imaging of astrocyte pr
voxels are given the same 
1unit=4.7 µm in D 1unit=1.6 µm in E. 
voxels quantified on the process (per unit area) and 
+ SEM, n=13).  
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Figure 4.16 Co-immunoprecipitation of Kir4.1 and Kir2.1 subunits from the brain 
and optic nerve. Brain and optic nerve protein extracts from P20
precipitated with anti
Immunoprecipitates (IP) were then subjected to western blot (wb) analysis using 
opposing antibodies to demonstrate co
and the corresponding anti
negative controls preincubated with the appropriate blocking peptide (A
panels). 
 
-Kir4.1 antibody (A) and anti-Kir2.1 antibody (B, C). 
-immunoprecipitation of the two subunits (A, B), 









Figure 4.17 Reduced Kir2.1 in the total lysate and plasma membrane fraction in the 
absence of Kir4.1 subunit.
plasma membrane fraction (PMF) from brain and optic nerve (ON) from P19 wild type and 
Kir4.1 knock out mice (
molecular weight of the Kir2.1 channel, and in the plasma membrane fraction a band was 
detected at ~60 kDa, the predicted molecular weight for plasmalemmal gycosyalted 
Kir2.1 channels.  (B) I
actin. * p<0.05, **p<0.01,*** p < 0.001, unpaired t
 
. Western blot analysis of Kir2.1 subunit in the total lysate 
A); in total lysate, a band was detected at ~ 45 kDa, the predicted 
ntegrated density of the Kir2.1 bands (n=3) normalised to beta 







4. 5.2 Heteromeric Kir5.1/Kir2.1 channels in optic nerve glia 
Analysis of wild type and PLP dsRED oligodendroglia (n=10) confirmed 
limited expression of Kir2.1 (33124 ± 8137 voxels per cell), compared to 
Kir5.1 (116470 ± 36729 voxels per cell), and colocalisation between the 
two subunits was barely detectable (13521 ± 4947 voxels per cells) (Fig. 
4.18Aiii, B). Line analysis and isoforming demonstrated that Kir2.1 and 
Kir5.1 subunits were often dislocated from each other (Fig. 4.18C, D; 
asterisks in 4.18D indicate dislocation of Kir2.1 and Kir5.1 subunits). In 
astrocytes, triple immunolabelling demonstrated extensive co-localisation 
of Kir2.1 and Kir5.1 subunits, especially along the processes (Fig. 4.19A). 
Quantification showed a high degree (<40%) colocalisation between Kir5.1 
Kir2.1 subunits in astrocytes (Fig 4.19C), 24537 ± 8315 co-localised 
Kir5.1/Kir2.1 voxels per astrocyte from a total of 59709 ± 21909 Kir2.1+ 
voxels and 150647± 28124 Kir5.1 voxels per cell (Fig. 4.19C). Line 
analysis (Fig. 4.19B) and isosurfacing (Fig. 4.19D), demonstrate the 
correspondence of Kir2.1 with Kir5.1 subunits.  
 
Heteromerisation of Kir2.1 and Kir5.1 was confirmed in vivo, by 
coimmunoprecipitation experiments in the brain and optic nerve of P20-30 
mice (Fig. 4.20). Notably, Kir2.1 and Kir5.1 subunits were not 
coimmunoprecipitated from the brain, but were from the optic nerve, with 
Kir2.1 protein being detected in the Kir5.1 immunoprecipitate (Fig. 4.20A), 
and Kir5.1 being detected in the Kir2.1 immunoprecipate (Fig. 4.20B); 
immunoblotting was absent in negative controls following preincubation 
with the appropriate blocking peptides (Fig. 4.20, left-hand lanes). This 
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result was confirmed in 3 experiments, all unequivocaly demonstrating the 
same result.   
 Figure 4.18 Analysis of Kir2.1 and Kir5.1 subunit expression in optic nerve 
oligodendrocytes: (A) 
type optic nerve explants cultured for 10 DIV. A co
Volocity software, illustrating 
intensity (Aiii), and the number of Kir5.1+, Kir2.1+, and Kir5.1+/Kir2.1+ 
per cell (B; data are means 
process in which Kir5.1+ (red) and Kir2.1+ (green) 
illustrating Kir2.1 and Kir5.1 subunits were most often dislocated. 
and B, 1unit=1.3 µm in (
correspondence of Kir2.1 (grey) with Kir5.1 (green), 
peaks (asterisks). (D). 
 
Double immunolabelling for Kir5.1 (Ai) and Kir2.1 (
localisation channel was created using 
voxels in which Kir2.1 and Kir5.1 are expressed at the same 
+ SEM, n=10). (C) Isosurface imaging of oligodendroglial
voxels are given the same intensity, 
Scale bars = 20 
C) Graphical illustration of line analysis showing the 
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 Figure 4.19 Analysis of Kir2.1 and Kir5.1 subunit expression in optic nerve 
astrocytes: (A) Triple 
astrocytes  from optic nerve explants cultured for 10 DIV. A co
created using Volocity software, illustrating 
expressed at the same intensity (
Kir5.1+/Kir2.1+ voxels quantified per cell (
analysis of Kir5.1 and Kir2.1 subunit immunocytochemistry (lines in Bi), and graphical 
illustration of the correspondence of Kir2.1 (red) with Kir5.1 (green) (Bii). 
imaging of astrocyte processes in which Kir5.1+ (red) and Kir2.1+ (green) 
given the same intensity, illustrating the extensive apposition of the two subunits. 
bars = 20 µm in A and B, 
 
immunolabelling for Kir5.1 (Ai), Kir2.1 (Aii) in GFAP+ (
localisation
voxels in which Kir2.1 and Kir5.1 are 
Aiii), and the number of Kir5.1+, Kir2.1+, and 
C; data are means + SEM, n=13). 



















Figure 4.20 Co-immunoprecipitation of Kir5.1 and Kir2.1 subunits from the brain 
and optic nerve. Brain and optic nerve protein extracts from P20-30 mice were 
precipitated with anti-Kir5.1 antibody (A; Santa Cruz) and anti-Kir2.1 antibody (B; Santa 
Cruz). Immunoprecipitates (IP) were then subjected to western blot (wb) analysis using 
opposing antibodies to demonstrate co-immunoprecipitation of the two subunits; 
immunoblotting was absent in negative controls preincubated with the appropriate 




4. 6 Clustering of the Kir subunits by the members of the 
MAGUK family 
Members of membrane-associated guanylate kinase MAGUK family, 
cluster PDZ binding motif containing Kir channels through the interaction 
with their PDZ domains, in particular (Horio et al., 1997, Pegan et al., 
2007, Tanemoto et al., 2002). Furthermore, although Kir5.1 homomeric 
channels are generally thought to be non-functional, clustering Kir5.1 
subunits by PSD-95 mediates the formation of functional homomeric Kir5.1 
channels in human embryonic kidney cells (Tanemoto et al., 2002). Here, I 
have focused on the expression of PSD-95 and Kir5.1 subunits in optic 
nerve glia. 
 
4.6.1 Expression of PSD-95 in optic nerve glia 
I used Western blot in total brain lysate to validate the anti-PSD-95 
antibody (see Fig. 4.23 below); a dense band was detected at the 
predicted MW of 95 kDa, and no band was detected in the negative 
controls. Figure 4.21 shows PSD-95 immunocytochemistry in PLP-
DsRED+ oligodendrocytes and GFAP+ astrocytes from optic nerve 
explants cultured for 10 DIV. Optic nerve oligodendroglia showed weak but 
definite punctate immunopositivity for PSD-95 anchoring protein, and no 
immunopositivity was detected in the negative control (Fig. 4.21A). In 
astrocytes, punctate plasmalemmal immunostaining was distinguished 




4.6.2 Clustering Kir5.1 subunits and PSD-95 in optic nerve glia 
PSD-95 can mediate the formation of functional homomeric Kir5.1 
channels (Tanemoto et al., 2002), and so this possibility was examined in 
optic nerve glia (Fig. 4.22). Co-expression of Kir5.1 subunit and PSD-95 
was observed in oligodendrocytes (Fig. 4.22A, boxed regions) and 
astrocytes (Fig. 4.22B, boxed regions), but not all PSD-95 and Kir5.1 were 
colocalised.  
 
4.6.3 Coimmunoprecipitation of Kir4.1 and Kir5.1 with PSD-95 and 
SAP-97 in vivo 
I used Western blot in total brain lysate to examine the expression of the 
MAGUK’s PSD-95 and SAP-67 (Fig. 4.23). For PSD-95, a dense band 
was detected at the predicted MW of 95 kDa, with weak bands at ~75 kDa 
and ~50kDa, corresponding to the heavy and light chains of IgG (Fig. 
4.23A). For SAP-97, a band was detected at the predicted MW of 130 kDa 
(Nakagawa et al., 2004), together with additional bands, suggesting low 
purity of the anti-SAP-97 antibody (Fig. 4.23B). No bands were detected in 
negative controls for both antibodies (Fig. 4.23). Heteromerisation of PSD-
95 and SAP-97 with Kir5.1 and Kir4.1 was tested using 
coimmunoprecipitation in brain and optic nerve extracts from P20-40 mice 
(Fig. 4.24). PSD-95 and SAP-97 were coimmunprecipiated with both 
Kir5.1 and Kir4.1 in the brain, but not from the optic nerve (Fig. 4.24A, B), 
presumably due to the low expression in the latter, as illustrated by 
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immunocytochemistry (Fig. 4.22). Notably, PSD-95 was strongly 
expressed in immunoprecipitate for Kir4.1 (Fig. 4.24A), and to a lesser 
extent for Kir5.1 (Fig. 4.25B), whereas SAP-97 was more strongly 
expressed in immunoprecipitate for Kir5.1 (Fig. 4.24D) than in Kir4.1 (Fig. 
4.24C). The results suggest that in vivo in the brain the Kir4.1 subunit may 
be primarily clustered with PSD-95 and the Kir5.1 subunit by SAP-97.  
However, expression levels in the optic nerve require further examination 
with greater amount of tissue. 
  
 Figure 4.21: Expression of PSD
immunolabelling of PLP
P8 optic nerve explants cultured for 15 DIV. Immunolabelling was absent in negative 
controls (inset, A) Scale b
Figure 4.22: Co-expression of Kir5.1 subunit and PSD
nerve glia: Kir5.1 subunit
astrocyte (B) from P7 wild type optic nerve explants cultured for 10 DIV.
expression of Kir5.1 subunit and PSD
Scale bars=20 µm 
-95 protein in the optic nerve glia: 
-DsRED+ oligodendrocytes (A) and GFAP+ astrocytes (B), from 
ars=20 µm. 
-95 anchoring protein in optic 
  and PSD-95 immunocytochemistry in oligodendrocyte (A) and 








 Figure 4.23. Western blot analysis of the members of PSD
mouse brain: (A) PSD
bands detected at ~ 130 kDa as predicted, but multiple bands suggest low purity of the 
SAP-97 antibody. Bands were absent in negative controls in which primary antibodies 
were omitted. 
Figure 4.24 Co-immunoprecipitation of PSD
subunits from the brain and optic nerve.
P20-40 mice were precipitated with anti
antibody (B; Santa Cruz). Immunoprecipitates (IP) were then subjected to western blot 
(wb) analysis using anti
immunoprecipitation in the brain lysate, but not optic nerve.
 
-95 and SAP
-95 bands were detected at ~ 95 kDa as predicted. (
-95 and SAP-97 with Kir4.1 and Kir5.1 
 Brain and optic nerve protein extracts from 
-Kir4.1 antibody (A; in-house) and anti












4.7  Discussion 
Kir4.1 is a major channel in glial cells and is known to form extensive 
heteromeric associations (Butt and Kalsi, 2006). In particular, Kir4.1 form 
heteromers with Kir5.1, which are notable in that they are thought not to 
be functional as homomers (Pessia et al., 1996, Tanemoto et al., 2000, Xu 
et al., 2000). In this chapter, I used immunocytochemistry, 
immunoprecipitation and western blot to examine associations between 
Kir4.1, Kir5.1 and Kir2.1 in optic nerve glia. I show that the bulk of Kir4.1 
(>80%) in optic nerve glia was not co- expressed with Kir5.1 or Kir2.1, 
suggesting most formed homomeric Kir4.1 channels. A key finding was 
that optic nerve astrocytes and oligodendrocytes express Kir4.1/Kir5.1 
heteromers, with >50% of Kir5.1 being co-expressed with Kir4.1 and 
present in the plasmalemma, indicative of functional heteromeric channels. 
Notably, genetic abaltion of Kir4.1 or knock-down using shRNA showed 
that plasmalemmal expression of Kir5.1 was laregly dependent on 
associating with Kir4.1 subunits. In addition, evidence is provided that 
clustering of Kir4.1 and Kir5.1 in the plasmalemma involves the MAGUK 
family PDZ-binding anchoring proteins PSD-95 and SAP-97. Astrocytes 
also expressed Kir2.1, whereas expression in oligodendrocytes was very 
low, and the bulk of Kir2.1 subunits colocalised with Kir4.1 and Kir5.1 
subunits in almost equal measure. The results indicate that optic nerve glia 
principally express Kir4.1 homomeric and Kir5.1/Kir4.1 heteromeric 
channels, whilst Kir2.1 channels almost exclusively form heteromeric 




My in vitro results for the first time raising the possibility for the existence 
of the heteromeric Kir4.1/Kir5.1 channels in optic nerve oligodendroglia 
and astrocytes. The colocalisation and line analyses, as well as the three 
dimensional isosurfacing, all support the existence of the Kir4.1/Kir5.1 
heteromeric channels in optic nerve. Heteromeric Kir4.1/Kir5.1 channels 
are stronger rectifiers than homomeric Kir4.1 channels, and in retinal 
Müller cells it is believed that heteromeric Kir4.1/Kir5.1 channels play an 
important part in the potassium siphoning, and it is confirmed that in the 
renal tubular epithelia they are crucial for the potassium reabsorbtion 
(Kofuji et al., 2002, Lachheb et al., 2008, Tanemoto et al., 2000). Hence, 
heteromeric Kir4.1/Kir5.1 channels in optic nerve astrocytes are likely to 
play a similar role in potassium clearance, altough this would require 
further electrophysiological examination. In addition, heteromeric 
Kir4.1/Kir5.1 channels have a high degree of pH sensitivity, and in the 
retrotrapezoid nucleus are proven have a role in the astrocytic CO2 
chemoreception (Mulkey and Wenker, 2011, Wenker et al., 2010). It is 
possible that heteromeric Kir4.1/Kir5.1 channel in optic nerve glia have a 
similar role. The majority of studies support the existence of heteromeric 
Kir4.1/Kir5.1 channels in various cell types, including renal tubular 
epithelia, retinal Müller cells, brain astrocytes derived from neocortex, 
retrotrapezoid nucleus and the glomeruli of the olfactory bulb, and 
brainstem neurons from the cardio-respiratory nuclei (Hibino et al., 2004, 
Ishii et al., 2003, Tanemoto et al., 2000a, Tucker et al., 2000, Wu et al., 
2004, Yamamoto et al., 2008). However, no previous reference could be 
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found in the literature about oligodendroglia expressing Kir5.1 subunits or 
Kir4.1/Kir5.1 heteromeric channels, and further studies are required to 
determine the functions of these channels. 
 
In the absence of Kir4.1, the Kir5.1 subunit failed to reach the plasma 
membrane. It has been shown previously in Madin-Darby Canine Kidney 
cells that the PDZ domain of the Kir4.1 channel regulates the cellular 
localisation of the Kir5.1 channel (Masayuki Tanemoto et al., 2004b), and 
my results suggest for the first time a similar role for the Kir4.1 channel in 
astrocytes. By clustering Kir5.1 in the plasma membrane, the PDZ domain 
of the Kir4.1 subunit prevents internalisation of Kir5.1. PSD95 and SAP-97 
play a role in clustering of Kir4.1 and Kir5.1 subunits via their PDZ-binding 
motifs, and the results demonstrate co-localisation of these proteins in 
optic nerve glia. Although the formation of plasmalemmal heterometic 
Kir4.1/Kir5.1 channels was also indicated in oligodendrocytes, I was 
unable to examine this in Kir4.1 knock out cultures or using shRNA due to 
technical difficulties. 
 
My results indicate heteromeric Kir4.1/Kir2.1 channels in optic nerve 
astrocytes and in oligodendroglia. The heteromeric assembly of Kir4.1 and 
Kir2.1 subunits has been demonstrated in Xenopus oocyte (Fakler et al., 
1996). Furthermore, due to the localisation and rectifying properties of 
heteromeric Kir4.1/Kir2.1 channels, they have been hypothesised to play 
an important role in potassium spatial buffering (Kofuji et al., 2002). 
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However, heteromeric Kir4.1/Kir2.1 channels have not been identified in 
vivo to date. The expression studies executed in retina demonstrated 
different expression pattern for the Kir4.1 and Kir2.1 subunits Tian et al., 
2003) and different regulation of the Kir2.1 and Kir4.1 subunits during 
ischemia (Iandiev et al., 2006), providing no evidence for the existence of 
the heteromeric Kir4.1/Kir2.1 channels in vivo. Colocalisation and line 
analysis as well as the three dimensional isosurfaceing all support the idea 
that Kir4.1/Kir2.1 heteromeric channels exist in optic nerve glia, in 
particular astrocytes, where heteromeric Kir4.1/Kir2.1 channels were 
localised to the plasma membrane ridges and processes. Moreover, my 
results demonstrate co-immunoprecipitation of Kir4.1 and Kir2.1 in the 
brain and optic nerve in vivo. The vast majority of cells in the optic nerve 
are glia, supporting the idea they express functional heteromeric 
Kir4.1/Kir2.1 channels in vivo as well as demonstrated in vitro by 
immunocytochemistry, where approximately 50% of Kir2.1 were co-
localised with Kir4.1. Furthermore, analysis of tissue from Kir4.1 knock out 
mouse, showed that Kir2.1 subunit protein levels in the optic nerve were 
decreased by 59% in the absence of Kir4.1, further evidence of 
heteromeric Kir2.1/ Kir4.1 channels in optic nerve glia. Interestingly, 
despite the decreased expression of Kir2.1 in Kir4.1 knock out brains, 
there was a 76% increase in Kir2.1 subunit protein in the brain plasma 
membrane fraction, suggesting a possible compensatory increase in 
plasmalemmal Kir2.1. Homomeric Kir2.1 are strongly rectifying K+ 
channels and are widely distributed in the brain (Derst et al., 2001, Prüss 
et al., 2005), and their upregulation in the absence of Kir4.1 could 
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compensate in K+ regulatory functions of astrocytes. Alternatively, in the 
absence of Kir4.1, increased plasmalemmal Kir2.1 may form electrically 
silent heteromers with Kir5.1 subunits. This would be consistent with the 
severely hampered K+ regulation in Kir4.1 knock out mice (Bay and Butt, 
2012). 
 
Coimmunoprecipitation provided evidence that Kir2.1 heteromerize with 
Kir5.1 in vivo, and my immunocytochemistry results indicated that 
approximately half of Kir2.1 subunits may form heteromers with Kir5.1 
subunits, particularly in astrocytes. In Xenopus oocytes, the heteromeric 
assembly of inward rectifying potassium channels from Kir5.1 and Kir2.1 
subunits formed electrically silent channels (Derst et al., 2001). I found a 
markedly higher proportion of Kir5.1/Kir2.1 colocalisation on astrocytic 
processes compared to the astrocytic cell somata (41% compared to 16%, 
respectively). My in vitro results for the first time support the idea of 
electrically silent heteromeric Kir5.1/Kir2.1 channels in glial cells, in 
particular in astrocyte processes. This has implications for K+ spatial 
buffering via Kir, which electrophysiological studies show are concentrated 
on astrocytic processes (Newman et al., 1984). Heteromerisation of Kir5.1 
and Kir2.1 subunits would essentially act to titrate them out of associations 
with Kir4.1 subunits, thereby potentially increasing the formation of weakly 
rectifying Kir4.1 homomeric channels, and reducing formation of strongly 
rectifying heteromeric Kir4.1/Kir2.1 and Kir4.1/Kir5.1 channels, as well as 
homomeric Kir2.1 channels (for which there was little evidence in the optic 
nerve). Homomeric Kir4.1 channels would favour K+
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heteromeric channels would favour uptake, and so Kir5.1 could provide a 
dynamic mechanism for regulating their function in potassium spatial 
buffering. 
 
In conclusion, the results indicate that optic nerve glia principally express 
Kir4.1 homomeric and Kir5.1/Kir4.1 heteromeric channels, although 
substantive Kir5.1 appears to exist as an intracellular pool, which may 







Na+/K+-ATPase and ATP-sensitive Kir6.1 channels 






5.1 Introduction  
In glia, Na+/K+ pumps together with Kir play a key role in [K+]o 
homeostasis, by uptake of K+ released by axons during action potential 
propagation, a process that is essential to avoid K+ build-up and maintain 
neuronal conduction properties (Bay and Butt, 2012, Ransom et al., 2000). 
Na+/K+ pumps are plasma membrane-bound ATPases that hydrolyse ATP 
to provide the energy to ‘pump’ Na+ out of the cell against the 
electrochemical gradient, and extrudes three Na+ out in exchange for two 
K+ entering the cell, and is thus electrogenic (Blanco and Mercer, 1998). 
The Na/K-ATPase enzyme is a heterodimer made of the assembly of α 
catalytic and regulatory β subunits (Lemas et al., 1994), with some cell 
types, including astrocytes, expressing an additional regulatory γ subunit. 
As many as four different alpha and three distinct beta-isoforms have been 
identified in mammalian cells (Blanco and Mercer, 1998). Astrocytes and 
oligodendrocytes express predominantly α1 and α2 isoforms of the 
catalytic subunit, whereas the β2 isoform of the regulatory subunit 
predominates in astrocytes while oligodendrocytes mainly express the β3 
isoform (Fink et al., 1996, Knapp et al., 2000, Martín-Vasallo et al., 2000). 
Notably, ouabain-affinity chromatography performed on astrocyte and 
brain extracts established that the Na/K-ATPase is part of a multiprotein 
complex with Kir4.1, together with AQP4, syntrophin and dystrobrevin 
(Brignone et al., 2011b). Recent studies performed on Kir4.1 knock-out 
mice showed increased activity of ouabain-sensitive Na+/K+-pumps in K+ 
regulation in the optic nerve (Bay and Butt, 2012), and upregulation of the 
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H+/K+-ATPase in the absence of Kir4.1 has been reported in parietal cells 
of the stomach (Song et al., 2011). These studies raise the possibility that 
glial Na/K-ATPase may be upregulated in the absence of Kir4.1. 
  
In addition, glial cells express ATP-sensitive potassium channels (K-ATP) 
composed of Kir6.x subunits and sulfonylurea receptor (SUR), which are 
directly coupled to the energy state of the cell (Ashcroft, 1988, Inagaki et 
al., 1995). Kir6.1 immunolabeling is restricted to astrocytes (A Thomzig et 
al., 2001) in most areas of the rat brain. Interestingly, electrophysiological 
experiments have identified K-ATP on the sarcolemma ("sarcKATP"), inner 
mitochondrial ("mitoKATP") and nuclear membranes ("nucKATP") (Choma et 
al., 2009, Hu et al., 1999, Inoue et al., 1991, Quesada et al., 2002). The 
pore forming KATP channel subunit Kir6.1 is reported to be primaraly 
expressed at the inner membrane of the mitochondria and weakly 
expressed at the plasmalemma (Liu et al., 2001, Suzuki et al., 1997, Zhou 
et al., 2005) whereas Kir6.2 is the crutial pore forming subunit of the 
sarcolemmal but not of the mitochondrial KATP channels (Sellitto et al., 
2011, Suzuki et al., 2002). Astrocytes in the hippocampus, cortex, and 
cerebellum are known to express the Kir6.1 subunit (Thomzig et al., 2001). 
Futhermore oligodendroglia in the corpus callosum, and cerebellar cortex 
have been shown to express Kir6.2 subunit (Zhou et al., 2002). Thus, 
Kir6.x channels in glia are likely to play an important role in maintaining the 
membrane potential when ATP levels are compromised. Given the 
associations between Kir4.1, Na+/K+-pumps and Kir6.x, and the fact that 
they are all involved in maintaining the membrane potential and in K+ 
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transport, the aim of this chapter was to examine these relationships in 




5.2 Na/K-ATPase is increased in the absence of Kir4.1 in optic 
nerve glia 
The Na/K–ATPase α1 subunit is ubiquitously expressed, and so I used 
antibodies to this isoform to examine Na/K-ATPase expression in optic 
nerve glia (see Chapters 3 and 4). Immunopositivity of optic nerve 
oligodendroglia was verified using PLP-dsRed optic nerve explants (Fig. 
5.1A), and for astrocytes using GFAP immunolabelling (Fig. 5.1B). The 
orthographic projection demonstrates no intracellular immunolabelling with 
Na/K-ATPase α1 subunit (Fig. 5.1Ai). As shown previously, Na/K-ATPase 
immunostaining was punctate and plasmalemmal; immunolabelling was 
absent in negative controls in which the primary antibody was omitted (Fig. 
5.1A, inset).  
 
Figure 5.2 compares the expression of Na/K-ATPase α1 subunit in optic 
nerve astrocytes transfected with scrambled shRNA (Fig. 5.2A) or Kir4.1 
shRNA (Fig. 5.2B). Efficiency of Kir4.1 KD in these cultures was 
demonstrated in Chapters 4; oligodendrocytes were very rarely transfected 
and so were not analysed. Analysis of Na/K-ATPase α1 subunit 
immunofluorescence in astrocytes, using Volocity software, shows the 
mean number of voxels in a constant 9 µm3 area was significantly 
increased by over 2-fold following knock down of Kir4.1 (p<0.001, 
unpaired t-test), from 7376 ± 1484 in controls transfected with scrambled 
shRNA (n=11), to 18333 ± 4672 in astrocytes transfected with Kir4.1 




Figure 5.3 compares Na/K-ATPase α1 subunit protein levels in optic nerve 
and in brain plasma membrane fractions (PMF) of the P19 wild type and 
Kir4.1 knock-out mice (n=3). Bands were detected at 112 kDa, at the 
predicted MW molecular weight of the Na/K-ATPase α1 subunit, and were 
absent in negative controls (Fig. 5.3A, B). Measurement of the integrated 
density of the 112 kDa bands (n=3), normalised to beta actin, shows the 
Na/K-ATPase α1 subunit was increased 2-fold in Kir4.1 knock out  
compared to age-matched wild type optic nerves (p<0.001, one-tailed t-
tests), from 1.02 ± 0.04 to 2.12 ± 0.07. An equivalent increase was 
demonstrated in the brain PMF, from 1.1 ± 0.08 in wild type to 2.4 ± 0.08 
in Kir4.1 knock outs. 
 
The results support the idea that glial Na/K-ATPase is increased in the 
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5.3 Kir6.1 is altered in the absence of Kir4.1 in optic nerve glia 
Kir6.1 is restricted to astrocytes in most areas of the brain (Thomzig et al., 
2001), and so I focused on this channel in optic nerve astrocytes, although 
they also express Kir6.2 (not illustrated). Here, I compared expression of 
Kir6.1 in wild type and Kir4.1 knock out optic nerve glia, using 
immunocytochemistry (Fig. 5.4) and western blot (Fig. 5.5). Figure 5.4 
shows Kir6.1 immunocytochemistry of wild type and Kir4.1 knock out optic 
nerve explants. There was weak punctate Kir6.1 immunostaining in wild 
type astrocytes (Fig. 5.4A), which was increased in Kir4.1 knock out optic 
nerve astrocytes that displayed altered, presumably mitochondrial 
distribution of the Kir6.1 subunit (Fig. 5.4B); as Kir6.1 is localised primiraly 
in the mitochondria (Liu et al., 2001, Suzuki et al., 1997, Zhou et al., 
2005). The mitochondrial Kir6.1 was most prominent in flat, pericyte-like 
GFAP-negative cells surrounding astrocytes. Western blot analysis 
confirmed that Kir6.1 in brain and optic nerve extracts were increased in 
Kir4.1 knock-out mice compared to age-matched wild-type controls (Fig. 
5.5). Bands were detected at ~ 48 kDa, the predicted MW of the Kir6.1 
subunit, and the lower bands most likely represent degradation products 
(Thomzig et al., 2001). Integrated density of the 48 kDa bands (n=3) was 
normalised to beta actin, and showed that Kir6.1 was increased 3-fold in 
the Kir4.1 KO brain (p<0.001, t-test), from 1.05 ± 0.03 in wild-type brain to 
3.18 ± 0.04 in Kir4.1 KO brain, but not in the optic nerve, where  levels 
were not significantly different. 
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5.4 Increased mitochondrial fraction in the absence of Kir4.1 
The elevated levels of Na/K-ATPase and apparent increased KATP 
suggested increased mitochondrial activity in the Kir4.1 knock out brain. 
Therefore, I examined the mitochondrial fraction from the whole brain of 
the age matched wild type and Kir4.1 knock out mice, and compared to 
the nuclear fraction, which is a measure of total number of cells (Fig. 5.6).  
The brain nuclear fraction was not significantly different in in wild-type and 
Kir4.1 KO, 0.36 ± 0.043g (n=3) and 0.28 ± 0.05g (n=3), respectively (Fig. 
5.6). In contrast, the mean (+SEM) mitochondrial fraction was significantly 
increased (p<0.05, one-tailed t- test) in the Kir4.1 knock out brain, 0.17 ± 
0.014 g, compared to 0.095 ± 0.018 g in age-matched wild-type brain. 
Normalised to the nuclear fraction, the mitochondrial fraction was 
increased 2-fold in Kir4.1 KO brain. This investigated further by western 
blot of the mitochondrial marker prohibitin 1,  in age matched wild type and 
Kir4.1 knock out brain (Fig. 5.6). Bands were detected at ~ 30 kDa, the 
predicted MW of prohibitin (Fig. 5.6A), and the integrated density of the 30 
kDa bands (normalised to beta actin) was 1.02 ± 0.03 (n=3) in wild-type 
and 2.06 ± 0.02 (n=3) in Kir4.1 KO (p<0.05, one-tailed t- test). The results 
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Figure 5.7 Prohibitin protein levels 
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Glial Na/K-APase form part of a multiprotein complex with Kir4.1, which 
together play a key role in [K+]o homeostasis (Bay and Butt, 2012, 
Brignone et al., 2011, Ransom et al., 2000) (Bay and Butt, 2012). 
Moreover, glia express K-ATP composed of the pore-froming Kir6.1 
subunit, which are directly couple to the energy state of the cell (Ashcroft, 
1988, Inagaki et al., 1995). I show here that both Na/K-ATPase and Kir6.1 
are upregulated in the absence of Kir4.1. Moreover, the Kir6.1 subunits 
might form mitoKATP channels, which help maintain ATP production in 
response to reduced cytosolic ATP, and I provide evidence of increased 
mitoKATP channel subunit Kir6.1 and increased mitochondria in the 
absence of Kir4.1. We have previously shown that ouabain-sensitive Na/K-
pumps play an increased role in K+ regulation in the absence of Kir4.1 
(Bay and Butt, 2012). The results of this chapter suggest that KATP 
channels and mitochondria are increased to sustain ATP production to fuel 
the up-regulated Na/K-ATPase and thereby maintain potassium and water 
homeostasis in the absence of Kir.4.1. 
 
Na/K-ATPase immunolabelling in optic nerve glia was punctate and 
localised to the plasmalemma, as predicted. Notably, Na/K-ATPase α1 
subunit was increased 2.5 times in vitro in response to knock-down of 
Kir4.1 using shRNA, equivalent to the >2-fold increase measured in vivo 
by Western blot of brain and optic nerve plasma membrane fractions in 
Kir4.1  KO mice, compared to age-matched wild-type. An equivalent 
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observation has been made in parietal cells of the stomach, where H+/K+-
ATPase is upregulated in the absence of Kir4.1 (Song et al., 2011). The 
increased level of Na/K-ATPase in optic nerve glia is consistent with an 
important compensatory role in K+ regulation in the absence of Kir4.1 (Bay 
and Butt, 2012). In addition, although myelin vacuoulation is widespread in 
Kir4.1 knock-out mice (Neusch et al., 2001), there remains extensive 
compacted myelin, supporting evidence that up-regulation of Na/K-
ATPase in oligodendrocytes is a compensatory mechanism for maintaining 
potassium and water movement that is essential for myelin compaction.  
 
In addition, optic nerve astrocytes were immunopositive for Kir6.1 
channels, which displayed punctate labelling on the plasma membrane in 
both wild type and Kir4.1 knock out optic nerves, very similar to the Na/K 
ATPase α1 subunit immunocytocheminstry. A marked difference in Kir4.1 
knock out explant cultures, was the increased in what appeared to be 
mitochondrial Kir6.1subunit expression (mitoKATP), which was not 
prominent in wild type optic nerve explants. The Kir6.1 was most marked 
in GFAP-negative cells that had a flat morphology, which had the 
phenotpye of type-1 astrocytes identified first by Raff and colleague in 
optic nerve cultures (Raff et al., 1984). Further studies would be needed to 
unequivocally identify these cells, but the GFAP-negative  cells are very 
unlikely to be oligodendrocytes or microglia. Western blot confirmed 
upregulation of Kir6.1 subunit in vivo in the Kir4.1 knock out whole brain, 
although the increase was not statistcally significant in the optic nerve. 
Kir6.1 mitoKATP channels help maintain the mitochondrial membrane 
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potential in response to metabolic stress and reduced cytosolic ATP, 
thereby providing the proton gradient necessary for mitochondrial ATP 
synthesis.  
 
Although not fully characterised, functional communication exists between 
Na/K-ATPase and mitochondria by mechanisms that involve the mitoKATP 
channel (Garlid et al., 2006, Pasdois et al., 2007, Tian et al., 2003). The 
proportional increase in Na/K-ATPase and mitoKATP chanel subunit 
Kir6.1 observed in the absence of Kir4.1 may therefore be functionally 
linked and part of the mechanism for maintaining ATP production to fuel 
the pumps required for potassium uptake in the absence of Kir4.1. In 
addition, mitoKATP play a central role in protection of cells against 
ischemia and apoptosis (Ardehali, 2005). Although prolonged ischemia 
results in severe damage to neural cells and ultimately cell death, brief 
ischemic episodes recruit mitoKATP to mitigate cellular injury. It is possible 
the brain is under metabolic stress in the absence of Kir4.1, not least to 
fuel the additional Na/K-ATPase. Furthermore, in Chapter 4, I showed that 
Kir4.1 heteromerises with Kir5.1, which are known to act as CO2 
chemoreceptors in the cental chemosensitive nuclei of the brainstem 
(Mulkey and Wenker, 2011, Wenker et al., 2010, Wu et al., 2004). Notably, 
the response to hypercapnic acidosis is dramatically reduced and delayed 
in the absense of Kir4.1/Kir5.1 channels (D’Adamo et al., 2011), and the 
resultant ischemia would activate neuroptective mitoK-ATP (Melamed-
Frank et al., 2001, Miura et al., 2003, Raeis et al., 2010, Schulz et al., 
2010, Zhang et al., 2008) .  
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The increased protein level of Na/K-ATPase and mitoKATP channel 
subunit Kir6.1 in Kir4.1 knock out mice was mirrored by a doubling of the 
mitochondrial membrane fraction and prohibitin 1 (PHB1), which 
assembles with PHB2 in the inner membrane of mitochondria. The 
prohibitin complex stabilises newly synthesised respiratory chain proteins 
and maintains functional integrity of mitochondria (Merkwirth and Langer, 
2009). Prohibitin is upregulated in the brain in ischemia and is markedly 
neuroprotective, by reducing mitochondrial free radical production (Zhou et 
al., 2012), and high levels of prohibitin in Müller glia is believed to underlie 
their relative resistance to ischemia in the retina (Mandal et al., 2011). In 
conclusion, the increased levels of mitochondria in the absence of Kir4.1 
are consistent with the greater metabolic needs for fuelling Na/K-ATPase, 
and increased prohibitin and mitoKATP channel subunit Kir6.1 suggest the 
tissue is under ischemic stress. 
  











Functionally, the membranes of mature glia are characterised by 
prominent inwardly rectifying potassium currents that generate the strongly 
negative RMP. However, the molecular basis of glial inward rectifying 
currents and their relative importance in the physiological functions of glia 
remains unclear. Astroglia are reported to express a wide-range of Kir 
channel subtypes, although the Kir4.1 subtype is the main channel in the 
majority of astroglia studied (Kalsi et al., 2004, Olsen et al., 2006, 
Poopalasundaram et al., 2000, Seifert et al., 2009). In addition, prominent 
roles have been proposed for the Kir5.1 and Kir2.1 sutypes in astrocytes. 
Most notably, Kir5.1 combine with Kir4.1 to form functional heteromeric 
channels, which are highly pH sensitive and have an identifed function in 
chemoreception in retrotrapezoid nucleus astrocytes, although Kir5.1 are 
widely expressed by astrocytes throughout the brain (Hibino et al., 2004, 
Ishii et al., 2003, Mulkey and Wenker, 2011, Wenker et al., 2010). 
Astrocytes also commonly express Kir2.1, which are proposed to be 
involved in K+ uptake through their formation of strongly rectifying 
channels, either as homomers or as heteromers with Kir4.1 (Howe et al., 
2008, Kang et al., 2008, Kofuji et al., 2002). However, few previous 
studies have examined the molecular composition of Kir subunits in 
astrocytes. Moreover, even less was known about the Kir expressed by 
oligodendrocytes, and it was even debated whether Kir4.1 were as 
prominent as in astrocytes (Butt and A. Kalsi, 2006). In this thesis, I have 
addressed these issues in optic nerve glial cultures, using 
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immunocytochemistry, confocal microscopy, co-localisation analysis, 
western blot, co-immunoprecipitation, shRNA transfection and Kir4.1 
knock-out mice.   
 
 
The key findings of the thesis are: 
1) optic nerve astrocytes and oligodendrocytes express Kir4.1, Kir5.1 
and Kir2.1 subunits;  
2) these subunits combine to form Kir4.1 homomeric and Kir5.1/Kir4.1 
heteromeric channels, whilst Kir2.1 exist almost exclusively as 
heteromers with Kir4.1 and Kir5.1 
3) the expression and subcellular of Kir5.1 and Kir2.1 is largely 
dependent on association with the Kir4.1 subunit; 
4) in the absence of Kir4.1, there is up-regulation of glial Na/K-ATPase 
and ATP-sensitive Kir6.1 channels, in addition to increased 
mitochondria and mitoKATP subunit (Kir6.1), which would serve to 
maintain potassium homeostasis and protection of glial cells against 
ischemia and apoptosis in the absence of Kir.4.1. 
 
6.2  Optic nerve glia express heterogeneous Kir subunits 
Kir subunit expression was tested using two different antibodies for Kir4.1, 
Kir5.1 and Kir2.1, and I tested three methods of fixation, as well as two 
different concentrations of blocking serum. In addition, the specificity of the 
antibodies was tested using western blot, blocking peptides and, in the 
 case of Kir4.1, knock
bands at the molecular weights predicted for the proteins in question, and 
these were absent in negative controls. In addition, double 
immunolabelling with Na/K
plasmalemmal expression of the Kir subunits, as predicted for functional 
ion channels. Thus, there are no real doubts over the validity of the 
findings using these antibodies, which demonstrated 
astrocytes and oligod
in vitro, and Western blot and co
expression and heteromerisation
identified expression of Kir6.1, Kir6.2 and Kir7.1 in 
6.1), although of these only Kir6.1 was studied further (Chapter 5). 
Figure 6.1: Expression of Kir6.1, Kir6.2 and Kir7.1 subunits in optic nerve glia
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2012; Bolton et al., 2006; Bolton & Butt, 2006; Neusch et al., 2000, 
Wenker et al., 2010). Kir4.1 channels are clustered by a dystrophin-
associated protein complex (DAPC) in cortical astrocytes and in the 
specialised astrocytes of the retina called Müller glia, and the same is 
likely to be true in optic nerve astrocytes (Connors et al., 2004, Connors 
and Kofuji, 2006). Similar to astrocytes, the Kir4.1 subunit and 
dystroglycan are likely to be part of the same complex in oligodendrocytes, 
although no studies addressed this question yet. Dystroglycan also serves 
as a laminin 2 receptor in oligodendrocytes and are crucial for 
oligodendrocyte development (Chun et al., 2003, Galvin et al., 2010, 
Palacios et al., 2005). Since Kir4.1 are also essential for oligodendrocyte 
development (Neusch et al., 2001), it seems likely that this may involve its 
complexing with dystroglycan and interactions with laminin 2.  
 
My findings in astrocytes are consistent with those showing prominent 
expression of Kir4.1 in vivo in the optic nerve and elsewhere in the brain, 
and to a lesser extent Kir5.1 and Kir2.1 (Butt & Kalsi, 2006). My results 
demonstrate unequivocally strong expression of Kir4.1, weak expression 
of Kir2.1 and, for the first time strong oligodendroglial expression of Kir5.1 
subunit, which supports the small number of previous reports on Kir4.1 
and Kir2.1 expression in oligodendrocytes (Kalsi et al., 2004; Neusch et 
al., 2000; Poopalsundurum et al., 2000; Stonehouse et al., 1999). A similar 
low expression of the Kir2.1 subunit releative to Kir4.1 and Kir5.1 has 
been shown in Müller glia, which had ~12 times less Kir2.1 than Kir4.1 
(Ulbricht et al., 2008). My immunocytochemistry data also demonstrated 
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heterogeneity in the expression of Kir4.1 subunits in optic nerve 
astrocytes, which was also demonstrated in vivo in the Kir4.1-EGFP 
transgenic mouse (Tang et al., 2009). The heterogeneity of Kir4.1 was 
mirrored by Kir5.1, supporting my evidence that they form hetermoers. The 
different levels of Kir4.1 subunit expression in astrocytes is believed to be 
the underlying cause for their heterogeneous RMP (Bolton et al., 2006, 
McKhann et al., 1997). My data did not indicate the strongly rectifying 
Kir2.1 subtype was highly expressed in optic nerve glia, compared to 
Kir4.1 and Kir5.1 (but was similar to Kir6.1, Kir6.2 and Kir7.1). Preliminary 
studies examining Kir2.2 or Kir2.3 in optic nerve explants were 
unimpressive, but these subtypes are worthy of further investigation, since 
Kir2.2 are present in Müller glia, Bergmann glia and astrocytes (Raap et 
al., 2002; Leonoudakis et al., 2001; Stonehouse et al., 2003), and Kir2.3 
has been localised to the perinodal microvilli of Schwann cells (Mi et al., 
1996). In addition, I did not examine G-protein coupled Kir3.x subunits, 
although heteromeric channels formed from combinations of Kir3.1, Kir3.2, 
Kir3.3 and Kir3.4 are found throughout the brain (Aguado et al., 2008, 
Duprat et al., 1995, Jelacic et al., 2000). Glial expression of Kir3.x is poorly 
studied and to my knowledge has only been examined at the mRNA level 
in Müller glia, which expressed Kir3.1 and Kir3.2, but not Kir3.3 or Kir3.4 
(Raap et al., 2002). Strong expression of Kir3.1 mRNA has been 
determined by qPCR in the optic nerve (Butt & Greenwood, unpublished 
data), and optic nerve glial G-protein activated Kir currents are mostly 
likely to be formed by heteromeric association of Kir3.1 and Kir3.2, which 
are the most common in the brain (Mathie et al., 2003). Interestingly, as is 
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the case for Kir4.1 channels, abnormal function of Kir3.2 is also implicated 
in increased seizure activity (Lüscher and Slesinger, 2010) 
 
6.3  Atypical localisation of Kir subunits in optic nerve glia 
Punctate plasmalemmal Kir2.1 immunolabelling was prominent in 
oligodendrocytes, but in astrocytes there was also intracellular Kir2.1 that 
appeared to be localised with GFAP intermediate filaments. This was not 
due to cross-reaction between the anti-Kir2.1 and anti-GFAP antibodies, 
since it was also observed in single immunolabelling. We also observed 
close association of Kir5.1 subunits with GFAP following ablation of Kir4.1, 
whereas this was not observed in the presence of Kir4.1. Although these 
results may be artefactual, they may suggest a previously unrecognised 
relationship between Kir and intermediate filaments, representing normal 
localisation in the case of Kir2.1 in wild-type astrocytes, and dislocalisation 
in the case of Kir5.1 in Kir4.1 KO astrocytes. The significance of this 
finding is unclear, but GFAP intermediate filaments are known to interact 
with F-actin, a member of the DAPC (Rutka et al., 1998), which forms 
complexes with Kir4.1 to cluster the channels in the plasmalemma 
(Connors et al., 2004, Connors and Kofuji, 2006). The expression pattern 
of Kir4.1/Kir5.1 along plasmalemmal ridges superficially followed 
intracellular GFAP intermediate filaments, and in the absence of Kir4.1, 
Kir5.1 remained mislocalised to the GFAP. In addition, recent studies 
show the importance of GFAP in vesicle/lysome trafficking in astrocytes 
(Middeldorp and Hol, 2011), and so GFAP may be involved in the 
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internalisation of Kir subunits via dynamin and clathrin-dependent 
endocytosis (Boyer et al., 2009, Mason et al., 2008). Several loss-of-
function mutations in Kir2.1 impair trafficking to the plasma, and it is 
possible these are expressed in optic nerve astrocytes and recognised by 
the Alomone anti-Kir2.1 antibody.  
 
The targeting of Kir2.x and Kir5.1 to specific membrane domains of glia 
cells is ascribed to their interaction with PDZ proteins. For example Kir2.2 
are directly associated with PDZ domain containing SAP-97 protein in 
Bergmann glia and other cerebellar astroglia (Leonoudakis et al., 2001), 
and I show Kir5.1 colocalizes with SAP-97 and PSD-95 in optic nerve 
astrocytes. Future studies should examine interactions between Kir2.1 and 
PSD-95/SAP-97, and whether, for example, over-expression of the later 
alters localisation of Kir channels in glia. Interestingly, Alexander disease 
(AxD) is associated with a GFAP mutation resulting in GFAP aggregation, 
and has an infantile onset with presence of seizures, as well as 
psychomotor developmental retardation, macrocephaly, and abnormalities 
in the superior frontal cerebral white matter (Yoshida and Nakagawa, 
2012). It would be of interest to determine whether the GFAP mutations 
are associated with dislocalisation of astroglial Kir, which would severely 
disrupt K+ homeostasis, with resulting increased seizure susceptibility, as 
observed in the Kir4.1 KO mouse.  
 
 A further unexpected finding was that the Santa Cruz anti-Kir2.1 antibody 
labelled the nuclei of oligodendrocytes, which was not observed in 
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astrocytes or using the Alomone anti-Kir2.1 antibody, whilst the Santa 
Cruz anti-Kir5.1 antibody labelled the nuclei of astrocytes, and this was not 
observed in oligodendrocytes or using the Alomone anti-Kir5.1 antibody. 
These results may be artefcatual, but this would not explain the 
combination of results. Furthermore, equivalent results have been reported 
for the expression of the Kir2.2 subunit at the nuclear envelope of 
hindbrain neurons and macroglia (Stonehouse et al., 2003). Multiple splice 
variants of Kir subunits have been shown (Dong et al., 2001; Namba et al., 
1996), and it is possible the Santa Cruz anti-Kir2.1 and Alomone anti-
Kir5.1 antibodies identify alternative splice variants of these subunits that 
are expressed at the nuclear membrane of oligodenrocytes and 
astrocytes, respectively. Indeed, nuclear ionic channels are ubiquitous in 
cells and are increasingly being recognised as playing a role in signal 
transduction pathways that influence gene transcription and other 
processes in the nucleus (Fig. 6.2; Guihard et al., 2000; Mazzanti et al., 
2001;Matzke et al., 2010). Ion gradients are generated across the nuclear 
membranes (inner and outer), and ions stored in and released from the 
perinuclear space (Fig. 6.2). The most comprehensive evidence is for Ca2+ 
channels, but patch-clamping has detected different types of K+ channels 
(Guihard et al., 2000). Notably, I also observed nuclear staining for Kir6.2 
in glia (but not Kir6.1), and nuclear KATP channels containing the pore 
forming subunit Kir6.2 have been identified in the nuclear envelope, where 
they modulate nuclear function (Quesada et al., 2002). My results suggest 
possible functions for Kir6.2, Kir5.1 and Kir2.1 subunits in the nuclear 
membrane, although it cannot be discounted that the antibodies used may 
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also identify other ‘off-target’ epitopes at the nuclear envelope. It will 
require comprehenisve molecular, genetic, electron microscopic and 
patch-clamp approaches to address these questions. 
 
Figure 6.2 Membranes, Ion Channels, and Transporters of the nuclear envelope. 
ONM, outer nuclear membrane; INM, inner nuclear membrane; PNS, perinuclear space; 
ER, endoplasmic reticulum; NR, nucleoplasmic reticulum; NPC, nuclear pore complex 
(depicted as two yellow bars).(B) Three routes of ion transport at the nuclear periphery 
(bidirectional black arrows): through the NPC (1), across the ONM (2), and across the 
INM (3).(C) Reported ion channel activities in the NE of mammalian cells. IP3-regulated 
Ca2+ channels in the INM (including the NR) and ONM are presumed to release Ca2+ 
from the perinuclear space into the nucleoplasm and cytoplasm, respectively. A Ca2+-
ATPase has been identified in the ONM. The direction of ion flow is unknown for K+ and 
Cl– channels.(D) Nuclear membrane ion channels, transporters, and NUPs acting in the 
Nod factor signaling pathway. Related cation channels (DMI1, CASTOR, POLLUX, and 
SYM8) and two NPC proteins (NUP85 and NUP133; enlarged for emphasis) have been 
identified in genetic screens for nodulation-defective mutants in several species of 
leguminous plants. These proteins are needed for Ca2+ oscillations (zig-zag line) that 
occur on both sides of the NE during Nod factor signaling (Sieberer et al., 2009). 
CASTOR and POLLUX (blue ovals) may be K+ channels that regulate the membrane 
potential of the INM and/or ONM to trigger release of Ca2+ from the perinuclear space 
through as yet unidentified voltage-sensitive Ca2+ channels (red ovals) (Charpentier et 
al., 2008). An (unknown) Ca2+-ATPase (orange spheres) presumably pumps Ca2+ back 
into the perinuclear space. A hypothetical function of NUP85 and NUP133 in perinuclear 
Ca2+ oscillations is regulation of the Ca2+ permeability of NPCs (Downie and Oldroyd, 




6.4 Possible role for Kir2.1/Kir5.1 channels in regulating Kir4.1 
channel formation in optic nerve glia 
I provided immunocytochemical and co-immunoprecipitation evidence that 
the Kir4.1 subunit preferentially co-assembles with Kir5.1 to form 
heteromeric channels, although non-colocalised immunostaining at the 
plasmalemma indicated Kir4.1 primarily form homomeric channels in optic 
nerve astrocytes and oligodendrocytes. In addition, the results indicated 
that in optic nerve glia Kir2.1 subunits exist almost exclusively as 
heteromers with Kir4.1 and Kir5.1, in approximately equal measure. The 
evidence for heteromeric assembly of the Kir5.1 and Kir2.1 subunits is of 
interest, because heteromeric Kir5.1/Kir2.1 channels are electrically silent 
(Derst et al., 2001). It is proposed that by heteromerizing with Kir5.1, the 
Kir2.1 subunit regulates the heteromeric assembly of functional 
Kir4.1/Kir5.1 channels. Furthermore, the co-immunoprecipitation data 
indicated heteromerisation of Kir5.1 and Kir2.1 subunits was found to be 
specific to the optic nerve. Immunolabelling indicated that Kir5.1/Kir2.1, 
Kir4.1/Kir2.1 and Kir4.1/Kir5.1 heteromeric channels were similarly 
localised to cytoplasmic ridges and the plasmalemmal borders of 
astrocytes. Heteromerisation between Kir5.1 and Kir2.1 to form silent 
channels would potentially reduce the formation of strongly rectifying 
Kir4.1/Kir2.1 and Kir4.1/Kir5.1 channels, the latter also being highly pH-
sensitive, with important implications for the astroglial capacity for K+ 
uptake. The co-assembly of Kir4.1 with the Kir5.1 or Kir2.1 subunits alters 
the channel biophysical properties, as the single channel conductance of 
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the homomeric Kir4.1 channel ranges between 12-27.2 pS, whereas the 
single conductance of the heteromeric Kir4.1/Kir5.1 and Kir4.1/Kir2.1 
channels is between 43-59.2 pS. Moreover, both heteromeric channels 
exhibit strong inward rectification, in contrast to the homomeric Kir4.1 
channels that are weak inward rectifying channels (Fakler et al., 1996, 
Pessia et al., 1996, Tanemoto et al., 2000, Yang et al., 2000). Consistent 
with this, electrophysiological experiments identified two types of Kir 
channels on cultured rat spinal cord astrocytes, with a single conductance 
of 28 and 80 pS (Ransom and Sontheimer, 1995). Due to their distinct 
rectification properties, however, weak and strong rectifying Kir channels 
have a different role in K+ buffering of the astrocytes (Fig. 6.3). Studies on 
the specialised astrocytes of retina called Mϋller glia revealed that strongly 
rectifying Kir2.1/Kir4.1 and Kir4.1/Kir5.1 channels are important for K+ 
uptake at sites of high neuronal activity, whereas weakly rectifying 
homomeric Kir4.1 channels are involved in the release of the K+ at sites of 
low K+ activity (Kofuji et al., 2002, Ishii et al., 2003). In addition, there is 
evidence that oligodendrocytes might be implicated in K+ buffering 
involving Kir4.1 and gap junctions (Menichella et al., 2006), while genetic 
deletion of astroglial gap junctions reduced, but did not abolish the K+ 
buffering of the glia (Wallraff et al., 2006). Moreover in the Schwann cells, 
localisation of Kir2.1 and Kir2.3 strongly inward rectifying channel subunits 
at perinodal processes strongly suggested their involvement in K+ 
buffering (Mi et al., 1996). 
Since the relative degree of heteromerisation between Kir4.1, Kir5.1 and 
Kir2.1 potentially determines the movement of K+ in glial cells, then the 
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mechanisms that regulate their formation are important for brain K+ 
homeostasis (Fig. 6.3). My results demonstrated plasmalemmal 
expression of Kir4.1 and Kir5.1, but immunocytochemical analysis also 
indicated significant intracellular localisation of these subunits in optic 
nerve glia. This is in agreement with findings in gastric parietal cells that 
showed a diffuse cytoplasmic Kir4.1 subunit immunolabelling in the resting 
gastric parietal cells, but a complete translocation of the Kir4.1 subunit to 
the secretory membrane in the stimulated cells (Kaufhold et al., 2008). The 
regulation of Kir plasma membrane expression is a common mechanism 
mostly via PKA- and PKC-dependent pathways (Béguin et al., 1999, Garg 
and Hu, 2007, Morishige et al., 1999,Yoo et al., 2003). 
 
Figure 6.3  A model of K+ spatial buffering. Astroglial Kir2.1 subunits, by 
heteromerizing with Kir5.1 subunits to form silent channels, provide a mechanism for the 
dynamic regulation of heteromeric Kir4.1 channels, and thereby control the direction of K+ 
movement. Thus, K+ uptake is favoured during action potential propagation, by the 
formation of strongly rectifying heteromeric Kir4.1/2.1 and Kir4.1/Kir5.1 channels, and K+ 
release for subsequent re-uptake into the axon is favoured by the formation of silent 
Kir2.1/Kir5.1 heteromers and weakly rectifying Kir4.1 homomeric channel. Adapted from 
(Bay & Butt, 2012).  
Kir4.1/Kir5.1 and Kir4.1/Kir2.1 
Kir4.1 homomers (and silent Kir2.1/Kir5.1) 
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6.5 Potential role for heteromeric Kir4.1/Kir5.1 channels as pH 
sensors in optic nerve glia 
Due to their unique pH sensitivity, heteromeric Kir4.1/Kir5.1 channels are 
implicated in the CO2 chemoreception (Xu et al., 2000), hence they may 
serve the same function in optic nerve astrocytes and oligodendrocytes. 
Evidence from Kir5.1 knockout mice provided further evidence that the 
Kir5.1 subunit is important for the cellular response to acidosis (D’Adamo 
et al., 2011, Trapp et al., 2011). It is possible that a similar mechanism 
exists in the optic nerve, whereby pH sensitive Kir4.1/Kir5.1 channels are 
important for maintaining glial RMP in the case of acidosis. Furthermore, 
inhibition of pH sensitive Kir4.1/Kir5.1 currents in RTN astrocytes 
stimulates them to release ATP, which in turn acts on respiratory neurons 
to increase their activity (Erlichman et al., 2008, Gourine et al., 2010, 
Wenker et al., 2010). We have shown previously that astrocytes in the 
optic nerve release ATP, which acts on P2Y1 and P2X7 receptors to 
evoke raised calcium in both astrocytes and oligodendrocytes (Hamilton et 
al., 2010). P2Y1 receptor activation in oligodendrocytes is known to 
activate the pro-survival PI3K/Akt pathway and the pro-differentiation 
MAPK/CREB pathways, which promote myelination (Butt, 2006). In 
addition, high levels of ATP, which could be released in ischemia, activate 
P2X7 receptors and are cytotoxic via the JNK pathway (Wang et al., 
2012). Indeed, downregulation of P2X7 receptors by oligodendrocytes 
may serve as a protective strategy in ischemia to compensate for the rise 
in extracellular ATP (Domercq et al., 2010). Hence, Kir4.1/Kir5.1 
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heteromers may play a central role in the glial response top metabolic 
stress in the optic nerve. Due to the S-glutathionylation of the Kir5.1 
subunit, Kir4.1/Kir5.1 heteromeric channels, but not homomeric Kir4.1 
channel, were reported to be sensitive to the oxidative stress (Jin et al., 
2012). Determination of the functions of Kir4.1/Kir5.1 channels as CO2 
sensors and their roles in oxidative stress in optic nerve astrocytes and 
oligodendrocytes would be an important area for future research, since 
oligodendrocytes are particularly sensitive to ischemia and their loss 
results in demyelination. It has been shown that oligodendrocytes and 
myelination are disrupted in the absence of Kir4.1 (Neusch et al., 2001), 
and my results suggest this may at least in part due to the loss of 
heteromeric Kir4.1/Kir5.1 channels. In this respect, it is interesting that a 
recent study indicated Kir4.1 was identified as a potential target of the 
autoantibody response in a subgroup of people with multiple sclerosis 
(Srivastava et al., 2012). 
  Figure 6.4  Effects of P2Y1 receptor activation in glia
oligodendrocytes is known to activate the pro
differentiation MAPK/CREB pathways
ATP levels activates the
 
. P2Y1 receptor activation in 
-survival PI3K/Akt pathway and the pr
 whereas the activation of P2X7 receptors 








There was also a large amount of Kir5.1 that was not localised with either 
Kir4.1 or Kir2.1 in optic nerve glia, and it can be assumed this represents a 
large intracellular pool of Kir5.1, since Kir5.1 do not normally form 
homomeric channels. However, Kir5.1 may also form heteromers with 
Kir4.2 subunits, which are expressed in the brain and may contribute to a 
range of mental and functional disabilities associated with Down’s 
syndrome (Gosset et al., 1997, Ohira et al., 1997). Expression of Kir4.2 
mRNA has been determined by qPCR in the optic nerve (Butt & 
Greenwood, unpublished data), and future studies should examine this, 
since homomeric Kir4.2 channels display a strong potassium sensitivity 
that is completely abolished when coexpressed with Kir5.1 (Edvinsson et 
al., 2011), which has clear implications for astroglial K+ uptake and brain 
K+ regulation. Kir4.2 channels display an extreme potassium selectivity 
and their plasmalemmal translocation is pH dependent in gastric parietal 
cells, where they are involved in K+ fluxes that drive H/K-ATPase (He et 
al., 2011; Pessia et al., 2001), which also has implications for Na/K-
ATPase mediated K+ uptake in the brain. Interestingly, I found that Na/K-
ATPase was upregulated in the absence of Kir4.1, and future studies 
should examine whether this is associated with a compensatory 
upregulation of Kir4.2. 
 
6.6 Altered metabolism in the absence of Kir4.1 
My immunocytochemistry and western blot data suggest that Kir4.1 
regulates the expression of Na/K-ATPase, which is also implicated in the 
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clearance of K+ released during neuronal activity (Bay and Butt, 2012,  
D’Ambrosio et al., 2002). Kir4.1 and Na/K ATPase are clustered by the 
same macromolecule complex (Brignone et al., 2011), and my results 
suggest a functional coupling between Kir4.1 and Na/K-ATPase, the latter 
being increased in the brain and optic nerve of the Kir4.1 knock out mice. I 
also identified a significant rise in the quantity of the mitochondrial fraction 
in the brain of the Kir4.1 knock out mice, which is likely to be coupled to 
the increased Na/K ATPase activity. Studies on retinal Müller glia have 
shown that under ischemia induced low ATP levels, the ATP sensitive 
KATP channels take over the roles of the Kir4.1 subunit (Skatchkov et al., 
2001, Skatchkov et al., 2002). In agreement with these findings, my results 
demonstrate a significant increase in the Kir6.1 protein level in the brain of 
the Kir4.1 knock out mice. Moreover, on the cellular level, I found a 
significant increase in the expression of Kir6.1 subunit in the mitochondria 
of Kir4.1 knock out cells. These hypoxia and ischemia activated KATP 
channels provide protection to cells against ischemia or hypoxia induces 
injuries (Ardehali, 2005, Choma et al., 2009). During ischemia and hypoxia 
the low intracellular oxygen levels decrease the rate of metabolism by 
slowing the Szent-Györgyi–Krebs cycle in the mitochondria. Unable to 
transfer electrons efficiently, the intracellular NAD+/NADH ratio decreases, 
activating the phosphotidylinositol-3-kinase and MAPK kinase/ERK 
dependent pathways that upregulate the transcription of the c-jun that is 
able to bind to the sur2 promoter and directly activate the transcription of 
the SUR2 gene (Crawford et al., 2003). Therefore, the low ATP level due 
to the increased Na/K ATPase activity found in the brain and optic nerve of 
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the Kir4.1 knock out mice might activate the KATP channels via these 
pathways. However, due to involvement of the Kir4.1/Kir5.1 channel in the 
sensation of the CO2 changes and oxidative stress, the loss of Kir4.1 
might also directly activate the KATP channels via these pathways (Jin et 
al., 2012, Wenker et al., 2010). To test whether the loss of the 
Kir4.1/Kir5.1 channels or the increased activity of the Na/K ATPase is 
responsible for the activation of the KATP channels in the brain of the Kir4.1 
knockout mice, I would compare the protein levels and the phosphorylation 
state of the members of the PI-3 kinase and MAPK kinase/ERK signalling 
pathways in the wild type, Kir4.1 KO and Kir5.1 KO mice. Furthermore, I 
would measure the effects of the long term ouabain treatment (Na/K 
ATPase blocker) on the KATP currents and expression of the KATP channel 
subunits.  
 
These results become especially relevant in conditions such as 
Amyotrophic lateral sclerosis, multiple sclerosis, hippocampal sclerosis 
with mesial temporal lobe epilepsy and spinal cord injury, all of which are 
associated with a progressive loss of Kir4.1 (Heuser et al., 2012, Kaiser et 
al., 2006, Min et al., 2012, Srivastava et al., 2012). In addition, conditions 
such as proliferative gliosis, proliferative vitreoretinapathy, malignant 
astrocytomas, transient focal brain ischemia and traumatic brain injury are 
all associated with the loss Kir4.1 current due to the mislocalisation of the 
Kir4.1 subunits (Bringmann et al., 1999, Olsen and Sontheimer, 2004, 
Steiner et al., 2012, Stewart et al., 2010, Ulbricht et al., 2008). In these 
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conditions, due to the loss of the Kir4.1 channel activity, the process of K+ 
buffering, glutamate uptake and water homeostasis are each impaired in 
the affected brain or spinal cord areas (Bataveljić et al., 2012, Haj-Yasein 
et al., 2011, Olsen et al., 2010, Steiner et al., 2012). My results indicate 
that Na/K ATPase and Kir6.1 subunits may compensate for the loss Kir4.1 
subunit, and therefore treatment with KATP channel openers and/or luteolin, 
which have been shown to be neuroprotective (Fang et al., 2010, Ran and 
Wang, 2011), could have therapeutic effects in traumatic spinal cord and 
brain injuries, transient focal brain ischemia, amyotrophic lateral sclerosis 
and hippocampal sclerosis with mesial temporal lobe epilepsy.  
 
6.7 Summary and Conclusions 
In summary, my studies describe the molecular composition of Kir 
subunits in optic nerve astrocytes and oligodendrocytes. The membranes 
of mature glia are characterised by prominent homomeric Kir4.1 channels 
and heteromeric Kir4.1/Kir5.1 channels. Homomeric Kir4.1 channels have 
a proven role in being the main current in glial cells and setting the 
strongly negative RMP. A key finding is that my results indicate that the 
loss of function in the absence of Kir4.1 is due at least in part to the 
mislocalisation of Kir5.1 channels, which normally form strongly rectifying 
and highly pH-sensitive K+ channels in astrocytes and oligodendrocytes. 
The physiological importance of heteromeric Kir4.1/Kir5.1 channels in 
optic nerve glia remains to be resolved, but their pH and CO2 sensitivity 
indicates they may be involved in maintining metabolic balance in the optic 
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nerve. It is significant, therefore, that the loss of Kir4.1/Kir5.1 channels in 
the Kir4.1 KO mouse was accompanied by an increase in mitochondria, 
prohibitin1 and mitoKATP, all of which are indicative of metabolic stress, 
and provide resistance to ischemia. I also showed a compensatory 
upregulation of Na/K-ATPase, which is important for maintaining K+ 
regulation in the absence of Kir4.1. Finally, optic nerve glia also expressed 
Kir2.1 subunits, that appeared to almost exclusively form heteromeric 
Kir5.1/Kir2.1 and Kir4.1/Kir2.1 channels, which are respectively 
functionally silent and strongly rectifying, suggesting a potential 
mechanism by which the direction of movement of K+ across the glial cell 
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